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1. INTRODUCTION 
1.1 Epstein-Barr virus – discovery and basic principles 
Epstein-Barr virus (EBV), also called human herpesvirus 4 (HHV 4), belongs to the family of 
γ-herpesviruses. EBV infects very efficiently human B cells due to the strong interaction of 
the viral glycoprotein gp350/220 with the complement receptor CD21, which is presented on 
the surface of B cells and certain epithelial cells (Nemerow et al., 1987).  
EBV’s discovery is closely related to an important characteristic of the virus: the association 
with different human tumors and lymphomas. In 1958, Denis Burkitt investigated a malignant 
tumor of children in equatorial Africa (Burkitt, 1958), which became to be known as Burkitt’s 
lymphoma (BL). Because of the conspicuous coincidence of this tumor disease with the 
distribution area of malaria, he assumed the connection of an infectious agent spread by 
arthropods to this disease (Burkitt, 1962). In 1964, the virologist Anthony Epstein and his 
student Yvonne Barr as well as R. J. Pulvertaft were able to cultivate a B cell line out of those 
tumor samples (Epstein et al., 1964; Pulvertaft, 1964). Epstein was capable to prove the 
existence of herpesvirus-like particles in those cells by electron microscopy (Epstein et al., 
1964). The classification of EBV as a new virus strain succeeded in 1966 by the work of 
Gertrud and Werner Henle (Henle et al., 1966), who named the new virus after its discoverers 
Epstein and Barr. Further serological assays identified EBV as etiological agent of infectious 
mononucleosis and as a common feature of another malignancy, i.e. NPC*(Henle et al., 1968; 
zur Hausen et al., 1970). EBV is also associated with a number of other human tumors 
including B-cell malignancies such as Hodgkin’s disease (HD) and lymphoproliferative                                                         
* undifferentiated nasopharyngeal carcinoma 
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disease, some T-cell lymphomas, and epithelial tumors such as gastric carcinoma 
(summarized in Young et al., 2003). All the connections of EBV to human tumor 
malignancies led to the decision of the WHO* to classify EBV as a group I carcinogen in 
1997 (IARC, 1997).  
Another characteristic of EBV is its success in its host: More than 95% of all adults are 
seropositive for EBV and carry a lifelong infection. What makes this virus so effective? The 
key to EBV’s success in infecting and remaining in host cells is an identifying feature of γ-
herpesviruses: EBV establishes a strict latency upon infection of resting human B-
lymphocytes and induces the indefinite proliferation of infected cells. EBV subdivides its life 
cycle into a latent phase, where the virus expresses only a subset of its genes for the steady 
establishment of its DNA as an extrachromosomal episome in the nucleus of infected cells, 
and a second productive, lytic phase, during which progeny virus is produced ready for the 
infection of new host cells (Kieff et al., 2007; Rickinson et al., 2007). As a consequence, EBV 
can circumvent the host immune response during latency but still propagates and infects new 
cells after induction of the lytic phase.  
Certain genes expressed during early infection and mainly during latency are functional 
analogues of cellular genes, all of them are important for cellular transformation and genome 
maintenance. It is a principal viral strategy to mimic cellular processes, which contributes to 
the very successful and lifelong infection of human B-lymphocytes with EBV.  
1.1.1 EBV and cellular mimics 
EBV’s important characteristics are an effective infection of host cells, a lifelong maintenance 
in those cells, and a successful spreading of viral progeny to new target cells. These features 
include (i) the prevention of apoptosis and the downregulation of the immune system after 
infection, (ii) the growth transformation of infected cells, (iii) the gain of EBV genome 
stability in infected cells, and (iv) the possibility to switch to a productive infection, where 
newly synthesized virus ready for the infection of new B-lymphocytes is produced. EBV 
genes that are cellular mimics control theses concepts. This suggests the existence of cellular 
ancestors of EBV genes that the virus has acquired during co-evolution with its host.  
(i) Prevention of apoptosis and downregulation of the immune system early after infection 
Two important mechanisms of the immune system control viral infections at an early stage:                                                         
* World Health Organization 
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the induction of apoptosis and the establishment of a cytotoxic T cell response. Apoptosis is a 
direct host cell reaction to infections that actively kills the cell prior to viral maturation. EBV 
encodes two mimics of the cellular anti-apoptotic BCL-2* protein to intervene with this 
process. The very early expression of the BCL-2 homologs BALF1 and BHRF1 is a 
mechanism to immediately evade apoptosis early after infection and is mandatory to initiate 
and maintain latency (Altmann et al., 2005). A second anti-apoptotic effect is obtained by 
another adaption of cellular principles: the expression of viral miRNAs†. Recently it could be 
shown that EBV’s miRNAs from the BHRF1 locus inhibit apoptosis and favor cell cycle 
progression early after infection (Seto et al., 2010).  
A further mechanism to control viral infections is the activation of the host immune system to 
induce a cytotoxic T cell response. Infected cells degrade intracellular viral proteins 
proteolytically and present the viral peptides in association with the MHC‡ class I molecule 
on the surface of infected cells to CD8+ cytotoxic effector T-lymphocytes. EBV’s BCRF1 
locus encodes a viral homolog to the cytokine IL10§, which modulates and regulates the 
expression of the TAP transporter** (Zeidler et al., 1997). TAP proteins play an essential role 
in the transport of peptides derived from proteolytic degradation in the proteasome (Neefjes et 
al., 1993). The transport of loaded MHC class I molecules to the cell surface is impaired by 
downregulation of TAP proteins, evading the cytotoxic immune response of T cells that 
recognize viral antigenic epitopes. EBV has adopted a mechanism to escape the cytotoxic T 
cell response by mimicking the cellular cytokine IL10 (Zeidler et al., 1997).  
(ii) Growth transformation of the infected cells  
EBV has to drive resting B-cells into proliferation before it establishes stable latency. One 
important protein, which has transforming potential and is necessary for B cell 
immortalization is the EBV-encoded latent membrane protein 1 (LMP1). LMP1 is a signaling 
molecule, which has limited homology but shares high functional similarity with cellular 
CD40, which is a co-stimulatory protein found on antigen presenting cells and required for 
their activation. LMP1 mimics many, if not all, downstream signaling cascades of CD40, 
transforms infected B cells, and governs the process of immortalization. One important 
difference between the viral and the cellular signaling molecule is the mode of activation. 
                                                        
* B-cell lymphoma 2 
† microRNA 
‡ major histocompatibility complex 
§ interleukin 10 
** transporter associated with antigen presentation 
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CD40 needs the protein CD40L as a ligand for the induction of signaling, which is present on 
helper T cells, but LMP1 is constitutively active through oligomerization of its C-terminal* 
domain by clustering of the N-terminal† transmembrane domain (Gires et al., 1997; Dirmeier 
et al., 2003).  
A second signaling molecule, which EBV has adopted from human cells, is the latent 
membrane protein 2a (LMP2a). Like LMP1, LMP2a is constitutively active, which is again 
accomplished by clustering of its transmembrane domain. The cytoplasmatic tail of LMP2a 
resembles the signaling domains of the B cell receptor (BCR). Somatic hypermutation takes 
place during the germinal center reaction. Mutations are randomly inserted into the 
immunoglobulin genes. These mutations can lead to cells expressing BCRs with higher 
affinity. However, most of the inserted mutations result in cells with no or nonsense BCRs. 
These cells are usually negatively selected and undergo apoptosis. In order to growth 
transform and activate these proapoptotic B cells, EBV has to provide this missing signal in 
BCR-negative B cells. This is realized by the expression of LMP2a in latently infected cells 
(Mancao et al., 2005; Mancao et al., 2007). Recently it was shown that the very early 
expression of BZLF1, a functional homolog of members of the AP-1‡ family of transcription 
factors, mimics the AP-1 function by the activation and G1-to-S transition of EBV infected 
cells during the early phase of infection (Kalla et al., 2010). As a consequence, BZLF1 
contributes to the activation and growth transformation of EBV infected B cells as well.  
(iii)  EBV’s genomic stability in infected cells 
EBV needs to ensure that its genome is efficiently and exactly copied in each round of mitosis 
to maintain genetic stability, once the cells are activated and proliferate. This is achieved by 
EBV’s origin of plasmid replication (oriP), which is a cis-acting element of the viral episome 
essential for DNA replication, nuclear retention, and viral gene regulation. The functions of 
oriP depend on EBNA1§, which is a mimic of cellular HMG1a**, a chromatin component 
(Yates et al., 1984; Marechal et al., 1999; Sears et al., 2004). HMG1a preferentially binds to 
the minor groove of AT tracks in the DNA sequence and induces conformational changes. 
Recently it was shown, that HMG1a recruits the origin recognition complex (ORC) to 
artificial origins of replication, demonstrating its essential role in the local formation of a 
                                                        
* carboxy-terminal 
† amino-terminal 
‡ activator protein 1 
§ EBV-encoded nuclear antigen 1 
** high mobility group protein 1a  
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prereplication complex (Thomae et al., 2008). Like HMG1a, EBNA1 is able to target ORC to 
oriP and is thus essential for the maintenance of the EBV episome in latently infected B cells 
(Schepers et al., 2001).  
(iv) Induction of the lytic phase 
EBV is compelled to possibly switch to the productive, lytic phase of infection in order to 
allow the horizontal spread of EBV from cell to cell or from individual to individual. The 
production of progeny virus allows increasing the pool of latently infected B cells, but also 
enables the infection of formerly EBV-negative people. The lytic switch is controlled by the 
AP-1 like transcription factor BZLF1, which has the extraordinary function to sequence-
specifically bind to and activate promoters of essential lytic EBV genes, even when they carry 
methylated CpG dinucleotides (Bhende et al., 2004; Bergbauer et al., 2010). The cognate 
sequences are termed “meZREs” (methylated BZLF1-responsive elements) and can be found 
predominantly in promoters of early lytic viral genes. With this unique protein, EBV has 
developed a clever mechanism to escape latency, once BZLF1 is expressed (Kalla et al., 
2010).  
In summary, EBV has evolved to adopt many cellular mechanisms for the infection, 
activation, and maintenance of its DNA in host cells, using cytokines, signaling molecules, 
anti-apoptotic proteins, and miRNAs. In my work I wanted to concentrate on yet another host 
cell mechanism, which EBV uses to regulate its gene expression. I already embraced the 
importance of CpG-methylation for the induction of the lytic phase of EBV. I aimed to further 
understand how epigenetic mechanisms influence the regulation of viral gene expression. 
Epigenetics is a growing field and technical progress facilitated many new insights recently. 
Key principles of epigenetic gene regulation are introduced in the next chapter.  
1.2 Epigenetics 
In multicellular organisms, all cells originate from the same pluripotent stem cell. Although 
they carry the same genetic information, their gene expression profile changes dramatically 
depending on cell type, cell function, environmental influences, or growth phase. One 
principle question in biology is therefore: “How do we get from one genotype to more than 
200 phenotypes?”  
Conrad Hal Waddington, a developmental biologist, proposed in 1957 the concept of the 
epigenetic landscape. This is a metaphor for the process of cellular decision-making during 
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development (illustrated in Fig. 1.1). In this 
image, the cell is represented as a marble, 
which is rolling down a hill. On the way 
down, the marble can take specific 
trajectories and consequently ends in 
different grooves at the foot of the hill. 
Conrad Waddington imagined the 
development of differentiated cells to be 
equal. Specific decisions in the 
developmental process would lead to 
different cell fates (Waddington, 1957; 
reviewed in Goldberg et al., 2007). By 
coining the subject of epigenetics, 
Waddington started to link developmental biology to the discipline of genetics, but without 
giving an explicit molecular definition of the principle of epigenetic changes. Several decades 
later, specific mechanisms were proposed, which suggested that information is superimposed 
on DNA sequences (Holliday, 2006). Today the word epigenetics is used to describe the study 
of heritable changes in genome function that occur without a change in DNA sequence (The 
Epigenome Network of Excellence (NOE), 2004-2008). But what defines the nature of these 
DNA changes? 
The detection of the structural details of the DNA double helix is one of the landmark 
discoveries in biology (Watson et al., 1953) and was the basis for the understanding of how 
genetic information is stored and propagated to the next generation. The fact that DNA is not 
freely distributed but organized in chromosomes inside the cell already implies that genetic 
information is not only stored, but also controlled by the structural organization of the DNA 
molecule. The molecular actors participating in epigenetic regulation are covalent 
modifications of single nucleotides and histone tails, noncoding RNAs (ncRNAs), 
transcription factors, and DNA binding proteins. In contrast to changes of the DNA sequence, 
most chromatin states are remarkably reversible and transient and are altered during aging or 
in response to environmental factors like physical exercise and diet. An epigenetic mark does 
not stand on its own, the sum of modifications defines, whether a certain chromatin segment 
is “active” or “poised” to be active (euchromatin) or whether the chromatin is “silent” 
(heterochromatin). Euchromatin largely consists of coding sequences, which only accounts 
for a small fraction of a mammalian genome (Lander et al., 2001). Although not necessarily 
Fig. 1.1 Waddington’s epigenetic landscape 
The metaphor explains the development of a 
differentiated cell from a pluripotent stem cell. 
The cell is illustrated as a marble, which can take 
different ways on its way down the hill. The 
outcome or the cell fate is defined by the decision 
that is taken at each crossing point of the groove 
(Waddington, 1957). 
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active, euchromatin is in a decompacted or open configuration and therefore accessible for 
transcription factors or other DNA binding proteins. Heterochromatin reflects the major part 
of the mammalian genome and consists mainly of noncoding and repetitive sequences. In 
contrast to euchromatin, heterochromatin is tightly packed and condensed, making it 
inaccessible for enzymes like RNA polymerase II (RNA Pol II) or DNA-binding factors like 
transactivators.  
One can distinguish three different layers of epigenetic modifications: DNA methylation of 
CpG dinucleotides, the positioning of nucleosomes, and the influence of histone 
modifications. These layers are exemplified in Fig. 1.2 (Jones et al., 2008) and will be 
discussed in detail in the following sections.  
 
1.2.1 DNA methylation  
Site-specific DNA methylation is an epigenetic mark found in organisms across all domains 
of life. In higher eukaryotes, DNA is frequently methylated at the C5 position of cytosines in 
a cytosine-guanine (CpG) dinucleotide. The methyl-group of 5-methylcytosine (5mC) is 
located in the major groove of the DNA, where it does not interfere with the Watson/Crick 
base pairing capacity of nucleotides (reviewed in Hermann et al., 2004a). 
Fig. 1.2 Levels of epigenetic regulation 
DNA methylation of CpG dinucleotides is the first 
level of epigenetic regulation. The accessibility of 
DNA for transcription factors is further affected 
by the organization of DNA into open areas 
(euchromatin) ore more closed patches 
(heterochromatin), which is determined by the 
position of nucleosomes. Chromatin remodelers 
influence their positioning, therefore affecting 
transcriptional regulation. Histone modifying 
enzymes provide a further stage of organization 
into active and silent chromatin by setting 
activating or repressing marks on the tails of 
histone proteins (Jones et al., 2008). 
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DNA methylation is usually linked to gene repression, which can be interpreted by different 
means. An obvious explanation is that DNA methylation interferes with the basal binding of 
the transcription machinery to DNA. Several transcription factor binding sites contain 
CpG dinucleotides in their cognate sequence. Binding to the cognate sequence is impaired by 
methylation of the cytosine (Watt et al., 1988). A second way of repression is the attraction of 
methyl-CpG-binding proteins (MBPs). This protein family comprises MeCP2, MBD1, 
MBD2, MBD3, and MBD4. MeCP2 is the founding member and contains a methyl-CpG-
binding domain (MBD) and a transcriptional repression domain (TRD). It is capable of 
binding to a single, symmetrically methylated CpG dinucleotide. Silencing of transcription 
can occur over a distance of several hundred base pairs by the establishment of a repressive 
chromatin environment with the help of the TRD (Bird et al., 1999). Interestingly, the target 
sites of different MBPs are largely non-overlapping and seem to have sequence specificity. 
For example, MeCP2 prefers CpG sites, which are flanked by AT-rich regions (Klose et al., 
2005).  
Functions of DNA methylation 
The majority of 5mCs is found in repetitive DNA elements, suggesting that cytosine 
methylation has evolved as a defense mechanism against transposons and parasitic elements. 
Transposons represent at least 35% of the genome and can be held inactive through 
methylation of their promoter sequences. Over time, C to T transition mutations through 
hydrolytic desamination at 5mCs destroys many of the intragenomic parasites (Yoder et al., 
1997). Beyond that, methylation is also necessary for the monoallelic expression of imprinted 
genes, which are normally expressed from only one of the two alleles according to the sex of 
the parent that contributed that allele. Failures in imprinting at specific loci are responsible for 
certain human disorders (reviewed in Paulsen et al., 2001). Also X-chromosome inactivation, 
the process by which one of the two X-chromosomes of females is downregulated by means 
of dosage compensation, depends on CpG-methylation (Panning et al., 1996). 
DNA from mammalian somatic tissues is heavily methylated: More than 70% of all CpG sites 
carry 5mCs. Most sequences are methylated according to their frequency of 
CpG dinucleotides, like the repetitive regions mentioned above. CpG islands are an exception 
from this rule. CpG islands are commonly located in promoter regions of genes, GC rich (> 
55% GC content), and about 0.4 - 3kb in length. They are associated with both tissue-specific 
and housekeeping genes and they are unmethylated or lightly and variably methylated in all 
tissues. The fact that they are unmethylated in tissues with active and inactive gene expression 
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leads to the assumption, that their activity is not only controlled by methylation (Goll et al., 
2005). But methylated CpG islands are strongly and heritably repressed. 
DNA methylation patterns are highly deregulated in cancer; failures in the repression of 
oncogenes through demethylation or the inactivation of tumor suppressors through promoter 
methylation can contribute to tumorigenesis. 
DNA methyltransferases implement DNA methylation  
Enzymes catalyzing the addition of a methyl-group to the cytosine molecule are termed DNA 
methyltransferases (DNMTs). So far, four members of DNMTs have been identified in 
mammals: DNMT1, DNMT2, DNMT3a, and DNMT3b. Additionally, DNMT3L has been 
characterized as a stimulator for DNMT3a/b.  
DNMT1 is called the maintenance DNMT, because it copies the methylation signature of the 
parental cell DNA to the daughter cell DNA in each round of replication. This is achieved by 
DNMT1’s preference for hemimethylated DNA (Hermann et al., 2004b). The N-terminal 
regulatory domain of DNMT1 contains a PCNA binding domain, which can interact with 
PCNA*, the processivity factor for the DNA polymerase. The association of DNMT1 with the 
replication machinery is proposed to be the mechanism to couple the maintenance of DNA 
methylation to DNA replication (Leonhardt et al., 1992; Chuang et al., 1997). The estimated 
kinetics of DNA methylation by DNMT1, which is approximately 3-4 times slower than the 
progression of DNA replication, argued against a stable interaction of DNMT1 with PCNA 
(Maga et al., 2003). Later it was shown that the interaction of both proteins is transient and 
highly dynamic (Schermelleh et al., 2007). 
DNMT2 is the most widely conserved methyltransferase, with homologues in protists, plants, 
fungi, and animals. Its function is still enigmatic and controversially discussed. The catalytic 
domain of the protein clearly predicts its function as a DNA methyltransferase, the structure 
undoubtedly resembles the bacterial DNA methyltransferase M.HhaI† (Dong et al., 2001), and 
also the DNA binding capacity of the protein was proven. Various studies could show that 
DNMT2 possesses DNA methyltransferase activity, although this activity is very weak 
(reviewed in Jeltsch et al., 2006). DNMT2 is also present in organisms that do not possess any 
sign for DNA methylation at all (Gutierrez et al., 2004). This suggests that DNMT2 has 
additional functions not related to DNA methylation. A study in 2006 supported this 
                                                        
* proliferating cell nuclear antigen 
† DNA cytosine C5 methyltransferase from Haemophilus hemolyticus 
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hypothesis: DNMT2 was found to have a prominent tRNA* methyltransferase activity (Goll et 
al., 2006). DNMT2 is not a canonical RNA methyltransferase, because it does not share any 
significant sequence similarity with known RNA methyltransferases. Merely, DNMT2 
utilizes a DNA methyltransferase mechanism for the methylation of tRNA, which suggests 
that the enzyme belongs to the DNMT family, but might have changed its substrate during 
evolution (Jeltsch et al., 2006).  
DNMT3a and DNMT3b are both considered as de novo methyltransferases. Unlike DNMT1, 
they do not differentiate between unmethylated and hemimethylated substrates (Okano et al., 
1998; Gowher et al., 2001). Disruption of both genes in mouse ES cells† is lethal, which 
confirms their importance during development (Okano et al., 1999). Both proteins partially 
substitute for each other, as the individual knockouts of the genes have less severe phenotypes 
than the double knockout. However, they have distinct biological roles. While DNMT3b is 
responsible for methylation of pericentromeric satellite regions (Okano et al., 1999), 
DNMT3a appears to be important for the methylation of single copy genes, retrotransposons 
(Bestor et al., 2004), and for the establishment of genomic imprinting during germ cell 
development (Kaneda et al., 2004). Mutations in DNMT3b are responsible for the ICF 
syndrome‡ in humans. Lymphoblastoid cell DNA from ICF patients shows reduced genomic 
methylation, specifically in repetitive DNA sequences associated with pericentromeric 
chromosome regions (Hansen et al., 1999; Ehrlich, 2003).  
Latest discoveries in DNA methylation research 
Although CpGs appear to be the main targets for methylation in differentiated cells, a recent 
study identified exceptions to this principle. Non-CpG-methylation was identified as a 
common feature of ES cells in a genome-wide screen. Nearly 25% of DNA methylation in 
pluripotent cells was in a non-CpG context, which disappeared after induction of 
differentiation. Non-CpG-methylation is probably maintained by continual de novo 
methyltransferase activity. This could be a key principal for the maintenance of cellular 
pluripotency (Lister et al., 2009).  
Recent studies start to deny 5mC to be the exclusive covalent change of DNA with an 
epigenetic impact. In 2009, two studies reported the occurrence of 5-hydroxymethylcytosine 
(hmC) as the “6th base” in DNA in ES cells and in neuronal cells (Kriaucionis et al., 2009;                                                         
* transfer RNA 
† embryonic stem cells 
‡ immunodeficiency, centromeric instability, and facial abnormalities 
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Tahiliani et al., 2009). It was shown that proteins of the TET* family are able to catalyze the 
conversion of 5mC to hmC. In mouse ES cells it was demonstrated that a knockdown of TET1 
leads to downregulation and promoter methylation of the protein NANOG, which is a protein 
important for ES cell self-renewability and maintenance. These results implicate a role for 
hmC in the regulation of the DNA methylation status. It is possible that the conversion of 
5mC to hmC is the first step of a locus-specific demethylation process, but the search for an 
enzyme that further processes hmC into an unmethylated cytosine is still ongoing (Ito et al., 
2010). Current research focuses on finding methods to distinguish between 5mC and hmC. 
First results on the distribution of the 6th base in a genome-wide manner have already been 
published (Song et al., 2010).  
1.2.2 Nucleosomes: More than just beads on a string 
According to textbook knowledge, packaging of DNA into higher order structures is 
necessary to achieve high compaction of DNA in the nucleus. But already in the 1980s the 
idea arose that chromatin could be inhibitory to the binding of proteins, for example 
transcription factors, which are needed to synthesize mRNA in the cell. It seemed likely that 
nucleosomes were important for a stable gene expression profile of a cell, despite of 
providing the DNA with structural stability and compactness. 
Nucleosomes are the primary repeating unit of chromatin. They usually consist of a core of 
histone proteins with two copies each of the canonical histones H2A, H2B, H3, and H4. They 
are wrapped nearly twice by 147bp of DNA and separated by a linker region, which is usually 
staffed with histone H1 (Kornberg, 1974; Luger et al., 1997). The synthesis of the canonical 
histone proteins is tightly coupled to the S-phase of the cell cycle to assure efficient 
packaging of DNA into nucleosomes during replication. The fact that histone genes are 
encoded in clusters and in multiple copies is very likely a way to ensure the expression of 
proper amounts of histones in the cell during replication (Marzluff et al., 2002). Histone 
chaperons are responsible for the replication-coupled positioning of histones. CAF-1† for 
example is a histone chaperone that facilitates the incorporation of histone H3-H4 dimers into 
the DNA, which is the first step of nucleosome assembly. CAF-1 can interact with PCNA 
similar to the maintenance methyltransferase DNMT1, which implies a link between 
nucleosome assembly and the progression of DNA replication (Loyola et al., 2004). 
Nucleosomes can encompass several histone variants, which alter the chromatin structure and                                                         
* ten-eleven translocation protein 
† chromatin assembly factor 1 
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function. For example, CENP-A* is a variant histone that is necessary for centromer 
formation, while histone H3.3 specifies active chromatin. Histone variants are usually 
deposited in a replication-independent manner, which involves the local eviction of a 
nucleosome and the replacement with a variant protein (Marzluff et al., 2002).  
Principles of nucleosomal positioning: Insights from genome-wide studies 
Genome-wide mapping of nucleosomes in different organisms from yeast, fly, worm and 
humans start to uncover the principle behind the positioning of nucleosomes (Yuan et al., 
2005; Barski et al., 2007; Mavrich et al., 2008; Shivaswamy et al., 2008; Valouev et al., 2008; 
Lantermann et al., 2010). The most apparent outcome of these studies is the difference in the 
nucleosome density between regulatory regions and transcribed genes. In the model organism 
Saccharomyces cerevisiae (S. cerevisiae), 90% of all promoters contain stretches of DNA 
with very low nucleosome occupancy, and most of them own a nucleosome-depleted region 
(NDR) at the transcriptional start side (TSS). Downstream of the TSS, DNA is usually 
occupied by well-phased nucleosomes. The so-called “+1-nucleosome” next to the TSS is 
very accurately positioned. Further upstream and downstream, nucleosomes gradually loose 
their phasing; an exact position is difficult to assess (Yuan et al., 2005). The stereotypical 
pattern of nucleosomes in promoter regions is more or less conserved throughout eukaryotic 
genomes. This observation caused the question of how nucleosomes become positioned and 
whether the mechanism of positioning is conserved throughout the species as well. In S. 
cerevisiae, the contribution of the DNA sequence alone seems to have a very high influence 
on the positioning of nucleosomes (Kaplan et al., 2009): Nucleosomes intrinsically oppose 
poly-AT tracks. But already the nucleosome occupancy map of S. cervisiae’s close relative 
Shizosaccharomyces pombe (S. pombe) revealed positioning mechanisms distinct from those 
of S. cerevisiae. Proteins like nucleosome remodelers, histone variants, and NDR boundary 
elements appeared to have a higher impact on the position of nucleosomes. In multicellular 
eukaryotes, the mechanisms must be even more difficult, as the nucleosome coverage at 
certain promoters can be cell type specific.  
The concepts mentioned above commonly apply for constitutively active promoters, which 
usually encode for housekeeping genes. The analysis of nucleosome occupancies at inducible 
promoters, which are regulated depending on certain environmental influences, provides 
insights into mechanisms of gene regulation by nucleosome positioning. 
                                                        
* centromer protein A 
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Effects of nucleosome positions on the activation state of inducible promoters 
The analysis of different nucleosome configurations on inducible promoters helps to 
understand the effect of nucleosome positioning on gene expression. The most well known 
example of the impact of nucleosomes on an inducible promoter is probably the phosphate-
regulated PHO5* promoter of S. cerevisiae, which becomes activated upon phosphate 
starvation and results in a 50-fold increased production of secreted acid phosphatase. In the 
repressed state, the promoter is assembled into an array of well-positioned nucleosomes, 
disrupted by a NDR of 80bp in length. The NDR contains one of the two binding sites for the 
transcription factor PHO4. Upon activation, nucleosomes -1 to -4 disassemble from the 
promoter, mediated by the ATP-dependent histone chaperone ASF1†. As a consequence, the 
promoter exposes an additional binding site for PHO4 and allows the transcription machinery 
to access the TATA box. Interestingly, a failure of nucleosome reassembly at the PHO5 
promoter after the addition of phosphate results in a persisting expression of the gene, 
although PHO4 disappears from its corresponding binding sites. This indicates that the 
nucleosome positions are solely responsible for the repression of the promoter (Svaren et al., 
1997; Adkins et al., 2004).  
Another example is the GAL1-10 promoter‡ of S. cerevisiae. Four binding sites of the 
activator GAL4 are covered by a complex of the nucleosome-remodeling enzyme RSC§ and 
an unstable nucleosome, which allows efficient binding of GAL4. This complex is flanked by 
an array of nucleosomes on each site, which is rapidly removed upon activation. But unlike 
the PHO5 promoter, nucleosomes are not the only determinants of the expression state of the 
genes because the promoter is silent even in the absence of nucleosomes (Bryant et al., 2008; 
Floer et al., 2010).  
There are certain other promoters of S. cerevisiae, which are known to behave similarly to the 
promoters described above (Bai et al., 2010). Equally well-studied examples of promoters of 
higher eukaryotes are rare. Nevertheless, research on human T cells during the G0 to G1 
transition provides hints that signatures of active chromatin, including a relatively low 
abundance of nucleosomes in the TSS, are already set prior to induction of these genes (Smith 
et al., 2009). A further study on the transcriptional induction of mammalian primary response 
genes by Toll-like receptors in macrophages provides new insights into distinct modes of 
regulation in different types of inducible promoters. This study identified two major                                                         
* phosphate metabolism gene 5 
† anti-silencing function 
‡ galactose metabolism genes 1-10 
§ remodels the structure of chromatin 
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functional classes of primary response genes: Class I is characterized by the abundance of 
CpG islands in the promoter region, which facilitates promiscuous induction from 
constitutively active chromatin without the requirement for SWI/SNF* nucleosome 
remodeling complexes. The high CpG content appeared to be responsible for the promoter to 
assemble into unstable nucleosomes, which might lead to the independence from nucleosome 
remodelers for the induction of genes. The second identified class of promoters does not 
contain CpG islands and assembles into stable nucleosomes. This class of promoters strictly 
depends on the remodeling of nucleosomes by SWI/SNF complexes prior to transcription and 
has therefore the capacity of being tightly regulated (Ramirez-Carrozzi et al., 2006; Ramirez-
Carrozzi et al., 2009). The authors hypothesize that cells could benefit from CpG island 
promoters because of the possibilities for constitutive expression and rapid induction without 
the requirement for energy consuming remodelers. This parallels the fact that many of these 
promoters are activated by common transcription factors like NF-κB† and MAP kinases‡, 
which are targeted by a large number of growth factors. In contrast to this, promoters, which 
are assembled into stable nucleosomes, are often activated by transcription factors with highly 
specialized function. A stable repressed chromatin configuration of the promoters could have 
the benefit of minimizing basal transcription that would be harmful to the cell.  
An example for a human inducible promoter is the IFN-β§ locus, which is activated in 
response to virus infection for example. Activation requires the assembly of an 
“enhancosome”, a protein complex that recruits chromatin remodelers and modifiers. Upon 
recruitment, one nucleosome slides in dependency on a remodeling complex, opening the 
promoter for the binding of the general transcription machinery to the TATA box (Agalioti et 
al., 2000; Lomvardas et al., 2002).  
Chromatin remodelers can jostle nucleosomes 
Nucleosome positions change depending on the activation state of the gene, particularly in 
inducible promoters. Efficient and specific modification of nucleosome positions requires the 
help of chromatin remodelers. Chromatin remodelers are enzymes, which use energy from 
ATP hydrolysis for the repositioning, reconfiguration, or eviction of nucleosomes. Chromatin 
remodelers create a chromatin architecture that either allows or represses the binding of 
transcription factors and RNA Pol II to target sites in the promoter (reviewed in Saha et al.,                                                         
* switch/sucrose nonfermentable 
† nuclear factor 'kappa-light-chain-enhancer' of activated B-cells 
‡ mitogen-activated protein 
§ interferon beta 
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2005). Eukaryotes contain at least five families of chromatin remodelers (SWI/SNF*, ISWI†, 
NURD/Mi-2/CHD‡, INO80§, and SWR1**), which fulfill distinct roles in the establishment of 
a given chromatin environment. The two best-studied families are the SWI/SNF and the ISWI 
family of chromatin remodelers.  
SWI/SNF remodelers contain a conserved ATPase subunit and a set of five additional core 
proteins (Vignali et al., 2000). They primarily disorganize nucleosomes by sliding and 
ejecting them from promoters and their presence is therefore often associated with gene 
activation. In conjunction with this feature, SWI/SNF complexes own domains that can 
recognize and bind to acetylated histone tails. This modification is linked to active gene 
expression (Martens et al., 2003).  
The ISWI family members of chromatin remodelers also share a conserved ATPase domain 
but have unique associated proteins depending on the function of the remodeling complex. 
Their purpose is mainly to organize nucleosomes into uniformly spaced arrays by evaluating 
the length of the linker region between two nucleosomes and sliding them until a certain 
distance is achieved. As a consequence, they generally contribute to gene repression (Langst 
et al., 2001). ISWI complexes contain two specialized domains in their C-terminus: The 
SANT†† domain recognizes histone tails, which lack activation marks like acetylation and 
guides the remodeling complex to genes that are prone to be repressed. The SLIDE‡‡ domain 
assists to determine the length of the linker region for the estimation of the distance the 
nucleosome has to slide (Grune et al., 2003).  
Both families share mechanistic features: They (i) bind to the nucleosome at a defined 
position close to the dyad, (ii) induce ATP-dependent conformational changes and break 
proximal histone-DNA contacts to create a DNA wave on the octamer surface, (iii) move the 
DNA wave in a directed manner along the histone core, and (iv) propagate the DNA wave 
around the nucleosome by one-dimensional diffusion (Saha et al., 2005).  
 
                                                        
* switch/sucrose nonfermentable 
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‡ nucleosome remodeling factor/ chromodomain helicase DNA-binding 
§ inositol 80 
** sick with rat8 ts 
†† switching-defective protein 3 (Swi3), adaptor 2 (Ada2), nuclear receptor co-repressor (N-CoR), transcription 
factor (TF)IIIB 
‡‡ SANT-like ISWI (imitation switch) domain 
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1.2.3 Histone modifications 
Not only histone proteins influence the strength of DNA binding to the histone octamer, but 
also modifications, which can be introduced to their N-terminal tails. Unlike the major part of 
the histone, which is globular in structure, the histone tails are unstructured, very flexible, and 
poke out of the very compact base of the nucleosome. This feature makes them highly 
accessible for histone-modifying enzymes, which can dynamically and rapidly establish a 
huge variety of modifications to the tails and consequently influence and manipulate different 
chromatin functions like transcription, DNA repair, DNA replication, and chromosome 
condensation. The character of modifications is very diverse and include the addition of a 
small chemical compound (acetylation, phosphorylation, or methylation of certain amino acid 
residues) or the incorporation of large and bulky peptides (ubiquitination, sumoylation, and 
ADP-ribosylation). There are four core histone proteins, at least eight modes of modifications, 
the possibility to modify different amino acids in the histone tail, some of which can be 
singly, doubly, or triply modified. Together the mode of different modifications is very high 
and reflects possible chromatin states. Nevertheless, the use of modification-specific 
antibodies in Chromatin Immunoprecipitation (ChIP) assays makes it possible to identify 
many different modifications and link them to different functions.  
Histone modifications and their mode of action 
Histone tails can be modified by (i) acetylation, (ii) phosphorylation, (iii) methylation, and 
(iv) the addition of bulky products. The modifications are specified by the histone protein that 
is targeted, e.g. histone “H3”, the amino acid residue that acquires the modification, e.g. “K4” 
for lysine four, and the mode and multiplicity of the modification, e.g. “me3” for 
trimethylation. The correct description of trimethylation at histone H3 and lysine 4 is thus 
H3K4me3. Modifications have diverse functions in the regulation of cellular pathways like 
DNA damage repair, cell cycle control, or replication. The focus of this overview will be on 
transcriptional regulation.  
(i) Acetylation of lysine residues in histone tails commonly correlates with active 
transcription. Acetylation neutralizes the positively charged lysine and eases the strong 
binding of the basic histone proteins to DNA. The acetylation reaction is carried out by 
histone acetyltransferases (HATs) but can be reverted by the action of histone deacetylases 
(HDACs). Many coactivators and corepressors possess either HAT or HDAC activity. For 
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example, the yeast SAGA complex* comprises HAT activity and assembles TATA-box 
binding protein (TBP) associated factors. Thereby the protein directly links histone 
acetylation to transcriptional initiation (Grant et al., 1998). A special protein domain, called 
bromodomain, can recognize acetylated histones. Bromodomains are found in many 
transcriptional coactivators but also in SWI/SNF chromatin remodeling complexes (Hassan et 
al., 2002).  
(ii) Phosphorylation of serine and threonine residues in histone tails is a modification that can 
influence the affinity of DNA and histones by introducing negative charges to the histone tail. 
The modification correlates with chromosome condensation during mitosis and meiosis (Xu 
et al., 2009). It is also present on promoters, where it can modulate and promote other 
modifications. For example, phosphorylation of histone H3T6 by PKC-β† in androgen-
receptor controlled gene activation leads to the prevention of the erase of methylation at 
histone H3K4 by the demethylase LSD1‡. Histone H3T6 phosphorylation contributes by this 
to keep the promoter active (Metzger et al., 2010). 
(iii) Methylation of histone tails is the most complex epigenetic mark, because it can occur on 
different lysine or arginine residues. It can have multiple methylated states on each residue 
and it includes activating and repressive functions. Methylation of lysines is set by histone 
lysine methyltransferases (HKMTs) and is erased by histone demethylases. Methylation at 
H3K4, H3K36, and H3K79 are implicated in transcriptional activation. Beyond that, H3K4 
and H3K36 are likewise involved in transcriptional elongation. Trimethylation of H3K4 
localizes at the 5’ end of active genes and is associated with the initiated form of RNA Pol II. 
H3K36me3 accumulates at the 3’ end of genes, and is found in association with the 
elongating form of RNA Pol II. One important function of H3K36me3 is the suppression of 
transcriptional initiation from cryptic start sites inside the gene body. This is supported by the 
observation that this modification represses transcription, if located in inducible promoters in 
their repressed state (Carrozza et al., 2005; Keogh et al., 2005). H3K79 methylation is mainly 
found in active promoters (Barski et al., 2007). It is an unusual modification, because it 
locates rather to the core of the nucleosome than in the tail. The addition of methyl-groups to 
this lysine residue leads to a reshaping of the nucleosomal surface near the C-terminus of 
histone H3, which probably effects chromatin structure and function (Lu et al., 2008). 
Methylation of H3K9, H3K27, and H4K20 is connected to transcriptional repression. H3K9                                                         
* spt-ada-gcn5-acetyltransferase complex 
† protein kinase C beta 
‡ lysine specific histone demethylase 1 
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methylation is involved in heterochromatin formation through the recruitment of HP1*. 
Special protein domains, called chromodomains, can read the modification, similar to 
bromodomains that recognize acetylated histone tails. HP1 encompasses a chromodomain and 
is therefore targeted to H3K9 methylated regions. H3K27 methylation is connected to three 
different functional states: It is found in silent euchromatic gene loci that are regulated by 
Polycomb proteins, in pericentromeric heterochromatin, and in the inactive X chromosome in 
mammals. H4K20 methylation is found in pericentromeric heterochromatin. Functionally, the 
monomethylated form of this modification is important for DNA repair via binding of the 
DNA checkpoint protein CrB2† in S. cerevisiae (Martin et al., 2005).  
Methylation of arginines is involved in both positive and negative regulation of transcription. 
For example, arginine methylation is important in the pS2 gene, which is a target of estrogen 
signaling. Stimulation leads to the recruitment of the estrogen receptor to the pS2 promoter, 
and it brings along the two methyltransferases CARM1‡ and PRMT1§, which methylate 
residues in the tails of histone H3 and histone H4. Concomitant to the occurrence of those 
histone marks, active RNA Pol II can be found on the promoter. Only minutes later, 
methylation and RNA Pol II disappear, but a new cycle of methylation and RNA Pol II 
recruitment can start right away. The flexibility and the dynamics of this process is probably 
the key to a rapid transcription shutoff, if needed (Metivier et al., 2003).  
(iv) The addition of bulky polypeptides like ubiquitin or SUMO** to histones is distinct from 
the modifications described above, because it increases the size of a histone by approximately 
two-thirds. Histone ubiquitination has been linked to transcriptional activation and repression, 
depending on the context, the multiplicity of addition, and the histone protein modified. An 
example of an activating function is the connection of histone H2B ubiquitination to histone 
H3K4 methylation, which is well studied in yeast. The ubiquitin ligase is recruited by 
polymerase associated factor I (PAFI) to sites of active transcription and elongation. The 
ubiquitination of histone H2B at lysine 123 leads to the subsequent recruitment of a histone 
methyltransferase, which trimethylates H3K4 (Wood et al., 2003). Whether these mechanisms 
are conserved in mammals is conversely discussed and still needs to be clarified (reviewed in 
Atanassov et al., 2010). 
This section is just a rough overview about the best-studied modifications of histone tails, but                                                         
* heterochromatin protein 1 
† crumbs homolog 2 
‡ coactivator-associated arginine methyltransferase 
§ protein arginine N-methyltransferase 1 
** small ubiquitin-like modifier 
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there are many more. In order to understand the contribution of modifications to 
transcriptional activation without getting lost in the different modifications and systems, it is 
useful to have a look at functional key mechanisms. 
Mechanisms and function of histone modifications 
There are two described mechanisms of how histone modifications can have an influence on 
chromatin function: The first includes the alteration of physical contacts between the histone 
proteins and the nucleosomal DNA, which leads to unraveling or wrapping of nucleosomes. 
For example, introducing a negatively charged adduct like an acetyl-group leads to a 
loosening of the DNA from the histone proteins due to the repulsion from the DNA backbone. 
This makes the DNA more accessible to transcription factors. The second mode of function is 
the recruitment of non-histone proteins that can then further affect the accessibility to DNA. 
For example, trimethylation of H3K4 can be recognized by a domain of the nucleosome-
remodeling factor (NURF), which belongs to the ISWI family of chromatin remodelers. The 
chromatin structure is opened locally, which improves the accessibility of the DNA to the 
transcription machinery (Wysocka et al., 2006). An example for gene repression by non-
histone proteins is the binding of HP1 to methylated H3K9. This protein is bound by 
SUV39H1*, an enzyme capable of catalyzing the methylation of H3K9, leading to a spread of 
this heterochromatin mark (Nakayama et al., 2001).  
The function of histone modifications can be divided into two categories: (i) the establishment 
of a global chromatin environment and (ii) the coordination of special DNA-based tasks. The 
first category mainly embraces the organization of genetic information into eu- and 
heterochromatin. While some modifications like methylation of H3K9 or H3K27 are 
necessary to keep the chromatin in a condensed and repressed state, others are responsible for 
maintaining the chromatin active or poised-to-be active. Mammals have evolved proteins to 
insulate active and inactive chromatin from each other: The protein CTCF† for example is a 
boundary element found on borders between eu- and heterochromatin, preventing 
heterochromatic marks from spreading to active regions (Bell et al., 1999). DNA-based tasks 
encompass the regulation of transcription, replication, DNA repair, and chromosome 
condensation. For example, regulation of transcription is affected by transcription factors that 
initiate a cascade of modification events, which results in the end in the activation or 
repression of a gene. Namely, H3K4me3 localizes at the 5’ end of active genes and is                                                         
* suppressor of variegation 3-9, homolog 1 
† CCCTC-binding factor 
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associated with the initiated form of RNA Pol II and is thereby related to active transcription.  
The association of certain modifications and functions suggested the existence of a histone 
code, comparable to the genetic code (Strahl et al., 2000). The simplest model would be a 
binary relationship between modification and function. But a single histone mark does not 
determine an outcome alone; it is the combination of modifications at a defined locus that 
dictates the effect on the chromatin state. A recent publication tried to find patterns of 
modifications linked to distinct functions. A dataset was analyzed that encompassed 38 
different histone modifications, histone variant H2AZ, RNA Pol II, and CTCF binding. The 
group identified 51 distinct chromatin states (Ernst et al., 2010). But still, these findings will 
rather be the start than the end of understanding the instructions encoded in the combination 
of epigenetic modifications. Schreiber and Bernstein suggested a more general model in order 
to account for all possible epigenetic states a cell can have: Histone modifications could serve 
as mediators for a nuclear, DNA-associated signal transduction pathway that is comparable 
with cytoplasmatic signaling pathways, which are mainly propagated through protein 
phosphorylation (Schreiber et al., 2002).  
1.2.4 The epigenetic memory 
The classic definition of epigenetics is the study of heritable phenotypes that do not involve 
changes in the DNA sequence. This concept is very important for maintaining cell fate and 
phenotype, as discussed previously. The recognition of hemimethylated DNA by DNMT1 and 
its association with PCNA is an efficient mechanism to maintain an epigenetic state over 
many generations. However, the heritability of histone modifications is discussed more 
controversially. For each histone-modifying enzyme another one was identified that can erase 
the modification. The use of the term “heritable” in the definition of epigenetics was therefore 
revisited. Epigenetics is now considered to cover a research field that encompasses generic 
information, which DNA does not encode. But epigenetics provide a non-genetic memory 
with modifications that are stably transmitted to daughter cells during mitosis and sometimes 
even during meiosis, thereby affecting the next generation (Silva et al., 1988). First evidence 
for a regulator responsible for the maintenance of a specific cell identity by histone 
modifications stems from work in drosophila: Pam and Ed Lewis discovered the protein 
Polycomb, which is responsible for maintaining the segment specific HOX* gene expression 
pattern throughout fly development (Lewis, 1978). Polycomb group (PcG) proteins are today 
defined as regulators that repress gene expression by keeping a transcriptionally inactive state,                                                         
* homeobox 
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which is mediated by H3K27 trimethylation. PcG proteins can be divided into two distinct 
complexes, Polycomb repressive complex 1 (PRC1) and PRC2. The common view is that 
PRC2 acts as the “writer” of the repressed state. It establishes H3K27 trimethylation with the 
histone methyltransferases EZH1 or EZH2*, which are part of the PRC2 complex. PRC1 is 
seen as the “reader” of the epigenetic state. It recognizes histone H3K27me3 with its 
chromodomain of CBX2, CBX4, or CBX8† and acts as a silencing complex by ubiquitination 
of histone H2A (Cao et al., 2005) or by chromatin compaction of defined nucleosome arrays 
(Francis et al., 2004). This model suggests that PRC1 acts downstream of PRC2. But this 
hierarchy does not necessarily apply for each and every locus. Although both PRCs share 
many binding sites in the chromatin, there are exceptions of this rule, suggesting that both 
complexes might also act independently of each other (Schoeftner et al., 2006; Ku et al., 
2008).  
The mechanism of maintaining the PcG-mediated repression during the cell cycle is discussed 
controversially. One theory suggests a replication-dependent inheritance of PRC2 repression, 
quite similar to maintenance of DNA methylation by DNMT1. The co-localization of PRC2 
with PCNA during S-phase and its ability to bind to its own target, i.e. H3K27me3, suggests a 
binding to the parental DNA strand and the spread of this mark to newly incorporated 
histones on the daughter strand (Hansen et al., 2008). However, a second theory rebuts that 
histone modifications themselves mediate epigenetic inheritance because they may rather be 
the consequence and not the cause of inherited information. Instead, a default silenced state of 
PcG target sequences, so-called Polycomb Responsive Elements (PREs), is proposed. An 
active state would be marked by ncRNAs‡ stemming from the PRE and could be propagated 
by specific chromatin-binding proteins or by H3.3 replacement (Ringrose et al., 2007).  
Not only H3K27me3 has an epigenetic memory, mechanisms to recall the epigenetic state 
after cell division are also known for other histone methylation marks. The counter players of 
PcG proteins are Trithorax proteins, which memorize an activated state through H3K4me3. 
And the heterochromatin mark H3K9me3 is maintained by the function of HP1. In general, 
there has to be a tight regulation of the epigenetic state of genes, balancing between an 
essential stability of the epigenetic state to maintain cell identity versus a required flexibility 
of the cell’s gene expression pattern for the ability to react to environmental changes.  
                                                        
* human enhancer of zeste 1/2 
† chromobox protein 2/4/8 
‡ non-coding RNA 
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1.3 Epigenetics in EBV 
The balance between epigenetic stability and flexibility is a conflict that has to be solved by 
EBV during its infectious cycle. On the one hand, latency guarantees a lifelong persistence in 
the host, but on the other hand, the lytic switch is mandatory to spread viral progeny to 
uninfected cells. Both aspects depend on different epigenetic states of the viral genome. It is 
therefore interesting to study epigenetics in EBV regarding the regulation of the viral life 
cycle.  
1.3.1 EBV’s life cycle  
According to our working model, EBV’s life cycle is comprised of three phases: the abortive 
lytic, the latent, and the lytic phase of infection (Fig. 1.3). During the abortive lytic phase, the 
viral genome is established as a plasmid-like minichromosome, a so-called episome, in the 
nucleus of infected cells. Characteristic for this phase is the W promoter (Wp)-inititated 
transcription of latent genes. But also a set of lytic genes and miRNAs can be identified. The 
gene products provide anti-apoptotic signals, pro-proliferative effects, or immune-inhibitory 
properties (Zeidler et al., 1997; Altmann et al., 2005; Wen et al., 2007; Katsumura et al., 
2009; Kalla et al., 2010; Seto et al., 2010). Importantly, the full set of early lytic genes, which 
are responsible for lytic DNA replication of the virus, and genes coding for EBV’s structural 
proteins are not expressed during the abortive lytic phase. As a consequence, viral progeny 
cannot be produced. The early expression of lytic genes is shut down eventually to establish a 
stable latent infection of the proliferating B cells. During latency, EBV’s episome behaves 
similarly to the host cell chromosomes: It replicates once per cell cycle and is propagated 
during mitosis to daughter cells (Adams, 1987; Kirchmaier et al., 1995). Latently infected B 
cells exhibit a restricted gene expression profile. At least three different latency gene 
expression profiles are known, i.e. latency I, latency II, and latency III. All latency profiles 
share the expression of EBNA1, but differ in the expression of the other EBNAs, the LMPs, 
and the EBERs. EBNA1 protein and the cis-element oriP are sufficient but indispensable for 
maintaining the viral episome in the B cell (Yates et al., 1984; Yates et al., 1985). The 
majority of EBV-infected B cells reside in the latent phase, which enables the virus to hide 
from the immune system of the host. Lymphoblastoid cell lines from in vitro-infected B cells 
usually hold the latency III expression profile. 
Eventually, the virus switches to the lytic phase of infection and progeny virus is released. 
Signaling cascades that are activated by the B cell receptor probably trigger expression of the 
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transcription factor BZLF1 (Campbell, 1999). Once BZLF1 is expressed, the activation of 
lytic genes is irreversible in latently infected cells: The transcription factor acts as molecular 
switch and induces the lytic phase in latently infected B cells. It activates the expression of 
the second EBV-encoded transcription factor BRLF1 but also stimulates its own promoter.  
 
Fig. 1.3 Three different phases comprise EBV’s life cycle in infected B cells in vitro  
The scheme shows our model of EBV’s life cycle in infected B cells in vitro. The abortive lytic phase is 
characterized by the expression of latent genes and certain late lytic genes. Expression of early lytic genes and 
EBV’s structural genes is blocked. During this phase, EBV’s genome is established as an episome in the nuclei 
of infected cells. The latent phase encompasses a restricted gene expression profile. Lymphoblastoid cell lines 
(LCLs) exhibit the latency III expression profile with the expression of all EBNAs, EBERs, LMPs and ncRNAs. 
BCR crosslink and expression of BZLF1 initiate the switch to the lytic phase, where early lytic genes that 
encode for the lytic replication machinery are expressed. EBV’s genome is massively amplified during lytic 
DNA replication. In a second step, structural proteins are made, the virus is packaged, and progeny is released, 
ready to start a new infectious cycle in uninfected B cells.  
 
The two transcription factors induce individually and synergistically the expression of a set of 
so-called early lytic genes (Countryman et al., 1987; Shimizu et al., 1989; Feederle et al., 
2000). Early lytic gene products code for the protein machinery that is necessary for lytic 
DNA replication of the EBV genome (Fixman et al., 1992, 1995). Lytic DNA replication 
takes place at discrete sites in so-called replication compartments in the nucleus of the 
infected cell and initiates at oriLyt (origin of lytic replication). Lytic replication leads to a 
100- to 1000-fold amplification of the EBV genome (Tsurumi et al., 2005). Subsequent to 
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DNA replication, the full set of lytic genes is expressed, including genes encoding structural 
proteins. Newly synthesized EBV DNA is packaged into capsids and progeny virus is 
released, ready for the spread to uninfected B cells. 
1.3.2 Important checkpoints of EBV’s life cycle rely on epigenetic 
mechanisms  
EBV’s genome acquires epigenetic modifications similar to the host cell DNA by the cellular 
epigenetic protein machinery (Shaw et al., 1979; Dyson et al., 1985). It is well established that 
EBV uses epigenetic mechanisms to regulate its growth program during early infection. 
Initially, B cells support early viral gene expression by the latent W promoter. Expressed 
genes code for EBV’s transforming genes, including EBNA1 and EBNA2 (Kieff et al., 2007). 
Later, EBNA1 protein induces the expression from the alternate EBNA promoter Cp, either 
directly or indirectly by binding of cellular proteins. The promoter switch is essential for the 
persistence of EBV in B cells, because Wp becomes inactive shortly after infection, 
presumably by epigenetic mechanisms (Tierney et al., 2000; Altmann et al., 2006). LCLs 
promote the latency III gene expression profile, which is characterized by the expression of 
all latent genes, including EBNAs, EBERs, LMPs, and miRNAs. In vivo, the latency III 
program leads to a strong immune response. DNA methylation and silencing of the C 
promoter ensures that a proportion of EBV-infected cells survive the cytotoxic T cell 
response, because the expression profile of the latency III program is replaced by the latency I 
program. The only promoter, which escapes epigenetic silencing, is the Q promoter (Qp). 
Transcription initiation from Qp results in the expression of EBNA1 only and is described as 
latency I phenotype (Schaefer et al., 1995; Paulson et al., 1999).  
Induction of the viral lytic phase is also controlled by DNA methylation. BZLF1 is the master 
regulator of EBV’s lytic switch in latently infected B cells (Countryman et al., 1987). The 
transcription factor owns the outstanding ability to bind to methylated DNA (Bhende et al., 
2004; Karlsson et al., 2008; Dickerson et al., 2009). We could previously show that CpG-
methylation of promoters of early lytic genes is a prerequisite to allow induction of the lytic 
phase. Binding of EBV’s transcription factor BZLF1 to the methylated promoter elements of 
certain viral genes abolishes repression and enables the expression of lytic genes and the 
production of progeny virus (Bergbauer et al.; Kalla et al., 2010).  
  INTRODUCTION    25 
1.4 Scope of my thesis work 
Epigenetic modifications play an important role in gene regulation. The mode of modification 
is complex as there are many different epigenetic states, which depend on the combination of 
DNA methylation, nucleosome positions, and modifications of histone tails (Ernst et al., 
2010). Key principles of epigenetics are known to be important in the regulation of EBV’s life 
cycles as well: DNA methylation regulates the promoter usage in the early phase of infection 
but is additionally required during lytic reactivation. Histone modification patterns were 
shown to be characteristic for different latency types in different EBV-positive cell lines 
(Minarovits, 2006), but the knowledge about fundamental principles of EBV’s epigenetic 
control during its life cycle was still poor. It was aim of my work to complement and 
complete the big picture of EBV’s different epigenetic states in the three phases of infection 
and to link my results to the “snapshots” of epigenetics in EBV that were previously 
investigated by others.  
The central hypothesis of my work was that ingenious epigenetic events govern the regulation 
of EBV’s life cycle. We postulated that chromatin changes are the key events responsible for 
the consecutive steps during the early phase of an EBV infection. I collected information 
about the temporal establishment of epigenetic patterns on EBV’s DNA to address this issue. 
Furthermore, I characterized the epigenetic nature in latently infected cells to understand, why 
and how lytic genes are repressed. A strict latency is the formula for EBV’s success: A 
discrete gene expression profile abrogates the expression of immune-reactive viral genes 
evading an immune response by the host. Last, I wanted to identify the epigenetic events that 
allow escape from latency after BZLF1 expression, a mechanism that guarantees the 
horizontal spread of progeny virus for the infection of uninfected cells and hosts. 
 2. MATERIAL 
2.1 Plasmids 
The following list contains all plasmids that were used in this thesis. All of them stem from 
the collection of the department of gene vectors. 
plasmid description 
p2089 wild type maxi-EBV: F plasmid (pMBO131) with eGFP and hygromycin resistance gene in B95.8 
DNA (Delecluse et al., 1998) 
p3862 pRTS-2-BZLF1-GFP: plasmid for the inducible expression of full length BZLF1 fused to GFP 
p3927 pCMV:GFP:BZLF1: plasmid carrying the DNA binding domain of BZLF1 under the control of the 
CMV promoter 
2.2 Antibodies 
Antibodies that were used in this work are listed below.  
specificity species distributor application amount/application 
anti-H3 rabbit Abcam (#1791-100) ChIP 5µg 
anti-H3K4me3 rabbit Active Motif (#39159) ChIP 5µg 
anti-H3K27me3 rabbit Upstate (#17-622) ChIP 4µg 
anti-H3K9me3 rabbit Active Motif (#39161) ChIP 5µg 
anti-RNA polymerase II (N20) mouse Santa Cruz (#39097) ChIP 10µg 
anti-EZH2 (clone AC22) mouse Active Motif (#39875) ChIP 3 µg 
rabbit-IgG rabbit Upstate (#12-370) ChIP 5 µl 
anti-tubulin mouse Santa Cruz (#sc 23948) ChIP 10 µl 
Rpb1-CTD (8WG16) rat E. Kremmer/D. Eick ChIP 100µl  
CTD Ser5-P (3E8) rat E. Kremmer/D. Eick ChIP 100µl  
anti-RNAPII (1C7) rat E. Kremmer/D. Eick ChIP 100µl  
Pol II Rpb1 (Pol3-3) mouse E. Bautz/Heidelberg Western 1:10 
α-IgG mouse, HRP goat Promega Western 1:2500 
anti 5-methyl-Cytosine  mouse Diagenode (MAb-600-500) MeDIP 10µg 
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2.3 Oligonucleotides 
Oligonucleotides used in this work were synthesized by Metabion, Munich. Their sequences 
are listed in the appendix.  
2.4 Bacterial strains 
For all cloning purposes and the preparation of plasmid DNA, the strain DH5-alpha (F-, lacl-, 
recA1, endA1, hsdR17, ∆( lacZYA- argF), U169, F80d lacZ∆M15, supE44, thi-1, gyrA96, 
relA1; Hanahan, 1985) was used.  
2.5 Eukaryotic cell lines 
Cell lines used in this study stem from the collection of the department of gene vectors or 
were established in this work (*) and are recorded below. 
name description 
B95.8 lymphoblastoid cell line, established by an in vitro infection of marmoset B-cells (Miller et al., 
1972) 
Bjab human EBV-negative Burkitt-lymphoma cell line 
Raji human EBV-positive Burkitt-lymphoma cell line (Pulvertaft, 1964) 
Raji/3927 Raji cells carrying a plasmid for GFP:BZLF1 (DNA binding domain only), clone 3927.4 
Raji/3862* Raji cells carrying a tet-inducible plasmid for BZLF1, clone 3862.1 
2.6 Cell culture media and additives 
2.6.1 Media for the cultivation of bacteria 
Bacteria were either cultivated in liquid culture or on solid agarose plates.  
appellation application distributor 
LB-medium medium for bacterial culture (1% (w/v) tryptone, 1% (w/v) NaCl, 0.5% 
(w/v) yeast extract) 
Invitrogen GmbH 
select agar LB-medium with 1.5% (w/v) select agar for the cultivation of bacterial 
clones 
Invitrogen GmbH 
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2.6.2 Media for the cultivation of eukaryotic cells 
The following list contains media and additives for eukaryotic cell culture used in this work.  
appellation application distributor 
RPMI-1640 cell culture medium for cultivation of all cell lines used 
in this study 
Invitrogen GmbH 
Opti-MEM I minimal culture medium for transfections Invitrogen GmbH 
alpha-thioglycerole and 
bathocupproine-disulfonic acid 
antioxidant agents (additive for RPMI-1640) Sigma Aldrich 
fetal calf serum (FCS) nutritive substance (additive for RPMI-1640) Chromatech 
sodium pyruvate antioxidant agent (additive for RPMI-1640) Invitrogen GmbH 
sodium selenite antioxidant agent (additive for RPMI-1640) Sigma Aldrich 
penicillin/streptomycin antibiotics (additives for RPMI-1640) Invitrogen GmbH 
hygromycin antibiotic for the selection of mutant cell lines Invitrogen GmbH 
2.7 Chemicals and enzymes 
The following list shows the used chemicals and enzymes and their distributors.  
appelation distributor 
RNAse A, Lysozyme Applichem, Darmstadt 
Bradford-Solution Bio-Rad, Munich 
PBS Biochrome AG, Berlin 
hygromycin B, L-alpha-lyso-lecithin (egg yolk) Calbiochem GmbH, Frankfurt (Main) 
phenol, chloroform, bovine serum albumbin fraction V (BSA) powder Carl Roth GmbH, Karlsruhe 
bacto-agar, yeast extract, trypton Difco Laboratories, Detroit, USA 
marker for DNA electrophoresis, restriction enzymes Fermentas, Leon-Roth 
(γ-P32)-dCTP Hartmann Analytik, Braunschweig 
Hoechst-Dye H33342 Hoechst, Frankfurt 
agarose, Luria broth base, trypsin-EDTA, UltraPure TM 20x SSC Invitrogen, Karlsruhe 
ammonium sulfate, boric acid (H3BO3), calcium chloride (CaCl), 
cesium chloride (CsCl), acetic acid, ethanol, ethidium bromide, 
ethylene diamine tetra-acetic acid (EDTA), glucose, glycine, glycerol, 
isoamyl-ethanol, isopropanol, potassium acetate (CH3COO-K+), 
potassium chloride (KCl), lithium chloride (LiCl), magnesium 
chloride (MgCl2), magnesium sulfate (MgSO4), sodium acetate 
(CH3COO-Na+), sodium chloride (NaCl), sodium hydroxide (NaOH), 
sodium dodecyl sulfate (SDS), paraformaledhyde (PFA), hydrochloric 
acid (HCl) sucrose, Triton X-100 
Merck-Eurolab GmbH 
Immobilon NY+ charged nylon transfer membrane Millipore 
restriction enzymes New England Biolabs, Frankfurt 
G418-Sulfate (Neomycin) PAA Laboratories GmbH, Cölbe 
RNAsin plus RNAse inhibitor Promega, Mannheim 
Complete Mini Protease Inhibitor Cocktail tablets, desoxy-
nucleotides, LightCycler 480 SYBR Green I Master, High Prime  
Roche Diagnostics GmbH, Mannheim 
ampicillin, beta-mercaptoethanol, bromophenol blue, 
chloramphenicol, dimethyl sulfoxide (DMSO), dithiothreitol (DTT), 
doxycycline, Igepal CA-630 (NP-40), calf thymus DNA, 
Proteinase K, RedTaq Polymerase 
Sigma-Aldrich, Munich 
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2.8 Buffers and solutions 
The following lists records the buffers and solutions that were used in this work.  
buffer/solution ingredients application 
agarose loading dye 1mg/ml bromophenol blue, 1mg/ml xylene cyanol, 50% 
sucrose 
ampicillin stock solution 100mg/ml ampicillin in 20% ethanol, sterile filtered 
PBS, pH 7.3 10mM Na2HPO4, 1.8mM KH2PO4, 140mM NaCl, 
2.7mM KCl 
SSC buffer 150mM NaCl, 15mM trisodium citrate, pH 7.0 with HCl 
TAE 40mM Tris-acetate, 1mM EDTA 
TBE 89mM Tris, 89mM boric acid, 2mM EDTA 
TE, pH 8.0 1mM EDTA, 10mM Tris-HCl 
TENS buffer 10mM Tris-HCl, 1mM EDTA, 100mM NaOH, 
0.5% SDS 
general lab 
techniques 
 
MeDIP buffer 
1 M sodium-phosphate, pH 7.0 
 
Proteinase K digestion buffer 
10mM sodium phosphate buffer (pH 7.0), 
140mM NaCl, 0.05% Triton X-100 
0.78M NaH2PO4, 1.22M Na2HPO4 
50mM Tris-HCl, pH 8.0, 10mM EDTA, 0.5% SDS 
MeDIP 
wash buffer I 2x SSC + 0.1% SDS 
wash buffer II 1x SSC 
wash buffer III 0.5x SSC 
EBV-microarray 
depurination solution 
denaturation solution 
church buffer 
 
SB wash buffer 
0.64% HCl 
1.5M NaCl, 0.5M NaOH 
0.5M Na2HPO4, 1mM EDTA, 7% SDS, 1% 
BSA, pH 7.2 (adjust with ortho-phoshoric acid) 
0.2x SSC, 1% SDS 
Southern Blot 
lysis buffer 10mM Tris-HCl, pH 7.9, 10mM NaCl, 3mM MgCl2, 
0.5% NP-40 
sonication buffer 10mM Tris-HCl, pH 7.9, 200mM NaCl, 3mM MgCl2, 
1mM CaCl2, 4% NP-40, 3mM EGTA, 1% SDS, 1x 
“Complete” proteinase inhibitor cocktail (Roche) 
IP dilution buffer 20mM Tris-HCl, pH 7.9, 2mM EDTA, pH 8.0, 
1% TritonX-100, 150mM NaCl, 1x “Complete” 
proteinase inhibitor cocktail (Roche) 
low salt buffer 20mM Tris-HCl, pH 8.0, 0.1% SDS, 1% Triton X-100, 
2mM EDTA, pH 8.0, 150mM NaCl 
high salt buffer 20mM Tris-HCl, pH 8.0, 0.1% SDS, 1% Triton X-100, 
2mM EDTA, 500mM NaCl 
LiCl buffer 10mM Tris-HCl, pH 8.0, 0.25M LiCl, 0.5% NP-40, 
0.5% deoxycholic acid, 1mM EDTA, pH 8.0 
elution buffer 25mM Tris-HCl, pH 8.0, 10mM EDTA, pH 8.0, 
0.5% SDS 
ChIP 
2x Tris/SDS pH 8.8 
 
2x Tris/SDS pH 6.8 
 
running buffer (10x) 
 
Laemmli buffer (2x) 
 
 
separation gel (6.5%) 
 
stacking gel (3%) 
22.68g Tris/Base, 2.5ml SDS (20%), ad 250ml (H2O), 
pH 8.8 with HCl 
7.56 g Tris/Base, 2.5ml SDS (20%), ad 250ml (H2O), 
pH 6.8 with HCl 
60.4g Tris/Base, 288g glycine, 5ml SDS (20%), ad 2L 
(H2O) 
2% SDS, 100mM DTT, 10mM EDTA, 10% glycerol, 
60mM Tris/HCl (pH6.8), 0.01% bromophenol blue, 
1mM PMSF 
8.6ml polyacrylamide (30%), 20ml Tris/SDS pH 8.8, 
11ml H2O, 334µl APS, 20µl TEMED 
1.5ml polyacrylamide (30%), 7.5ml 2x Tris/SDS 
pH 6.8, 5.9ml H2O, 90µl APS, 20µl TEMED 
western blot 
immunodetection 
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buffer/solution ingredients application 
transfer buffer 
 
blocking solution 
60.4 g Tris/Base, 288 g glycine, 5ml SDS (20%), 200ml 
methanol, ad 2L (H2O) 
10% (v/v) TBS, 0.1% Tween 20, 5% milk powder 
western blot 
immunodetection 
permeabilizing buffer 
 
TNESK buffer 
150mM sucrose, 50mM Tris-HCl, pH 7.9, 50mM NaCl, 
2mM CaCl2 
20mM Tris-HCl, pH 7.9, 200mM NaCl, 2mM EDTA, 
2% SDS, 20µg/ml Proteinase K 
micrococcal 
nuclease digestion 
2.9 Commercial kits 
Commercial kits that were used are listed below.  
appellation distributor 
illustra Nick Columns GE-Healthcare, Munich 
Jet-Star DNA Maxi Kit Genomed, Bad Oeynhausen 
BioPrime Total Genomic Labeling System, SuperScript III First Strand 
Synthesis SuperMix, pCR 2.1 TA Cloning Kit Invitrogen GmbH, Karlsruhe 
NucleoBond PC 500, NucleoSpin Extract II Kit, NTB Buffer Macherey-Nagel, Düren 
QIAamp DNA Mini Kit, QIAprep Spin Miniprep Kit, RNeasy MiniKit, 
QiaShredder Qiagen, Hilden 
GenomePlex Complete WGA2 Sigma Aldrich, Munich 
EZ DNA Methylation-Gold Kit Zymo Research, Irvine, USA 
2.10 Software 
Software tools that contributed to this work are listed below.  
appelation distributor 
Adobe-CS3 Adobe Systems Inc., San Jose (USA) 
AIDA Alias Software Raytest Isotopenmessgeräte GmbH, Straubenhardt 
Bioconducter Fred Hutchinson Cancer Research Center, Seattle (USA) 
BiQ Analyzer HT 0.9 (beta test version) MPI for Informatics and Saarland University, Saarbrücken 
CLC Genomics Workbench CLC bio A/S, Katrinebjerg, Denmark 
DNA baser Multi-Fasta to Fasta Converter Heracle BioSoft S.R.L., Romania 
EndNote X2 Thomson Reuters, New York (USA) 
FlowJo 9.1 TreeStar Inc., Ashland (USA) 
FreeHand MX11.0 Adobe Systems Inc., San Jose (USA) 
Genepix Pro 6.0 Molecular Devices, Sunnyvale (USA) 
MacVector 11.0 Accelrys, Cambridge (UK) 
Microsoft Office 2008 Microsoft, Redmond (USA) 
Prism 5 Graphpad Software, La Jolla, USA 
R The R Foundation for Statistical Computing Vienna, Austria 
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2.11 Devices and consumables 
The list below comprises devices and consumables that were used in this work. 
appelation distributor 
CP100 developer machine AGFA, Cologne 
CoulterCounter Z1, ultracentrifuge L8-70M/XL-70, centrifuge Avanti 
J-25 and Avanti-26XP 
Beckman, Heidelberg 
FACS-Calibur, FACS-Aria II, cell culture flasks, 6-/12-/24-/48- and 
96-well plates 
Becton Dickinson GmbH, Heidelberg 
Gene-Pulser II electroporation device  Bio-Rad, Munich 
Branson Sonifier S-250D Branson, Danbury, USA 
Bioruptor (UCD-200) Diagenode, Liège, Belgium 
BioPhotometer, PCR machine MasterCycler Personal, reaction tubes, 
desk centrifuge 5415, thermomixer comfort 
Eppendorf, Hamburg 
cover slips, glass slides, forceps, whatman paper, Neubauer cell 
chamber 
Hartenstein, Würzburg 
H Scan-Jet G4050 Hewlett Packard (USA) 
Bovivet veterinary needle Henry Schein Vet GmbH, Hamburg 
sonifier nozzle for Branson sonifier, 5 mm G. Heinemann, Schwäbisch Gmünd 
DyNAQuant Fluorimeter Hoefer Scientific Instruments (USA) 
Phosphoimager FLA 5100, film cassettes, intensifier screen FujiFilm, Kleve 
plastic consumables for cell culture and laboratory work Greiner Bio One, Solingen 
X-ray film Kodak Company, New York (USA) 
water deionizing device Milli-RO 60 PLUS Millipore, Schwalbach 
Axon GenePix 4100A Microarray Scanner Molecular Devices (USA) 
vacuum centrifuge univapo H150 Montreal Biotech Inc., Montreal, 
Canada 
cell culture dishes, cryotubes 1.8 ml Nunc GmH, Wiesbaden 
EBV-microarray, hybridization buffer Ocimum Biosolutions (Netherlands) 
chambers for agarose gel electrophoresis, NanoDrop ND-1000, 4 mm 
electroporation cuvettes, reaction tubes 
Peqlab, Erlangen 
LightCycler 480 Real Time PCR System 
454 Genome Sequencer FLX System 
Roche Diagnostics GmbH, Mannheim 
glass ware Schott, Mainz 
HS 4000 Pro Hybridizing Station Tecan, Crailsheim 
Heraeus Multifuge 3L-R, orbital shaker, incubators Thermo Scientific (USA) 
phase contrast microscope Axiovert 40C Zeiss, Göttingen 
glass pipettes 5 ml, 10ml and 25 ml Brand, Wertheim 
0.8 µm and 1.2 µm filter Schleicher & Schüll, Dassel 
DNA-Sequencing Sequiserve 
Roboycler Gradient 96 Stratagene, Heidelberg 
 3. METHODS 
3.1 Bacterial culture 
Escherichia coli (E.coli) suspension cultures were grown in LB medium at 37°C and 200rpm 
in orbital shakers.  
For isolation of single cell clones, bacteria were streaked with an inocculating loop on LB 
agar plates and incubated at 37°C over night. Antibiotics (100µg/ml ampicillin, 30µg/µl 
chloramphenicol, or 30µg/ml kanamycin) were added to autoclaved LB medium to select for 
resistance genes.  
For long-term storage, 25% glycerol stocks of over night cultures were frozen at -80°C.  
3.2 Eukaryotic cell culture 
3.2.1 Cell culture conditions 
Eukaryotic cells were cultivated in 37°C incubators in an atmosphere of 5% CO2 and 95% air 
humidity. All working steps were carried out in lamina hoods. Cells were centrifuged at 300g. 
Washing steps were performed with PBS unless stated otherwise.  
Cells were grown in RPMI-1640 medium with 10% fetal calf serum, 100µg/ml streptomycin, 
100 I.U.*/ml penicillin, 1mM sodium pyruvate, 100nM sodium selenite, 20µM bathocuproin 
disulfonic acid, and 0.0004% α-thioglycerole (full medium).  
                                                        
* international unit 
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Cells were counted with the CoulterCounter Z1 (Beckman Coulter) according to the 
instructions of the company or alternatively with a Neubauer cell chamber.  
All suspension cells were cultivated at an average density of 3-5x 105 cells/ml. The cell lines 
Raji 3927 and Raji 3862 were selected with 1.5mg/ml G418 sulfate or 300µg/ml 
hygromycin B, respectively. 
3.2.2 Storage of eukaryotic cells 
Cells were frozen in 10% DMSO and 90% FCS in the gas phase of liquid nitrogen at a 
concentration of 1x107 cells/ml for long-term storage.  
For gentle freezing, cells were transferred to a 2ml CryoTube (Nunc) and slowly cooled in a 
“Nalge Nunc Cryo 1°C Mr. Frosty Freezing Container” (Nunc) with a cooling rate of 
-1°C/min.  
For thawing, cells were warmed to 37°C, washed with 50ml of full medium, and taken up in 
5ml full medium. If required, selection pressure was applied the day after thawing.  
3.2.3 Electroporation of eukaryotic cells 
Raji cells were electroporated with the gene pulser II electroporator (Biorad). 5x106 cells were 
spun down and resuspended in 250µl Opti-MEM I. 5-10µg plasmid DNA were added and 
cells were incubated on ice for 15min. Electroporation was performed in 4mm cuvettes at 
230V and 975µF. After pulsing, cells were supplied with 400µl FCS, transferred to 5ml full 
medium, and cultivated at 37°C.  
3.2.4 Establishment of stable cell lines 
Electroporated cells (3.2.3) were grown in bulk culture for two days. For the establishment of 
single cell clones, cells were diluted in 96 well plates and cultivated under selection for four 
weeks. Medium was changed if necessary, and outgrowing cells were expanded continuously. 
Expression of the transgene was evaluated using flow cytometry.  
3.2.5 Isolation, separation, and infection of human B cells 
Adenoids were repeatedly cut and washed with PBS to isolate human primary mononuclear 
cells (PBMCs). Human T cells were depleted from PBMCs by resuspending in 30ml PBS and 
500µl sheep blood and subsequent Ficoll-Hypaque density-gradient centrifugation at 1900rpm 
at 10°C for 30min. B cells were collected from the interface and washed three times with 
  METHODS  34 
PBS. Cells were infected with B95.8 virus at an MOI of one. Cells were spun down and 
transferred to fresh full medium one day post infection.  
3.2.6 Collection of B95.8 virus stocks 
For the preparation of wildtype virus stocks, B95.8 cells were cultivated in high density. 
Virus is continuously released to the medium because a proportion of cells spontaneously 
undergoes lytic reactivation. Virus containing medium was collected and stored at 4°C. 1ml 
of supernatant contains approximately 1x106 infectious particles (experienced data from the 
department of gene vectors). 
3.2.7 Flow cytometry 
Raji 3862 cells were washed with PBS and analyzed in a FACS Calibur (Beckton Dickinson) 
to detect and count GFP-positive cells. Data was evaluated with the FlowJo 9.1 software.  
3.2.8 Sorting of GFP expressing cells 
Raji 3862 cells were sorted using a FACS Aria II device according to the instructions of the 
manufacturer to get pure populations of cells expressing the transgene GFP. Briefly, Raji cells 
were resuspended in PBS with 2% FCS and 2mM EDTA to a final concentration of 
3x107 cells/ml and subsequently filtered to obtain single cells. Sorting criteria were (i) living 
cells, (ii) exclusion of duplets, and (iii) GFP positivity. Cells were sorted with a 100µm 
nozzle and a velocity of 6000 events/second with a sorting mask of “yield 32” and “purity 
16”. 
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3.3 Nucleic acid techniques 
General methods like phenol/chloroform extraction, DNA precipitation with ethanol, 
electrophoretic separation of DNA, enzymatic restriction hydrolysis, or ligation of free DNA 
ends were performed according to standard protocols (Sambrook et al., 2001).  
3.3.1 DNA purification from E.coli 
(i) small-scale purification of plasmids <20 kb 
Small-scale purification was performed for the evaluation of plasmid DNA after cloning. 2ml 
of a bacterial culture in the stationary phase were harvested through centrifugation at 
4500rpm for three minutes and resuspended in 300µl TENS buffer (10mM Tris-HCl, 1mM 
EDTA, 100mM NaOH, 0.5% SDS). After addition of 150µl sodium acetate (3M), cells were 
centrifuged at maximal speed for eight minutes. DNA was precipitated with 900µl 100% 
ethanol and centrifugation at maximal speed for five minutes. The pellet was dried and 
resuspended in 50µl TE containing 10µg/ml RNase A.  
(ii) high-scale purification of plasmids <20 kb 
Quantitative purification of plasmids for transfection and cloning was carried out using the 
JetStar Maxi-Prep-Kit (Genomed) according to the manufacturer’s instructions with 400ml 
bacterial culture in the stationary growth phase.  
(iii) high scale purification of plasmids >20 kb (maxi EBV DNA) 
Maxi EBV DNA was purified using the Nucleobond PC 500 Kit (Macherey-Nagel) according 
to the manufacturer’s instructions with 400ml bacterial culture in the stationary growth phase.  
3.3.2 DNA purification from eukaryotic cells 
Isolation of genomic DNA was performed using the QIAamp DNA Mini Kit (Qiagen) 
following the manual of the company.  
3.3.3 Purification of DNA from PCR products and agarose gels 
Purification of DNA from PCR products was carried out with the NucleoSpin Extract II Kit 
(Macherey-Nagel) following the manufacturer’s instructions. SDS containing samples were 
purified with five volumes of NTB buffer instead of the standard binding buffer.  
  METHODS  36 
3.3.4 Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) amplifies defined nucleic acid fragments exponentially 
(Mullis et al., 1992). The components of a PCR reaction and a typical PCR program are listed 
below. 
component Sigma Red Taq Go Taq Polymerase 
template 1ng up to 50ng 1ng up to 50ng 
forward and reverse primer 100pm each 100pm each 
buffer (5 x) / 4µl 
nucleotides / 5µM each 
preMix (2 x) 25µl / 
H2O ad 50µl ad 20µl 
  
step temperature time cycles 
denaturation 98°C 5min 1 
denaturation 
primer annealing 
elongation 
98°C 
50-60°C, depending on primer pair 
72°C 
1min 
1min 
500bp/min 
30-40, depending on the application 
final elongation 72°C 10 min 1 
 
Amplified DNA was separated on a 1% TBE agarose gel to control the size of the PCR 
product or for preparative gel purification (see 3.3.3).  
3.3.5 Quantitative real time PCR 
Immunoprecipitated DNA or cDNA was quantified with a Roche LightCycler 480 device. 
The detection method is based on the incorporation of the fluorescence dye SYBR-Green I 
into the newly synthesized DNA double helix, which is measured after each elongation cycle 
(Higuchi et al., 1993). 
Immunoprecipitated DNA was analyzed with “absolute quantification”. This method allows 
the calculation of the sample concentration by comparing the crossing points (Cp) of the 
unknown sample, in this case the immunoprecipitated DNA, with a defined standard curve, 
which encompasses different dilutions of input DNA. The analysis was done automatically 
with the LightCycler 480 software according to the second derivative maximum method. The 
amount of immunoprecipitated DNA was displayed as an absolute value (% input).  
Evaluation of RNA expression levels was done with “relative quantification”. The crossing 
points of different target genes were compared to the crossing point of a reference gene in 
different samples. The reference gene is a constitutively expressed gene or housekeeping 
gene, which is not regulated in all conditions tested. The analysis was done automatically with 
  METHODS  37 
the LightCycler 480 software in the advanced modus. The result was displayed as the ratio of 
the expression level of the gene of interest to the reference gene, which is a dimensionless 
number. Both methods included the PCR efficiencies by entrainment of internal or external 
standard curves. The PCR mix and the PCR program for qPCR are listed below.  
component amount 
template 1µl immunoprecipitated DNA or cDNA 
primer 5pm each 
SYBR Green I Master (2 x) 5µl 
H2O 3.5µl 
 
program target temperature 
(°C) 
hold (s) acquisition 
mode 
RampRate 
(°C/s) 
Cycles Analysis mode 
pre-incubation 95 600 none 4.4 1 none 
amplification 
95 
62 
72 
75 
1 
10 
10 
3 
none 
none 
none 
single 
4.4 
2.2 
4.4 
4.4 
45 quantification 
97 1 none 4.4 
67 10 none 2.2 melting curve 
97 / continuous 0.11 
1 melting curve 
cooling 37 15 none 2.2 1 none 
3.3.6 Isolation of RNA from cells 
Isolation of RNA from cells was carried out with the RNase Mini Kit (Qiagen). 1x107 cells 
were used in each sample. The lysate was homogenized with QiaShredder columns (Qiagen). 
All subsequent steps were performed according to the instructions of the manufacturer. RNA 
was eluted in 80µl of RNase-free water and stored at -80°C.  
3.3.7 Reverse transcription of RNA 
RNA was transcribed into cDNA to determine expression levels of certain genes of interest. 
Prior to cDNA synthesis, contaminating DNA was removed from the RNA preparation with 
the enzyme DNase I* (Invitrogen). 2µg of extracted RNA were incubated for 90 min at 37°C 
in the presence of 2U DNase, 40U RNase inhibitor and 1x DNase buffer in a 20µl approach. 
Remaining DNase was heat inactivated by incubating at 65°C for ten minutes. The efficiency 
of DNase treatment was controlled by PCR. Reverse transcription of RNA was performed 
with the SuperScript III First Strand Synthesis SuperMix Kit (Invitrogen) according to the 
manufacturer’s instructions. Quantification of cDNA was either done semiquantitatively using 
PCR (3.3.4) or quantitatively using qPCR (3.3.5).                                                         
* desoxyribonuclease I 
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3.3.8 Transfer of DNA to membranes (Southern blot) 
Southern blotting was performed according to standard protocols (Sambrook et al., 2001). 
DNA was separated on a 1% TAE agarose gel. The gel was shaken for 15min in depurination 
buffer to facilitate the transfer of large DNA fragments to the membrane and afterwards 
denatured for 30min in denaturation buffer. Southern blotting was performed via an upward 
capillary transfer of the DNA from the agarose gel to a positively charged nylon membrane 
(Immobilon NY+, Millipore). The gel was placed upside down on a plastic wrap and capped 
air bubble free with a membrane of the same size. Two pieces of thin whatman paper with 
1cm overhang at each side were positioned on top and overlaid with several layers of paper. 
The paper was changed if wet and the blot was allowed to stand for approximately three 
hours. Afterwards, the membrane was washed in 2x SSC and further processed.  
3.3.9 Radioactive labeling of DNA 
DNA was radioactively labeled with the High Prime mix (Roche). 100ng of denatured DNA 
were labeled at 37°C for one hour in a 20µl approach containing 4µl 5x High Prime mix and 
100µCi α-P32 dCTP. The labeled probe was separated from contaminating free nucleotides by 
gravity-flow chromatography with illustra NICK Columns (GE Healthcare), which are 
prepacked with Sephadex G-50. The instructions of the company were followed. The purified, 
radioactive labeled probe was denatured at 95°C for 10min before use.  
3.3.10 DNA-DNA hybridization 
DNA blots were pre-incubated in Church buffer at 60°C for one hour. The denatured, α-P32 
dCTP labeled probe was added and hybridized at 60°C over night with constant rotating in a 
hybridization oven. The membrane was washed at least two times with Southern blot washing 
buffer (0.2x SSC, 1% SDS) at 58°C for ten minutes.  
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3.4 Methylated DNA immunoprecipitation (MeDIP) 
Methylated DNA Immunoprecipitation (MeDIP) is a method to specifically enrich DNA 
containing methlylated cytosine-guanine pairs (CpG dinucleotides) with an antibody 
recognizing methylated CpG dinucleotides. Quantitative real-time PCR or microarray 
hybridizations (MeDIP-on-Chip) were readouts to evaluate the enrichment of DNA as 
compared to input DNA.  
3.4.1 Immunoprecipitation of methylated DNA (MeDIP) 
DNA was prepared using the QIAamp DNA Mini Kit (Qiagen) according to the instructions 
of the manufacturer. MeDIP was performed as described previously (Weber et al., 2005) with 
minor modifications. 4µg of DNA were sheared using the Biorupter UCD-200 for five 
minutes, 30s on/off with 320W. After purification with the NucleoSpin Extract II Kit 
(Macherey-Nagel), DNA was denatured and immediately cooled on ice. Immunoselection of 
4µg of this so called “input” DNA was carried out using 10µl of monoclonal 5-
methylcytosine antibody (Diagenode) in a final volume of 500µl IP buffer (10mM sodium 
phosphate, pH 7.0, 140mM NaCl, 0.05% Triton X-100) for three hours at 4°C by overhead 
shaking. Immunopreciptiation was performed using 40µl of preblocked M-280 sheep anti-
Mouse IgG Dynabeads (Invitrogen) for two hours at 4°C by overhead shaking. After three 
washing steps with 750µl IP buffer, DNA was Proteinase K treated for three hours and 
recovered by phenol/chloroform extraction and ethanol precipitation. DNA was resuspended 
in 20µl H2O. 
3.4.2 Quantification of MeDIP DNA by real time PCR (qPCR) 
The DNA content MeDIP and input samples was quantified using quantitative real time PCR 
with the Roche LightCycler 480 system (see 3.3.5). Stepwise dilutions of total input DNA 
ranging from 0.01% to 10% and MeDIP-DNA were analyzed with primers for Cp, EBER, 
Lmp1p, OriP, Qp, Wp, BBLF4, and BZLF1. The content of MeDIP DNA was determined as 
compared to input DNA for each locus. Oligonucleotide sequences are listed in the appendix.  
3.4.3 Genome-wide analysis of MeDIP DNA by microarray 
hybridization (MeDIP- on-ChIP) 
DNA was amplified prior to microarray hybridization with the GenomePlex Complete Whole 
Genome Amplification (WGA) Kit (Sigma-Aldrich) according to the manufacturer’s 
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instructions with minor modifications. The fragmentation step in the protocol was omitted 
because MeDIP-DNA was already sheared. After the reaction, DNA was checked for linear 
amplification by qPCR using the same primer pairs as described before (3.4.2). Labeling of 
enriched and input DNA was performed using the BioPrime Total Genomic Labeling System 
(Invitrogen). 2µg of MeDIP and input DNA were labeled with Alexa5 or Alexa3 dye, 
respectively. The efficiency of fluorochrome incorporation was determined at 647nm and 
555nm. Labeled samples were combined, evaporated and resuspended in 130µl hybridization 
Buffer (Ocimum Biosolutions). The labeled samples were analyzed using our custom made 
EBV microarray (Kalla, 2007). One slide of the microarray contains four copies of a complete 
set of 285 separate, partially overlapping PCR fragments with a length of 500-700bp covering 
the complete genome of the prototype B95.8 EBV strain.  
Hybridization of the slides was performed using a Tecan HS 4000 Pro Hybridization Station 
at 60°C with gentle agitation for 16h. After three washing steps with 2x SSC and 0.1x SDS, 
1x SSC and 0.5x SSC at 30°C for each one minute, slides were dried with nitrogen and 
immediately scanned with a GenePix Personal 4100A Scanner (Axon). Analysis of visual 
data was performed using the GenePix Pro 6 software. The signal ratios of precipitated versus 
input DNA of the four copies of each fragment were averaged. Single spots with a standard 
error >0.15 were excluded from analysis. For normalization, the calculated median ratio was 
set at one. 
For the analysis of the methylation pattern in the cell line Raji, ratios of three independent 
MeDIP experiments were averaged. 
To analyze the kinetics of methylation pattern formation in primary B cells, the adjusted data 
were processed as the ratio to the constant point of reference, Cp, which was set at one in each 
experiment. The C promoter region is free of methylated CpGs even in established 
lymphoblastoid cell lines (Tierney et al., 2000). To validate the data, two biological replicates 
with two technical replicates each were conducted.  
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3.5 Bisulfite sequencing 
3.5.1 Bisulfite modification of DNA 
Bisulfite modification of DNA was carried out using the EZ Methylation Gold Kit (Zymo) 
according to the instructions of the manufacturer with minor modifications. DNA of Raji cells 
was sonicated prior to modification for three seconds at 10% in a Branson Sonifier to open 
secondary structures. 500-1000ng DNA was used in each reaction. The incubation time at 
65°C was prolonged to five hours to improve the conversion rate. After purification of the 
bisulfite modified DNA, samples were eluted in 12µl of the supplied elution buffer.  
3.5.2 PCR of bisulfite modified DNA 
PCR amplification of bisulfite modified DNA was carried out using the Sigma Red Taq 
Polymerase in 50µl reactions with 5µl DNA and 50pmol of each primer pair. Typically, the 
reaction started with an initial denaturation step for 5min at 95°C. DNA was amplified in 40 
cycles with one minute denaturation at 95°C, one minute annealing at 56°C, and one minute 
elongation at 72°C. PCR fragments were purified and directly sequenced by the Sanger 
method and a commercial service provider (http://www.sequiserve.de). 
3.5.3 Deep bisulfite sequencing 
60 PCR products of bisulfite modified DNA with 100ng each and an average product size of 
463bps were pooled for deep sequencing on a Roche Genome Sequencer FLX system (“454 
sequencing”). Sequencing was performed in collaboration with Microsynth GmbH 
(Switzerland). Library preparation and DNA sequencing was carried out according to the 
standard protocols of the company. 
3.5.4 Data analysis 
For alignment of sequences, I used the CLC genomics workbench software with parameters 
for high throughput sequencing in the menu “reference assembly”. The local alignment was 
performed with parameters for long run reads (mismatch cost = 2, insertion cost = 3, deletion 
cost = 3, length fraction = 0.5 and similarity of 0.9). Sequence reads were aligned to a 
modified version of the B95.8 wildtype sequence, in which I converted all cytosines in a non-
CpG context to thymines. Cytosines of CpG dinucleotides were kept unconverted. The 
parameters of the sequence alignment were set to tolerate RY-mismatches in the context of 
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CpG dinucleotides, allowing mismatches of purines and pyrimidines, which are expected if 
cytosines are unmethylated. Non-specific matches (situations, where a read aligns to more 
than one sequence, which is expected in overlapping PCR products) were placed randomly. 
Each contig was saved separately and the included sequences were extracted in multifasta-
format. Methylation analysis was carried out using the BiQ analyzer HT 0.9/beta-test version 
(Bock et al., 2005). For this, multifasta-files were extracted with the “Multi-Fasta to Fasta 
Converter” of the “DNA baser” software. A Matlab script was developed to extract the 
information of the BiQ analyzer output file to identify the total number of methylated CpG 
dinucleotides at each position and the EBV-genome location of the CpG-dinucleotide. Details 
of the Matlab script are listed in the appendix. Data were graphically analyzed and visualized 
in the Prism software. 
3.6 Analysis of nucleosome occupancy  
The enzyme micrococcal nuclease (MNase) preferentially cuts the linker region of two 
nucleosomes. DNA, which is part of nucleosomal structures, is protected from hydrolysis if 
the amount of MNase is carefully titrated. After cleavage of chromatin, protected DNA can be 
purified and used as a sample for quantitative real-time PCR or for microarray hybridization.  
3.6.1 MNase digestion of chromatin 
1x107 cells were harvested, washed once with PBS, and resuspended in 250µl permeabilizing 
buffer (150mM sucrose, 50mM Tris-HCl, pH 7.9, 50mM NaCl, 2mM CaCl2). Cells were 
incubated for two minutes at 37°C in the presence 0.1% lysolecithine to destabilize 
membranes and allow access of MNase to chromatin. MNase digestion was carried out using 
50U MNase for five minutes at 37°C, which typically resulted in a pattern of about 90% 
mononucleosomal DNA. After MNase treatment, cells were lysed in TNESK buffer 
(20mM Tris-HCl, pH 7.9, 200mM NaCl, 2mM EDTA, 2% SDS, 20µg/ml Proteinase K) and 
incubated at 50°C for five hours. DNA was phenol/chloroform purified, precipitated with 
ethanol and sodium acetate, and loaded quantitatively on an agarose gel to purify the 
mononucleosomal DNA. Gel purification was carried out using the NucleoSpin Extract II Kit 
(Macherey-Nagel). For the preparation of input DNA, DNA was extracted from whole cells 
using the QIAamp DNA Mini Kit. DNA was sheared 15 times for five minutes in a biorupter 
device (Diagenode), to obtain DNA fragment sizes similar to MNase digested DNA.  
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3.6.2 Labeling of DNA for microarray hybridization 
DNA was chemically labeled with the Universal Linkage System (ULS) of Kreatech 
diagnostic. The ULS molecule consists of a monofunctional platinum complex, which is 
coupled to the detection dyes Cy3 or Cy5. The platinum atom forms a coordinative bond with 
the DNA by binding to nitrogen seven of guanine. In contrast to Klenow labeling, this method 
is independent of any enzymatic step and therefore suitable for labeling of small-sized DNA. 
Labeling of DNA was carried out in cooperation with Imagenes.  
3.6.3 Microarray hybridization 
A custom designed Nimblegen 385k array with overlapping oligonucleotides of a length of 
50 nucleotides, a spacing of ten, and an offset of five nucleotides between upper and lower 
DNA strand was designed. Labeling and hybridization was done in cooperation with 
Imagenes according to their standard protocols.  
3.6.4 Data analysis 
Raw data from the custom Nimblegen microarrays (.PAIR format) were analyzed with the 
software “R” (http://www.r-project.org) and the software “Bioconductor” 
(http://www.bioconductor.org). All functions were called using default parameters if not 
indicated otherwise. Raw data signals of all replicates were “scale normalized” to compensate 
for potential biases introduced during the manufacturing process (Yang et al., 2002). The 
log2-ratios (enriched/input) of the normalized signals were determined and averaged for each 
replicate. The ZREs that had been identified in the EBV genome (Bergbauer et al., 2010) 
were reviewed for the following criteria for a subsequent bioinformatical analysis: Clusters of 
ZREs and meZREs or single BZLF1 binding sites had to be at least 1500bp apart from each 
other in the EBV genome. In regions that encompass two or more closely spaced ZREs in a 
cluster, the position with the strongest binding of BZLF1 was selected and included in the 
analysis. 32 ZREs and meZREs fulfilled the criteria and were selected for the analysis (see 
Tab. A5 in the appendix). Average nucleosome occupancies were determined separately for 
the three different conditions: Raji cells, Raji 3927 cells, and lytically induced Raji 3862 cells. 
A window of ±2000bp, centered at the start position of each ZRE, was chosen. The log2-ratios 
(enriched/input) were averaged in sliding sub-windows of 150bp, which is approximately the 
length of one nucleosome, and a step size of 10bp. To identify differences between the latent 
and lytic phase, subtractions of log2-ratios (enriched/input) of lytically induced Raji 3862 
cells and parental Raji cells were calculated for each individual ZRE and visualized in a heat 
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map. A hierarchical cluster analysis using the Ward's minimum variance method was 
performed on the same heat map matrix with a window of ±350bp, centered at the start 
position of each ZRE to probe for functional groups among ZREs. Average nucleosome 
occupancy profiles of each group identified by the cluster analysis were presented separately. 
As a second step, subtraction of log2-ratios (enriched/input) and cluster analysis was 
performed on ZREs that comprised a difference between the latent and lytic states with the 
datasets Raji 3862 and Raji 3927 to determine the role of BZLF1’s activation domain on 
nucleosome occupancies. 32 randomly chosen positions that lack ZREs were chosen and 
analyzed similar to the ZREs as a control.  
3.7 Chromatin Immunoprecipitation (ChIP) 
Chromatin Immunoprecipitation (ChIP) is a technique to study interactions between proteins 
and DNA. The protein/DNA complex can be isolated with specific antibodies. The output can 
be analyzed with quantitative real time PCR upon DNA purification. Usually the chromatin is 
crosslinked with formaldehyde prior to immunoselection to stabilize the protein-DNA 
interactions. Formaldehyde reversibly links primary aminogroups of proteins with nitrogen 
atoms of nearby proteins or DNA.  
3.7.1 Chromatin preparation 
4x107 cells were harvested by centrifugation at 1200rpm for seven minutes and washed twice 
with ice-cold PBS to remove any residual serum from full medium. Crosslinking was carried 
out in a total volume of 20ml PBS (room temperature) and 1% formaldehyde for seven 
minutes at room temperature with constant rotating. Addition of 2.5ml 1M glycine and 
incubation for five minutes at room temperature stopped the reaction. Cells were pelleted and 
washed with ice-cold PBS in three centrifugation steps at 500g and 4°C for five minutes. The 
cells were resuspended three times in 10ml of ice-cold lysis buffer (10mM Tris-HCl, pH 7.9, 
10mM NaCl, 3mM MgCl2, 0.5% NP-40) and centrifugation at 300g for 10min to isolate 
nuclei. Nuclei were resuspended in 2ml sonication buffer (10mM Tris-HCl, pH 7.9, 200mM 
NaCl, 3mM MgCl2, 1mM CaCl2, 4% NP-40, 3mM EGTA, 1% SDS, 1x “Complete” 
proteinase inhibitor cocktail). Chromatin was fragmented by sonication with a BRANSON 
sonifier W-250 D (amplitude = 35%, total pulse time = 180s with 36 cycles of 5s pulse and 
25s pause). The sonicated samples were transferred into 1.5ml Eppendorf tubes and 
centrifuged at maximum speed at 4°C for ten minutes. Samples were analyzed for their 
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protein content with the Bradford method, subsequently frozen on dry ice, and stored at 
-80°C. The fraction size of the chromatin was analyzed after treatment of 10µg chromatin 
with Proteinase K at 65°C over night. After DNA purification with the NucleoSpin Extract kit 
II (Macherey-Nagel), samples were loaded on a 1% TBE agarose gel to visualize the DNA 
size.  
3.7.2 Chromatin immunoprecipitation and purification of ChIP DNA 
100µg of chromatin in a total volume of 100µl sonication buffer was adjusted to 1ml with IP 
dilution buffer (20mM Tris-HCl, pH 7.9, 2mM EDTA, pH 8.0, 1% TritonX-100, 150mM 
NaCl, 1x “Complete” proteinase inhibitor cocktail) to obtain a final SDS concentration of 
0.1%. After addition of the antibody, the chromatin was incubated at 4°C over night with 
constant overhead rotating. 100µl of protein G or protein A resin (50% slurry) were pre-
equilibrated with IP dilution buffer and incubated at 4°C over night with overhead shaking. 
The next day, beads were spun down at 2000rpm for two minutes, added to the antibody-
chromatin mixture, and incubated at 4°C for two hours by overhead rotating. Beads were 
washed for five minutes each with (i) low salt buffer, (ii) high salt buffer, (iii) LiCl buffer, 
and (iv) TE buffer to remove unspecific proteins and DNA. DNA/protein complexes were 
eluted off the beads with 125µl elution buffer at 65°C and constant shaking for 15min. The 
supernatant was transferred to a new tube and the elution step was repeated. The two 
supernatants were combined, supplied with 40µg of Proteinase K and incubated at 65°C over 
night to reverse the formaldethyde crosslink. DNA was purified with the NucleoSpin 
Extract II Kit (Macherey-Nagel) following to the instructions of the manufacturer and eluted 
in 60µl elution buffer. ChIP samples were immediately analyzed or stored at -20°C.  
3.7.3 Quantification of ChIP DNA by real time PCR (qPCR) 
ChIP and input samples were analyzed by quantitative real time PCR with the LightCycler 
480 system (see 3.3.5) to quantify the DNA content. Stepwise dilutions of total input DNA 
ranging from 0.01% to 10% and ChIP DNA were analyzed with primer pairs specific for 
different loci of latent, early lytic, and late lytic EBV regions. Oligonucleotide sequences are 
listed in the appendix.  
 
 
  METHODS  46 
3.8 Indirect endlabeling 
Indirect endlabeling is a method to map nucleosomes in a region of interest. Chromatin is 
treated with MNase; DNA is purified and cleaved with a restriction endonuclease with a 
restriction site close to the region of interest. Southern blotting and hybridization with a probe 
that binds in close proximity to the restriction start site visualize the digestion pattern of the 
region of interest. Each band in the resulting autoradiogram represents the boundary of a 
nucleosome or a hypersensitive site.  
MNase digestion was performed similarly to the sample preparation for microarray 
hybridization but with minor changes. The digestion of chromatin with MNase has to be mild 
to achieve a partial digestion, only. Buffer volumes were increased to 1ml to ensure proper 
isolation of DNA after MNase treatment and MNase digestion was performed with 0.1-1.5 U 
MNase in each sample, only. Chromatin was Proteinase K treated and purified by 
phenol/chloroform extraction and ethanol precipitation. Cleavage of MNase treated DNA was 
carried out using 30µg of DNA and 100U of the specific restriction endonuclease at 37° C for 
two hours. Samples were purified and loaded on a 1% TAE agarose gel. Fragments were 
separated at 50V over night. Transfer of the fragments to a membrane and DNA-DNA 
hybridization was done as described in 3.3.8-10. 
3.9 Western blot immunodetection of RNA Pol II 
2.5x106 cells were harvested by centrifugation. Cell pellets were resuspended in 2x Laemmli 
buffer (200µl each) and immediately heat denatured for five minutes at 100°C. 20µl of each 
sample were size separated in a 7% SDS polyacrylamid gel electrophoresis for 2.5h and 
30mA. Transfer to a nitrocellulose membrane was performed and 450mA for 90min. The 
membrane was washed with water and incubated at room temperature in blocking solution for 
60min. The membrane was incubated at 4°C over night with a 1:10 dilution of an antibody 
specific for the amino-terminal part of RNA polymerase II (Pol 3-3) in 5ml blocking solution. 
The membrane was washed three times in TBST for five minutes. Secondary antibody 
binding was performed at room temperature for two hours. After several washing steps (three 
times with water, three times with TBST, three times with water, and five minutes for each 
washing step), antibodies were visualized by incubation with ECL solution.TRick 
 4. RESULTS I  
EPIGENETIC REGULATION IN THE EARLY PHASE 
OF AN EBV INFECTION 
Upon infection of primary B cells, EBV establishes a latent infection as a rule. Eventually, the 
virus switches to the lytic phase of infection, and progeny virus is released, ready for the 
horizontal spread to infect other cells. BZLF1 is an EBV-encoded transcription factor 
responsible and sufficient for the switch to the lytic phase. BZLF1 is expressed in EBV 
infected cells very early after infection, but virus release cannot be detected before day twelve 
post infection (pi), with a gradual increase of released progeny virus until day 21 pi (Kalla et 
al., 2010). This contradiction was not understood, but the discovery that DNA methylation at 
CpG sites is essential for the expression of crucial lytic genes was the key to solve it. Certain 
viral genes carry a class of BZLF1 responsive elements (ZREs), which are exclusively or 
preferentially bound by BZLF1, if the central CpG dinucleotide in their cognate sequence 
carries a methyl-group (Bergbauer et al., 2010; Kalla et al., 2010). These special cognate 
sequences are termed meZREs (for methylated BZLF1 responsive elements). Virion DNA is 
epigenetically unmodified or “naked” at the time of infection, but acquires modifications 
similar to human chromatin after the establishment of the episome in the nucleus of infected 
cells. Accordingly, expression of essential lytic genes that encompass meZREs in their 
promoters is not possible in the early phase of infection. But once the methylation pattern is 
instituted, these promoters are ready to become activated. The dynamics of CpG-methylation 
of EBV’s DNA, which is the precondition to induce EBV’s lytic phase, still had to be solved. 
It was part of my work to study the kinetics of DNA methylation in primary infected B cells, 
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and to compare it with the occupation of EBV’s DNA with another epigenetic mark, i.e. the 
nucleosomes. I could show that DNA methylation is slow, starting not earlier than one 
week pi. A characteristic LCL methylation profile was evident three weeks pi. In contrast, my 
experiments demonstrated that incorporation of EBV’s DNA into nucleosomes is a fast and 
gradual process.  
4.1 Early epigenetic events can be monitored in 
infection experiments with primary B cells in vitro 
It is nearly impossible to study epigenetic events on EBV’s DNA in vivo with human cells, 
because the percentage of cells infected by EBV is very low. Genome-wide studies require 
scores of cells, which precludes this cell source for many experimental approaches. However, 
the infection of B cells can be simulated in cell culture. Adenoids of young children provide a 
source of uninfected, primary B lymphocytes. They can be isolated and separated from T cells 
with Ficoll-Hypaque density gradient centrifugation in the presence of sheep erythrocytes. 
Upon infection with EBV, cells start to proliferate and grow out to lymphoblastoid cell lines 
(LCLs), which can be kept in cell culture indefinitely and are a perfect source for material like 
chromatin, DNA, or RNA from stably and predominantly latently infected B cells (Fig. 4.1).  
 
 
Fig. 4.1 Source of primary B cells and 
schematic view of infection experiments  
One source of primary B cells are adenoids, 
which are surgically removed from the upper 
throat of young children. The B cells were 
infected to study epigenetic modifications at 
EBV’s viral DNA in a time course infection 
experiment. EBV transforms or immortalizes the 
primary B cells to yield latently infected, 
proliferating lymphoblastoid cell lines (LCLs).  
Preparation of DNA, Chromatin or RNA was 
performed at several time points post infection.   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4.2 EBV’s DNA methylation is a slow, but precise 
process and can be followed in vitro 
Tracking of DNA methylation in vitro requires a robust, effective and economic technique to 
identify methylated DNA in a genome-wide manner. Methylated DNA can be enriched in so-
called “methylated DNA immunoprecipitation” (MeDIP) experiments with an antibody that 
specifically recognizes methylated CpG dinucleotides in single stranded DNA (Weber et al., 
2005). Genomic DNA was isolated and sheared to an average length of 500bp by sonication. 
After heat denaturation, the single stranded DNA molecules were incubated over night with a 
monoclonal 5-methylcytosine antibody (Diagenode). The DNA-immuno-complexes were 
precipitated with sheep anti-mouse IgG1 magnetic beads. Proteinase K digestion followed by 
DNA purification resulted in a sample (“MeDIP”) that was enriched in methylated DNA 
compared to the “input” DNA (Fig. 4.2 A). Input DNA is total genomic DNA from the very 
same DNA sample, but which was not immunoselected and immunoprecipitated. It is 
representative for the DNA content of the analyzed cells and enables comparison of samples 
with different genomic loads. MeDIP DNA can be further analyzed locus specifically with 
quantitative real-time PCR (qPCR) or EBV-genome-wide with microarray technology 
(MeDIP-on-Chip).  
4.2.1 MeDIP experiments in the cell line Raji  
The human Burkitt-lymphoma cell line Raji was used to implement MeDIP with EBV-
positive cells. The Raji genome is highly methylated, and the methylation pattern of certain 
latent gene promoters is well characterized. For example, the C promoter is highly methylated 
in Raji cells, while the Q promoter, the LMP1 promoter, and the EBER locus completely lack 
methylation (Minarovits et al., 1992; Salamon et al., 2001; Fernandez et al., 2009). With this 
information at hand, it was possible to assess the results of this approach. 
Locus specific qPCR analysis revealed an overall high enrichment of MeDIP DNA compared 
to input DNA at the tested promoters. Only the EBER locus was not enriched in the MeDIP 
fraction (Fig. 4.2 B). As pointed out above, the C promoter is highly methylated in Raji cells, 
while the EBER locus is free of methylation, which is in line with the MeDIP results. 
However, the LMP1 promoter and the Q promoter were highly enriched in the MeDIP 
sample, which is controversial to published data. These observations uncover the restriction of 
MeDIP experiments: The resolution is limited, because the fragments have an average length 
of 500bp. The resolution might be too low for specific and shorter promoter sections. The 
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hypomethylated region in the EBER locus exceeds 1000bp and can be detected with MeDIP. 
In contrast, the Q promoter is located in close proximity to the very densely methylated F 
promoter. Accordingly, it cannot be identified by MeDIP and a false-positive result is 
obtained.  
 
 
Fig. 4.2 MeDIP (methylated DNA immunoprecipitation) experiments in Raji cells 
(A) For MeDIP experiments, Raji DNA was isolated, sheared to an average length of 500bp by sonication and 
heat denatured. To enrich for the methylated fraction, DNA was incubated over night with an antibody, which 
specifically recognizes methylated CpG dinucleotides. After immunoprecipitation of antibody/DNA complexes 
with anti-IgG1 magnetic beads, samples were Proteinase K digested and DNA was purified for further analysis 
by qPCR (B) or microarray hybridization (C).  
(B) Analysis of CpG-methylation of selected EBV promoter regions by qPCR. MeDIP-enriched DNA of three 
independent experiments was quantified for precipitated DNA compared to input DNA in a Roche LightCycler 
480 real-time PCR system at eight selected promoter regions. While the C promoter, the LMP1 promoter, the Q 
promoter, the W promoter and the BBLF4 promoter show a high degree of CpG-methylation (exceeding 10% of 
input DNA), the BZLF1 promoter and OriP show a lower degree of methylation (about 5% of input DNA). The 
EBER locus seems to be spared from methylation (below 1% of input DNA).  
(C)Genome-wide microarray analysis of the methylation profile of EBV DNA in Raji cells. MeDIP DNA and 
input DNA of three independent experiments were hybridized to a custom-made EBV-tiling array. The array 
consists of four identical sets of 285 PCR fragments with an average length of 500bp, covering the entire 
genome of B95.8 strain of EBV. Data was normalized such that the median of signal ratios was set to one. The 
ratio of MeDIP enriched DNA (IP) versus input DNA from the same cell sample is depicted on the y-axis, the 
genome location is shown on the x-axis. Selected features of EBV’s genome are illustrated below the x-axis and 
locations that were also analyzed in qPCR (B) are highlighted in red. The methylation profile indicates an overall 
high degree of CpG-methylation in Raji cell DNA. An exception is the EBER locus, which is free of methylation 
in a region of >1kb (two spots on the microarray/two bars in the diagram), which is in line with the qPCR results 
in (B).  
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I switched to MeDIP-on-Chip to obtain a genome-wide methylation profile of the EBV 
genome in Raji cells. The EBV-genome-wide MeDIP-on-Chip analysis was performed with a 
custom-made EBV microarray. The microarray consists of 285 probes of PCR fragments with 
an average length of 500bp, covering the whole EBV genome (strain B95.8) in tiling, i.e. 
partially overlapping fragments (Kalla, 2007). MeDIP DNA and input DNA were amplified 
with the whole genome amplification kit (Invitrogen), labeled with Alexa5 and Alexa3 
fluorochromes, respectively, and hybridized to the EBV microarray. The fluorescence signal 
of hybridized DNA was measured in a GenePix Personal 4100A scanner. The ratio of 
MeDIP/input signal reflects the methylation state of EBV’s DNA.  
Fig. 4.2 C shows the results of the microarray analysis. The normalized ratio of MeDIP/input 
is depicted on the y-axis and the x-axis indicates the EBV genome location. The experiment 
revealed differentially methylated regions. The EBER locus was completely spared from 
methylation, and the C promoter was enriched in methylated DNA. Unfortunately, the 
resolution of the analysis was again too low to detect the unmethylated region in the Q 
promoter or the LMP1 promoter.  
Summing up the experiment, (i) the establishment of MeDIP experiments in EBV-positive 
cell lines was possible, (ii) differently methylated DNA regions could be detected by qPCR 
and MeDIP-on-Chip, i.e. the EBER locus and the C promoter, (iii) the experiment is robust 
and reproducible, as experiments were done in triplicates, but (iv) the resolution of MeDIP 
was limited. This experimental setting is unfeasible to study discrete methylation patterns of 
small loci (<500bp). But a high resolution is not necessary to analyze the temporal changes of 
DNA methylation in primary infected B cells. For this, the overall methylation profile is 
needed, but not the methylation pattern at single CpG sites. Thus, MeDIP-on-Chip 
experiments fulfill all criteria listed at the beginning of this chapter: It is a reliable, robust, and 
economic technique for the analysis of the EBV-genome-wide change of DNA methylation 
over time. 
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4.2.2 Kinetics of DNA methylation in primary infected B cells 
B cells were isolated from adenoids as depicted in Fig. 4.1 and infected with B95.8 wildtype 
virus at an MOI of 1.0 to analyze EBV’s methylation profile in the early phase of infection. 
MeDIP-on-Chip experiments were conducted with infected cells one, two, three, nine, and 
twelve weeks pi. The cells had different EBV genome loads, especially in the early phase of 
infection. Thus, the ratio of a constant point of reference was always set to one to normalize 
and compare the different datasets. 
 
Fig. 4.3 Kinetics of EBV methylation in primary infected B cells  
(A) MeDIP on Chip analysis of primary infected B cells at several weeks post infection (wpi). DNA from 
isolated B cells infected with B95.8 virus at an MOI of 1.0 was prepared after different time points pi. MeDIP 
analysis was carried out as described in Fig. 4.2, and samples were hybridized to our custom-made EBV tiling 
microarray. To analyze the kinetics of methylation pattern formation in samples with different genome loads, the 
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adjusted data were processed so that the ratio of a constant point of reference, Cp, was set to one in each 
experiment, because the C promoter region is free of methylated CpG dinucleotides even in established LCLs 
(Tierney et al., 2000), in contrast to EBV genomes in Raji cells. CpG dinucleotides in EBV DNA were entirely 
or mostly unmethylated early after infection but became increasingly methylated in resident EBV DNA of 
latently infected LCLs over time. The results of one of two biological repeats are shown.  
(B) The x-axis of the diagram shows the ratio of MeDIP-enriched EBV DNA versus input DNA of cells twelve 
weeks pi as in (A). The y-axis shows the number of CpG dinucleotides that occur in each of the 285 tiling PCR 
fragments of the EBV microarray. The regression curve was flat, its coefficient of determination was extremely 
low (R2 = 5 × 10−6), and the correlation coefficient was <0.003. The results indicated that there is no correlation 
between the degree of CpG-methylation in latently infected B cells and the occurrence of CpGs in EBV DNA. 
(C) RNA isolated from primary B cells infected with B95.8 virus at an MOI of 1.0 was transcribed into cDNA 
and analyzed by semiquantitative PCR. The expression of DNA methyltransferases (DNMTs) and other genes 
involved in DNA methylation was assessed, as indicated on the right of the gel image with the number of PCR 
cycles in brackets. DNMT1 and DNMT3a show an increase in their expression level one week pi, pointing to a 
role in EBV’s DNA methylation. DNMT3b likewise revealed a slight increase, at much lower levels than the two 
other DNMTs. Expression levels of NP95, which is a protein involved in maintenance methylation by DNMT1, 
followed the same pattern seen for DNMT1 and DNMT3a, while PCNA, which is a proliferation marker, showed 
only a minor increase in expression one week pi. Expression of the housekeeping gene β-glucoronidase (GUSB) 
was stable in all samples. The results of one representative experiments out of three biological replicates are 
shown. 
 
In contrast to Raji cells, the C promoter is unmethylated in LCLs (Tierney et al., 2000) and 
the ratio of MeDIP/input at the C promoter was the lowest value in all experiments. 
Therefore, this locus served as the reference point. Fig. 4.3 A shows the representative 
MeDIP-on-Chip result of one out of two biological replicas with two technical repeats each. 
The genome-wide methylation profile of B cells one week pi did not display a significant 
enrichment of any locus. This finding indicated that the DNA was unmethylated or only 
slightly methylated. Two weeks pi, an enrichment of methylated DNA was visible. The most 
substantial increase in methylation happened between week two and three pi. A manifest 
DNA methylation profile was visible three weeks pi comprising highly methylated regions 
and DNA segments that were spared from methylation like the C promoter and the EBER 
locus, respectively. This profile did not further change, as the MeDIP-on-Chip profile seen 
nine or twelve weeks pi did not exhibit any significant difference to the profile at week three. 
This experiment showed that CpG-methylation of EBV DNA is a slow, but specific process 
that culminates in a distinct methylation profile after several weeks pi. 
The amount of MeDIP DNA is not only a function of the methylation state of the fragment, 
but also of CpG density in the respective DNA sequence. The ratios of MeDIP/input of each 
microarray probe at twelve weeks pi was plotted against the number of CpG dinucleotides in 
the particular probes to test whether the methylation profile seen in LCLs was only dependent 
on the CpG density. The regression curve was flat, with a very low coefficient of 
determination (5×10−6), and the correlation coefficient (ranging from one for high correlation 
to minus one for anti-correlation) was close to zero (Fig. 4.3 B). The analysis indicated no 
sequence bias in MeDIP enrichment. Other mechanisms but CpG density seem to be 
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important to determine the methylation profile of EBV’s DNA in LCLs.  
Semiquantitative real-time (RT)-PCR experiments were performed to test, whether de novo 
methylation of EBV’s DNA might stem from the upregulation of the expression of DNA 
methyltransferases (DNMTs) in freshly infected B cells (Fig. 4.3 C). RNA of freshly infected 
B cells was prepared at different time points pi and transcribed into cDNA.  
The maintenance methyltransferase DNMT1 was expressed already at day one pi, but 
expression increased further, starting seven days pi. DNMT3a and DNMT3b encode for the 
two de novo methyltransferases. Both genes were weakly expressed at one day pi. The 
expression level started to rise seven days pi, similar to DNMT1 expression. Previous reports 
demonstrated that EBV’s latent membrane protein 1 (LMP1) induces the expression of all 
methyltransferases in nasopharyngal carcinoma cell lines (Tsai et al., 2002) and that DNMT1 
expression is upregulated by LMP1 via the JNK pathway (Tsai et al., 2006). These reports 
suggest that LMP1 is responsible for the upregulation of DNMT expression in my 
experiments, as it is expressed early after infection. The nuclear protein of 95 kDa (NP95) is a 
protein that is associated with maintenance and de novo DNA methylation. It recruits DNMT1 
to hemimethylated CpG sites in the DNA, but also interacts with de novo DNMTs, histone 
methyltransferases, and trimethylated H3K9 and connects the DNA methylation pathway to 
the establishment of repressive histone marks (Meilinger et al., 2009; Rottach et al., 2009). 
NP95 was upregulated in EBV infected, primary B cells seven days pi, indicating that this 
protein is involved in the establishment of epigenetic modifications in EBV as well. The 
proliferative cell nuclear antigen PCNA is a marker for proliferating cells, but is also involved 
in maintenance DNA methylation through interactions with DNMT1 at the replication fork. 
The slight upregulation in primary infected B cells was most likely a consequence of the 
growth transformation of these cells caused by the EBV infection. The expression of the 
housekeeping gene β-glucoronidase (GUSB) was stable in primary infected B cells over time.  
The results of the expression analysis suggested that cellular methyltransferases introduce 
CpG-methylation at EBV DNA. Upregulation of important genes involved in DNA 
methylation paralleled the increase in DNA methylation at EBV’s DNA. The slow increase in 
DNA methylation of EBV’s DNA could probably be the reason for the lack of virion 
synthesis until day twelve pi (Kalla et al., 2010). 
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4.3 EBV’s DNA is governed by nucleosomes very early 
after infection 
Nucleosomes are the fundamental repeating unit of eukaryotic chromatin. They organize the 
packaging of the huge genome inside the nucleus, while still ensuring proper access to the 
DNA. Nucleosomes consist of eight core histones, which are wrapped 1.67 fold by 
approximately 147bp of DNA. This core structure is separated from the next nucleosome by a 
linker region with a length of up to 80bp. A fraction of DNA is part of regularly arrayed 
nucleosomes that resemble “beads-on-a-string” (Fig. 4.4 A, middle). Some parts of the 
genome are very densely packed (Fig. 4.4 A, top) or contain stretches that lack nucleosomes 
in a DNA segment, which exceeds the size of a normal linker region (Fig. 4.4 A, bottom). The 
mode of nucleosomal organization constitutes a mechanism for gene regulation by adjusting 
the accessibility of DNA for regulatory proteins.  
 
Fig. 4.4 Digestion of chromatin with micrococcal nuclease (MNase)  
(A) Chromatin can be classified into different categories according to the accessibility to MNase digestion. 
Insensitive sites are tightly packed into nucleosomes, covering all contact surfaces for the enzyme and 
precluding it from DNA digestion. This chromatin moiety is usually found in heterochromatic regions. Sensitive 
sites have regular arrays of nucleosomes. The internucleosomal spaces are cleaved by MNase, which can reach 
the linker regions between regularly spaced nucleosomes easily. Hypersensitive sites contain long stretches of 
DNA, which are not packaged into nucleosomes and are therefore the preferred targets of MNase. Cutting sites 
of MNase are indicated with red arrowheads.  
(B) Partial digestion of chromatin with different amounts of MNase leads to a ladder of nucleosomal DNA in an 
agarose gel. Chromatin was prepared from Raji cells and treated with either 0.5U or 2U of MNase at 37°C for 
five minutes. After Proteinase K digestion and DNA purification, DNA was loaded on a 1% TAE agarose gel 
with ethidium bromide for visualization of the digestion pattern. Mononucleosomal DNA has a length of 147bp, 
which is one nucleosome encompassing eight core histone proteins. Chromatin, which is partially digested with 
MNase, will show a ladder of mononucleosomal DNA fragments and multimers thereof as indicated in this 
image.  
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4.3.1 Micrococcal nuclease is a tool to study nucleosomal DNA 
The accessibility of DNA can be used to study nucleosomal structures in the DNA on isolated 
chromatin in vitro. The enzyme micrococcal nuclease (MNase) is a relatively unspecific 
endo-exonuclease. Its cleavage efficiency depends on its accessibility to DNA, and therefore 
on the nucleosomal organization of the DNA. In regular nucleosomal arrays, MNase targets 
the histone-free linker region. DNA is nearly inaccessible to MNase in tightly packed 
nucleosomes. The preferred cleavage sites for MNase digestion are so-called hypersensitive 
sites, i.e. stretches of DNA, which lack histone proteins. In an agarose gel, partial digestions 
can be visualized as “MNase ladder” with mononucleosomal DNA at a length of 147bp and 
multimers thereof (Fig. 4.4 B). Chromatin preparation and treatment with MNase is used in a 
variety of methods that aim to analyze nucleosome positioning and/or occupancy on DNA. 
4.3.2 A Southern blot analysis detects EBV DNA in nucleosomes nine 
days pi 
The kinetics of nucleosome occupancy of EBV DNA can be analyzed in Southern blot 
experiments. Chromatin of infected primary B cells at several time points pi was treated with 
limited amounts of MNase, the DNA was purified, loaded in equal amounts on a 1% TAE 
agarose gel, and the MNase ladder was visualized by ethidium bromide staining (Fig. 4.5 A, 
upper part). The DNA was transferred to a nylon membrane and hybridized to a radioactively 
labeled probe (135.16), recognizing a specific part of EBV’s genome ranging form 
coordinates 7315 to 56081, but containing only two W repeats (Fig. 4.5 B). Only EBV DNA 
that is already part of nucleosomes is protected from degradation and will result in a typical 
MNase ladder in an autoradiogram (Fig. 4.5A, lower panel). Raji cells served as a positive 
control. In contrast, MNase treated chromatin from the EBV-negative cell line BJAB, 
uninfected primary B cells, and infected primary B cells one and three days pi did not give 
rise to discrete signals. The first specific signal emerged at day nine pi, indicating that EBV’s 
DNA was partially protected and adopted nucleosomal structures. The signals increased 
gradually, which could result from either an increase in the genome copy load per cell, like it 
is probably the case between day 16 and day 22 pi, or an increase of the fraction of EBV’s 
DNA protected from digestion in the MNase treatment over time.  
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Fig. 4.5 Southern Blot hybridization estimates the temporal formation of nucleosomal occupancy of viral 
DNA 
(A) Chromatin of uninfected and freshly infected B cells was prepared at various time points pi as indicated. 
Chromatin was treated with different amounts of MNase (0.5 U and 2 U per sample) to achieve a partial 
digestion. After Proteinase K treatment and DNA purification, equal amounts of DNA were separated on a 1% 
TAE agarose gel with ethidium bromide (upper part). Separated DNA was blotted to a nylon membrane and 
hybridized over night with a radioactively labeled probe (135.16). The probe will detect DNA only, which is 
already part of nucleosomal structures, because MNase will degrade nucleosome-free DNA. Raji cells served as 
a positive control compared to the EBV-negative cell line BJAB. As early as day nine pi, viral DNA appeared 
partially protected from MNase-mediated degradation as can be seen from the occurrence of a typical MNase 
ladder in the autoradiogram (lower part). The signal intensity of the MNase ladder increased over time and 
reached its maximum 22 days pi. The strong signal increase between day 16 and day 22 probably reflects a raise 
in the viral genome load per cell.  
(B) The diagram provides a general overview of the EBV genome. The probe used in (A) was a recombinant 
plasmid DNA covering a part of EBV’s genome ranging from nucleotide coordinates 7315 to 56081, with two 
BamW repeats, only.  
 
4.3.3 OriP nucleosomes are detected as early as three days pi in a qPCR 
approach 
The detection of DNA in Southern blot experiments has one limitation, namely sensitivity. To 
obtain a signal, DNA amounts of >10pg are necessary. This is particularly difficult in bulk 
cell cultures of primary B cells early after infection, because EBV will not infect every cell. 
Thus, nucleosomal positioning could take place earlier than its first detection in a Southern 
blot experiment. A more sensitive method is quantitative real time PCR (qPCR), because in 
theory, one molecule of DNA is enough to obtain a significant signal after PCR amplification.  
The positions of two nucleosomes flanking the dyad symmetry element (DS) of oriP are 
known (Zhou et al., 2005). With this information, I designed primer pairs for the 
amplification of the respective nucleosomal DNA (NucI and NucII, details in Fig. 4.6). A 
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third primer pair, termed NucII/III, encompassed the internucleosomal space between 
nucleosome II and III and served as an internal negative control. Chromatin was treated with 
MNase, and the mononucleosomal DNA was purified and analyzed by qPCR. The negative 
control PCR product of NucII/III was always set to one to normalize for different genome 
loads in a time course experiment or in different cell lines.  
 
Fig. 4.6 EBV DNA packed in nucleosomes at oriP can be detected in a qPCR approach 
(A) The exact positions of three nucleosomes around the dyad symmetry element (DS) of OriP is known (Zhou 
et al., 2005). With this information at hand, primers were designed to assess the nucleosomal positioning in the 
course of an EBV infection. Two primer pairs amplify the nucleosomal DNA (NucI and NucII, as indicated in 
A), whereas a third primer pair (termed NucII/III) spans the internucleosomal space between nucleosome II and 
III. The negative control PCR product of NucII/III was always set to one to calculate the relative enrichment of 
the PCR products of NucI and NucII. 
(B) Chromatin of different cell lines was prepared and digested with MNase to determine the relative occupancy 
and positioning of nucleosomes I and II. After gel purification of mononucleosomal DNA, quantitative real time 
PCR analysis was carried out with the primer pairs described in (A). Mononucleosomal DNA from Raji cells and 
a long term LCL showed a clear enrichment of the products of NucI and NucII as compared to the product of 
NucII/III. The cell line BJAB served as a negative control.  
(C) Primary B cells infected with EBV (strain B95.8) revealed an enrichment of the products of NucI and NucII 
as early as three days pi, which was increasing subsequently. Uninfected and mock-infected cells did not show 
enrichment of any PCR product. The result of one out of four biological replicates is shown. This analysis 
clearly indicated that the positioning of nucleosomes on EBV DNA flanking DS is a fast but gradual process. 
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Long-term LCL and Raji cells were analyzed for the positioning of the two DS-nucleosomes. 
Both cell lines were highly enriched in the PCR products for NucI and NucII at comparable 
levels (Fig. 4.6 B), indicating that the nucleosomes are likewise positioned. The EBV-
negative cell line BJAB served as a negative control and did not show any enrichment of the 
PCR products. The first detectable enrichment of the NucI PCR product was visible in 
infected primary B cells on day three pi. The signal increased gradually, demonstrating a 
rapid and fast incorporation of EBV’s DNA into nucleosomes (Fig. 4.6 C). The NucII PCR 
product showed a similar pattern, but was delayed by one day. Uninfected and mock-infected 
cells did not display any enrichment of either PCR product, as expected.  
The qPCR approach identified EBV DNA to become part of nucleosomal structures very 
early after infection at oriP. In terms of timing, qPCR was more sensitive in comparison with 
the Southern blot experiment. But both experiments demonstrated a gradual increase of 
nucleosome occupancy of EBV DNA. As indicated above, this could reflect different genome 
loads in the cells, or a steady increase of EBV nucleosomes over time. 
 5. RESULTS II  
EPIGENETIC MODIFICATIONS ON EBV’S DNA 
DEFINE LATENCY – AND A CHANGEOVER 
CAUSES THE LYTIC SWITCH 
DNA methylation at CpG dinucleotides is important for the regulation of EBV’s life cycle. 
The viral transcription factor BZLF1 has the unique characteristic to activate genes, even if 
their promoters contain BZLF1 responsive motifs with methylated CpG dinucleotides 
(Bhende et al., 2004; Bergbauer et al., 2010; Kalla et al., 2010). We previously identified 
numerous viral promoters and the cognate sequence motifs in a genome-wide ChIP 
sequencing approach. So-called meZREs* are preferentially located in promoters of early lytic 
genes. BZLF1’s ability to bind and activate promoters, which are repressed by extensive 
DNA methylation, is a viral strategy to escape from latency and induce the lytic phase. DNA 
methylation is one epigenetic mechanism but the overall chromatin configuration at lytic 
promoters was unclear when I started my PhD work. It was unknown whether promoters, 
which encompass meZREs, are methylated in vivo. This aspect is fundamental because our 
hypothesis relies on this concept to mediate escape from viral latency. Similarly, the 
occupancy of EBV DNA with nucleosomes and its role during latency was unclear. Certain 
post-translational modifications of histone tails have been studied at latent gene promoters, 
but the contribution of the histone code to establish and maintain the repressed state of lytic 
promoters during latency has not been analyzed thoroughly. It was the aim of my work to                                                         
* methylated BZLF1 responsive elements 
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address and clarify these open issues. I wanted to reveal the epigenetic status of the lytic 
promoters during latency and identify the changes that accompany induction of EBV’s lytic 
phase, which overrides repressive epigenetic events at lytic promoters.  
5.1 EBV’s DNA methylation at the nucleotide level 
The BRLF1 promoter and the BBLF4 promoter are two prominent examples of promoters that 
contain meZREs. Both promoters were strongly bound by purified BZLF1 protein in a pull 
down assay with in vitro methylated EBV DNA (Fig. 5.1, red line, lower y-axis). 
Unmethylated DNA was not or only weakly bound (Fig. 5.1, black line, lower y-axis). The in 
vivo binding of BZLF1 protein to DNA in viral chromatin in Raji cells was assessed by 
Chromatin Immunoprecipitation (ChIP) experiments (Fig. 5.1, grey line, upper y-axis). The 
grey line is a nearly perfect mirror image of the red line indicating that the meZREs identified 
in vitro were important binding sites for BZLF1 in vivo. Nevertheless, the DNA methylation 
state of the meZREs in vivo was uncertain. 
 
 
Fig. 5.1 BZLF1 can bind to its cognate sequences even if they carry methylated CpG dinucleotides 
As described previously by us, a genome-wide screen identified BZLF1-responsive elements (ZREs) with a 
ChIP sequencing approach (Bergbauer et al., 2010). The grey line, mapped on the upper part of the y-axis, 
represents the result of a conventional Chromatin Immunoprecipitation (ChIP) experiment in Raji cells, while 
the red and the black lines (represented on the lower part of the y-axis) depict the results of in vitro pulldown 
assays, using either completely methylated (red) or unmethylated (black) EBV DNA as a substrate for binding to 
purified BZLF1 protein. Plotted is the sequencing depth, i.e. the number of sequence reads per base pair (y-axis), 
versus the genome coordinates of EBV strain B95.8 (x-axis).  
(A) The two promoters of BZLF1 and BRLF1 encompass ZREs. The promoter of BRLF1 contains ZREs, which 
are exclusively or preferentially bound by BZLF1 protein when CpG-methylated. These motifs are termed 
meZREs. The grey line (top part of the y-axis) depicts the situation in Raji as in vivo; the red line (bottom part of 
the y-axis) is almost a mirror image at the BRLF1 promoter. The BZLF1 promoter is different, because it does 
not appear to be accessible to BZLF1 protein in vivo. 
(B) The BBLF4 promoter contains several binding sites for BZLF1, which are exclusively bound if the DNA is 
methylated in vitro. The meZREs perfectly match the binding sites of in vivo ChIP experiments.  
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I analyzed selected regions of the EBV genome with deep bisulfite sequencing to assess their 
state of methylation including meZRE motifs of early lytic promoters. The methylation 
pattern of certain latent and late lytic promoters was also determined to understand the overall 
concept of viral gene regulation by DNA methylation. I could prove that all meZREs are 
highly methylated in latent Raji cells and that induction of the lytic phase does not cause a 
change in the methylation profile of EBV’s DNA. 
5.1.1 Deep bisulfite sequencing assesses EBV DNA methylation at the 
nucleotide level  
The chemical treatment of DNA with bisulfite allows the discrimination between methylated 
and unmethylated cytosines. The addition of a sulfur trioxide group to the C5 position of the 
pyrimidine ring causes the hydrolytic desamination of the cytosine, i.e. the amino group is 
substituted by a ketone. As a consequence, cytosines are converted into uracils. Methylated 
cytosines are protected from the conversion, because the methyl-group is located at the C5 
position. Fig. 5.2 provides an overview about the working steps I performed to obtain the 
DNA methylation pattern of certain viral genomic sequences on the nucleotide level.  
Genomic DNA from Raji cells was bisulfite modified. 60 partly overlapping PCR products 
encompassing a total of 26 EBV regions formed contigs, which contained a selection of 
latent, early lytic, and late lytic gene promoters. PCR products had an average length of 461bp 
and covered 27869bp of EBV’s genome. They were purified and pooled in equimolar 
amounts and sequenced on a Roche Genome Sequencer FLX system in cooperation with the 
Microsynth AG (http://www.microsynth.ch).  
I used the CLC genomic workbench software for sequence alignment. Sequence reads were 
aligned to a modified version of the B95.8 wildtype sequence, in which I converted all 
cytosines in a non-CpG context to thymines. Cytosines of CpG dinucleotides were kept 
unconverted. The parameters of the sequence alignment were set to tolerate RY-mismatches 
in the context of CpG dinucleotides, allowing mismatches of purines and pyrimidines, which 
are expected if cytosines are unmethylated. A total number of ~88000 reads with an average 
length of 346bp was successfully mapped to the EBV genome. Aligned sequences were 
extracted and the percentage of methylated cytosines was assessed with the BiQ analyzer HT 
software/beta-test version (Bock et al., 2005).  
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Fig. 5.2 High-resolution analysis of viral DNA methylation at the nucleotide level by deep bisulfite 
sequencing 
(A) DNA of Raji cells was isolated and treated with bisulfite, which leads to the hydrolytic desamination of 
cytosines to uracils. After PCR amplification and purification of 60 regions of the viral genome, samples were 
pooled in equimolar amounts and sequenced with a Roche Genome Sequencer FLX system (“454 sequencing”). 
Sequences were aligned to the EBV genome to identify methylated CpG dinucleotides.  
(B) Example of ten PCR products after purification and equimolar adjustment. PCR products had an average 
length of 461bp and covered 27869bp of the viral genome, representing 20% of EBV’s unique sequences. The 
sequenced regions include latent, immediate early, early, and late promoters of EBV. 
 
The deep sequencing results of four contigs are graphically represented in Fig. 5.3. Each bar 
represents a CpG dinucleotide in the EBV B95.8 sequence and is plotted against its genome 
location on the x-axis. The percentage of methylation of each CpG dinucleotide is depicted in 
red on the left y-axis. The sequence coverage is indicated as grey area and is pictured on the 
right y-axis in logarithmic scale. The coverage of each CpG dinucleotide was 840 reads/bp on 
average and >10 reads/bp were considered as representative. Selected features of the EBV 
genome are shown above the graphs. Deep bisulfite sequencing detected certain sequence 
variations between Raji DNA and B95.8 wildtype DNA. CpG dinucleotides missing in Raji 
DNA are illustrated as black bars with a star on top, additional CpG dinucleotides have a 
circle on top of the red or grey bar. 
The F/Q promoter was completely unmethylated in Raji cells between genome coordinates 
62200 and 62600, in sharp contrast to the highly methylated region upstream (Fig. 5.3 A). A 
previous study compared the methylation state of 20 CpG dinucleotides in a region between 
genome coordinates 62200 and 62500 in several cell lines including Raji cells (Tao et al., 
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1998). The 20 CpG dinucleotides were hypomethylated in most cell lines, but a minor fraction 
showed variable methylation in the first eight CpG sites that encompass the F promoter. My 
deep sequencing results demonstrated that Raji cells completely lack CpG-methylation in this 
region. Two CTCF binding sites flank the eight CpG sites that are methylated to some degree 
in certain cell lines (Tempera et al., 2010) and presumably shield the Q promoter from DNA 
methylation and other repressive modification in its close vicinity.  
The BZLF1 promoter does not encompass meZREs and CpG sites are underrepresented in this 
promoter in comparison with the average CpG density in EBV (Fig. 5.3 B). The six CpG sites 
downstream of the BZLF1-TATA box were hypomethylated, although BZLF1 is not 
expressed in latent Raji cells. This finding indicated that repressive mechanisms distinct from 
DNA methylation are responsible to repress the BZLF1 promoter. For example, ZEB-
proteins* were shown to bind to the transcriptional initiation site of BZLF1 and to suppress 
gene activation during latency (Kraus et al., 2003; Yu et al., 2011).  
The CpG-rich BBLF4 promoter was heavily methylated, reaching nearly 100% methylation at 
most CpG dinucleotides (Fig. 5.3 C). The high percentage of methylation especially in 
meZREs indicated a homogenous pattern of CpG-methylation of all genome copies of EBV in 
Raji cells. The high degree of CpG-methylation at the BBLF4 promoter also indicated that all 
cells within the population of Raji cells have a repressed BBLF4 gene during latency. Other 
early lytic promoters showed an equally high and uniform methylation of meZREs (Tab. A4, 
appendix). Methylated meZREs offer a platform for BZLF1 binding, once the protein is 
expressed. The consistently high degree of CpG-methylation of meZREs is presumably a 
mean to target the BZLF1 protein to most motifs and induce a high expression of early lytic 
genes upon the onset of the lytic phase. Other CpG sites in the BBLF4 promoter, like the five 
CpGs between genome coordinate 114525 and 114575, were variably methylated. This 
suggested that the methylation state of the respective sites was less important for epigenetic 
regulation of EBV.  
The BDLF4/BDRF1 promoter showed a high degree of CpG-methylation (Fig. 5.3 D), 
indicating a tight repression of these late lytic genes during latency. Remarkably and in 
contrast to most early lytic genes, meZREs are absent in the BDLF4/BDRF1 promoter, as are 
conventional ZREs (Bergbauer et al., 2010). It is clear from this observation that BZLF1 does 
not reverse the repression of this late lytic promoter. The deep bisulfite sequencing results of 
the remaining 22 contigs are presented as a table in the appendix (Tab A4).                                                         
* zink finger E-box binding proteins 
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Fig. 5.3 Graphical representation of four selected regions of the viral genome in Raji cells with results 
from deep bisulfite sequencing 
Each bar represents a CpG dinucleotide and is plotted versus its genome coordinate on the x-axis. The 
percentage of methylation is displayed on the left y-axis and is indicated in red. The right y-axis provides the 
sequencing coverage, which is depicted as a grey area in the diagrams in logarithmic scale. Coverage above ten 
reads/bp was considered to be representative for the analysis. Deep bisulfite sequencing detected single sequence 
variations between Raji DNA and B95.8 wildtype sequence. CpG dinucleotides missing in the Raji genome but 
present in B95.8 are indicated as black bars with a star on top, while additional CpG dinucleotides in Raji cells 
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are indicated with a circle on top of the red or grey bar. Selected annotation of the EBV genome can be found 
above the graph, with ZREs and meZREs indicated as black or red circles, respectively.  
(A) Methylation pattern of the region with the latent Q promoter. The Q promoter was clearly spared from CpG-
methylation, in sharp contrast to the upstream and downstream regions, which were heavily methylated. These 
findings indicate that the Q promoter is protected from methylation and is active in latency, which is in line with 
a recently identified CTCF binding site, situated exactly at the left border between methylated and unmethylated 
regions (Tempera et al., 2010).  
(B) Methylation profile of the immediate early promoter of BZLF1. The BZLF1 promoter contains only six CpG 
dinucleotides, which were not methylated in Raji cells, pointing to a repressive mechanism distinct from DNA 
methylation during latency.  
(C) Methylation pattern at the early lytic promoter of BBLF4. The BBLF4 promoter is highly enriched in CpG 
dinucleotides, most of them showed a very high percentage of methylation. All CpG dinucleotides, which are 
part of known meZREs and bound by BZLF1 in a methylation dependent manner, were methylated to nearly 
100%.  
(D) The ZRE-free late lytic promoters BDLF4 and BDRF1 were methylated indicating their tight repression 
during latency.  
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5.1.2 Lytic induction does not change the DNA methylation of EBV 
promoters  
I established a conditional system for the induced expression of BZLF1 to analyze possible 
changes of epigenetic modifications on viral DNA in the lytic phase of EBV. The plasmid 
pRTS-2 comprises the constitutively active, bicistronic coding sequence of the Tet-repressor-
KRAB fusion gene and the tetracycline controlled transactivator rtTA2s-M2 (Fig. 5.4 A). The 
repressor binds tightly to the bidirectional tet promoter and inhibits activation of the tet-
controlled genes in the absence of tetracycline or its analogue, doxycycline. Upon addition of 
doxycycline, the activator replaces the repressor, and the tet-controlled genes are expressed 
(Bornkamm et al., 2005). The coding sequences of BZLF1 and the green fluorescent protein 
(GFP) were placed under the control of the tet promoter to obtain an inducible BZLF1 
expression that can be monitored by GFP positive cells with, for example, flow cytometry 
(Fig. 5.4, A and B). 
 
Fig. 5.4 Conditional expression of BZLF1 in Raji cells 
(A) The plasmid 3862 pRTS-2-BZLF1 contains the bicistronic coding sequence of the Tet-repressor-KRAB 
fusion gene and the tetracycline controlled transactivator rtTA2s-M2 under the control of the constitutively 
active chicken beta-actin promoter. The two genes are separated by an internal ribosomal entry site (IRES). In 
absence of tetracycline or its analogue, doxycycline, the repressor binds tightly to the so-called tet promoter, and 
inhibits its activation. After addition of doxycycline to the cells, the repressor is released from the promoter and 
replaced by the activator, which induces transcription. The promoter in the plasmid is bidirectional, allowing the 
simultaneous expression of the two transgenes GFP and BZLF1 (Bornkamm et al., 2005).  
(B) GFP expression in single Raji cells is a measure of induced transgene expression of BZLF1. The addition of 
100 ng/ml doxycycline to the cells for 15 h led to 87% of GFP positive cells, as measured by flow cytometry.  
(C) Nine single cell clones of Raji cells stably transfected with the plasmid 3862 pRTS-2-BZLF1 were analyzed 
for cell viability and inducibility of transgene expression by flow cytometry. Cells were cultivated and induced 
in three independent experiments to validate a robust and reproducible transgene expression. Clone 3862.1 was 
chosen for further analysis.  
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Raji cells were stably transfected with the plasmid 3862 pRTS-2-BZLF1. Nine single cell 
clones of Raji 3862 cells were analyzed for viability and inducibility of the transgenes using 
flow cytometry. The inducibility varied between the clones, but a robust and high expression 
of the GFP gene was obtained in Raji 3862 cells clone 1. This clone was chosen for further 
experiments (Fig. 5.4 C). An important characteristic of Raji cells and its derivates is the lack 
of the BALF2 locus. The BALF2 protein is essential for the lytic DNA replication of the viral 
genome. As a consequence, downstream gene expression of all late viral genes is blocked and 
Raji 3862 cells can be induced to express early lytic genes, only, but the late lytic phase does 
not commence and remains incomplete. This aspect is important for the analysis of epigenetic 
modifications on EBV’s DNA upon lytic induction, because this Raji cell model does not give 
rise to the synthesis of viral progeny DNA, which would be a major problem as it is free of 
CpG-methylation and other epigenetic modifications. 
The methylation state of four selected regions was assessed by bisulfite sequencing after lytic 
induction. Raji 3862 cells were incubated with 100ng/ml doxycycline over night and sorted 
for GFP positive, i.e. lytically induced cells, with a FACS Aria II instrument. DNA of 
lytically induced and parental Raji cells was isolated, bisulfite treated and amplified with 
primers spanning the F/Q promoter, the BZLF1 promoter, the BBLF4 promoter, and the 
BDLF4/ BDRF1 promoter. Resulting PCR fragments were purified and directly sequenced by 
the Sanger method and a commercial service provider (http://www.sequiserve.de). The ratio 
of the height of the cytosine peak to the height of the thymine peak in the sequencing 
chromatogram provides the conversion rate, i.e. the methylation state of the promoters. 
Fig. 5.5 represents the results graphically in a way comparable to Fig. 5.3. The methylation 
state of parental Raji cells is depicted in red; the percentage of methylation in induced Raji 
3862 cells is shown in green. There was no remarkable difference between the DNA 
methylation pattern of parental Raji cells and induced Raji 3862 cells in any locus. Slight 
variations were visible only in regions, which are variably methylated in parental Raji cells, 
like the five CpG dinucleotides around position 61925 in the F/Q promoter. The region 
downstream of the F promoter remained hypomethylated (Fig. 5.5 A), similar to the BZLF1 
promoter (Fig. 5.5B). The meZREs in the BBLF4 promoter remained highly methylated after 
lytic induction (Fig. 5.5 C). Also the late lytic BDLF4/BDRF1 promoter was heavily 
methylated in both cell lines. My findings indicated that lytic induction does not alter the 
methylation state of EBV’s DNA. 
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Fig. 5.5 The DNA methylation profile of Raji EBV DNA does not change upon induction of EBV’s lytic 
phase 
DNA of Raji cells or induced Raji 3862 cells, which had been sorted for expression of GFP, was isolated and 
treated with bisulfite. Bisulfite modified DNA was amplified with primers specific for (A) the latent Q/F 
promoter, (B) the immediate early BZLF1 promoter, (C) the early lytic BBLF4 promoter, and (D) the late lytic 
BDLF4/BDRF1 promoter. PCR fragments were directly sequenced by the Sanger method and the resulting 
chromatograms were analyzed for the ratio of the height of the cytosine peak to the thymine peak, which reflects 
the rate of conversion after chemical bisulfite modification. Similar to Fig. 5.3, the percentage of methylation in 
Raji cells (latent) is depicted in red, while the percentage of methylation in lytically induced Raji 3862 cells 
(lytic) is indicated as green bars.  
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5.2 Nucleosome occupancies in EBV 
Nucleosomes are barriers to transcription. The tightly packed complex of histone proteins and 
DNA constricts the accessibility of the DNA for proteins that are important for gene 
regulation and transcription (Bai et al., 2010). Most of the knowledge about the role of 
nucleosomes during transcriptional regulation originates from research in yeast. S. cerevisiae 
holds several inducible promoters, which serve as model systems for nucleosomal 
rearrangements upon transcriptional induction (i.e. the PHO promoter, Svaren et al., 1997; 
Adkins et al., 2004), but similar studies are rare in humans.  
The nucleosome occupancy in EBV’s DNA and its role during latency and lytic reactivation 
has not been studied so far. It was part of my work to analyze the occupation of EBV’s DNA 
by nucleosomes with a focus on promoters that become activated upon lytic induction through 
the binding of BZLF1. I could show that certain BZLF1-regulated early lytic promoters were 
densely packed in nucleosomes during latency. Induction of the lytic phase caused major 
rearrangements in those promoters as compared to the rest of the genome. My studies 
identified different promoter subgroups, which have alternative modes of regulation by 
nucleosome occupancy and eviction, indicating different classes of genes and a hierarchy in 
the stringency of repression during latency.  
5.2.1 Mononucleosomal DNA on Chip (MND-on-Chip) experiments 
assess the nucleosomal occupancy of viral DNA 
MND-on-Chip experiments rely on the different accessibility of DNA to MNase cleavage in 
the context of chromatin (compare chapter 4.3.1 and Fig. 4.4). A digestion of chromatin with 
MNase leads to the degradation of free DNA, whereas DNA that is part of nucleosomes is 
protected and can be identified in a microarray hybridization.  
Chromatin of different Raji cell derivates was treated with MNase. The DNA was purified 
and size-selected for mononucleosomal DNA on an agarose gel. Mononucleosomal DNA and 
sonicated input DNA with an average length of 150bp were labeled with the fluorochromes 
Cy5 and Cy3, respectively, and hybridized to a high-resolution EBV microarray (Fig. 5.6). 
The microarray contained the whole EBV B95.8 sequence in tiling oligonucleotides of 50 
nucleotides in a step size of ten and an offset of five nucleotides between upper and lower 
DNA strand. In theory it provided a final resolution of five nucleotides.  
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Fig. 5.6 Mononucleosomal DNA on Chip (MND-on-Chip) experiments analyze the nucleosome occupancy 
of DNA 
Chromatin was treated with 50U/sample MNase and digested with Proteinase K. After DNA purification, 
mononucleosomal DNA was size selected on agarose gels and purified. Nucleosomal DNA was labeled with the 
fluorochrome Cy5 and hybridized together with sheared, Cy3-labeled DNA from the same cells (“input”) to a 
custom Nimblegen microarray. The microarray encompasses the whole EBV B95.8 genome in tiling oligomers 
with a length of 50, a spacing of ten and an offset of five nucleotides between upper and lower DNA strand, 
providing a final resolution of five nucleotides.  
5.2.2 Nucleosome occupancy in EBV’s BZLF1-responsive promoters 
MND-on-Chip experiments were conducted with three different sets of cell lines. Parental 
Raji cells were analyzed as a model of the latent state. Doxycycline-induced Raji 3862 cells 
express full-length BZLF1 and GFP as transgenes upon induction (compare chapter 5.1.2 and 
Fig. 5.4). Chromatin of lytically induced and GFP-sorted cells was prepared to analyze the 
nucleosome occupancy in EBV’s lytic phase. Raji 3927 cells constitutively express a 
truncated version of BZLF1 that lacks its N-terminal activation domain. Chromatin of this cell 
line was analyzed to study the influence of BZLF1’s DNA binding domain (DBD), only, on 
nucleosomal occupancies at BZLF1-regulated promoters. Experiments were performed with 
two independent preparations of mononucleosomal DNA each. The ZREs that had been 
identified in the EBV genome (Bergbauer et al., 2010) were reviewed for the following 
criteria for a subsequent bioinformatical analysis: Clusters of ZREs and meZREs or single 
BZLF1 binding sites had to be at least 1500bp apart from each other in the EBV genome. In 
regions that encompass two or more closely spaced ZREs in a cluster, the position with the 
strongest binding of BZLF1 was selected. 32 ZREs and meZREs fulfilled the criteria and 
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were selected for my analysis. For simplicity, they are further denoted as “ZREs”, because the 
discrimination between methylation dependent and methylation independent ZREs is not 
important for this analysis. A list of the 32 ZREs can be found in the appendix (Tab. A5). The 
“enriched versus input” log2-ratios (log2-ratios) indicate the occupancy of DNA with 
nucleosomes.  
The log2-ratios of the 32 ZREs were averaged and the average nucleosome occupancy profiles 
of the three Raji derivates were overlaid in a window ±2000bp, centered at the start of the 
ZRE (Fig. 5.7 A) The average nucleosome occupancy profile displayed an increased 
nucleosome occupancy at ZREs during latency (parental Raji cells, black line), indicated by a 
high log2-ratio. The elevated log2-ratio dropped after lytic induction (Raji 3862 cells, red line) 
and after binding of the DBD of BZLF1 (Raji 3927 cells, green line). This observation 
indicated that full length BZLF1, but also binding of the truncated version of BZLF1, which 
encompassed the C-terminal half of BZLF1 with the DBD, only, caused the loss of 
nucleosomes at ZREs.  
Subtraction of the log2-ratios of the individual ZREs of lytically induced Raji 3862 cells and 
parental Raji cells are shown in a heat map in Fig. 5.7 B (left panel). The rows depict the 
subtracted values shown in Fig. 5.7 A at each individual ZRE in a window size of ±2000bp, 
centered at the start of the ZRE. A cluster analysis was performed to probe for functional 
groups among all ZREs. The cluster analysis of all ZREs was done on the same heat map 
matrix with a window size of ±350bp, centered at the ZRE start. The resulting dendrogram 
shown on the left side of the heat map identified three functional groups of ZREs. We 
concentrated the following analysis on the two most divergent groups, situated at the upper 
and lower part of the dendrogram, i.e. group 1 and group 2, respectively. Group 1 of ZREs 
was comprised of 15 ZREs as indicated in the heat map. The average nucleosome occupancy 
profile of group 1 ZREs during latency (right panel, parental Raji cells, black line) did not 
display elevated log2-ratios at the ZRE. The average log2-ratios did not change in lytically 
induced cells expressing full-length BZLF1 (Raji 3862 cells, red line) or in cells containing 
the binding domain of BZLF1, only (Raji 3927 cells, green line), indicating that the average 
nucleosome occupancy was similar in all Raji derivates. In contrast, group 2 ZREs, which 
contained the lower cluster of ZREs as indicated in the heat map, had elevated average 
nucleosome occupancies at the ZRE during latency (parental Raji cells, black line). The 
average log2-ratios dropped after induction of the lytic phase (Raji 3862 cells, red line). 
Binding of BZLF1 to the ZREs caused a similar reduction of average nucleosome 
occupancies at the ZREs (Raji 3927 cells, green line). 
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Fig. 5.7 Nucleosome occupancy in BZLF1-regulated promoters  
MND-on-Chip experiments were carried out as described in Fig. 5.6. Parental Raji cells (black line), Raji 3927 
cells expressing the DNA binding domain (DBD) of BZLF1 constitutively (green line), and induced Raji 3862 
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cells, which express full length BZLF1 protein upon addition of doxycycline were analyzed. The log2-ratios of 
enriched versus input data, cluster analyses, and heat maps were obtained as described in the methods section.  
(A) Overlay of the average nucleosome occupancy profiles of 32 ZREs in Raji cells (black line), Raji 3927 cells 
(green line), and lytically induced Raji 3862 cells (red line) in a window of ±2000bp, centered at the start 
position of each ZRE.  
The average nucleosome occupancy appeared elevated at the positions of ZREs in latency as indicated by the 
increased log2-ratio in parental Raji cells. Upon induction of the lytic phase (red line), the ratio dropped, 
indicating a loss of nucleosomes in those cells. Raji 3927 cells, which express the truncated BZLF1, showed a 
reduced average nucleosome occupancy in comparison to Raji cells, similar to induced Raji 3862 cells.  
(B) Left panel: Subtractions of the log2-ratios of lytically induced Raji 3862 cells and latent parental Raji cells 
for the 32 single ZREs were visualized in a heat map in a window of ±2000bp, centered at the start position of 
each ZRE. The rows of the heat map represent individual ZREs. Negative values of the subtraction are in blue, 
positive values are shown in yellow, and values close to zero are marked in green. A dendrogram was obtained 
after performing a cluster analysis on the same heat map matrix with a window of ±350bp, centered at the start 
position of each ZRE, and is shown on the left side of the heat map. Based on this dendrogram, different 
categories of functional groups among the ZREs were uncovered. We concentrated our analysis of the two most 
divergent groups of the upper and the lower part of the dendrogram. Group 1 comprised 15 ZREs, which are in 
the upper part of the dendrogram, as indicated. Group 2 contained all 11 ZREs of the lower cluster, as indicated.  
Right panel: The overlay of the average nucleosomal occupancy for group 1 ZREs and group 2 ZREs were 
obtained as in (A). The average nucleosomal occupancy of group 1 ZREs was low and did not reveal noticeable 
differences between the three Raji cell derivates, as the log2-ratios indicated. Group 2 ZREs showed a high 
nucleosome occupancy during latency (black line, right panel), which disappeared in lytically induced Raji 3862 
cells (red line). Again, Raji cells, which constitutively express the DBD of BZLF1 only, displayed a pattern 
comparable to Raji 3862 cells, which express full length BZLF1.  
(C) Subtractions of the log2-ratios of lytically induced Raji 3862 cells (full length BZLF1) and Raji 3927 cells 
(truncated BZLF1) of the eleven single ZREs of group 2 were analyzed in a heat map (left panel) and in an 
overlay of the average nucleosome occupancy of the three datasets (right panel) similar to (B). The dendrogram 
shown on the left side of the heat map clearly illustrated two subgroups. Subgroup 2a ZREs comprised seven 
ZREs of the upper cluster of the dendrogram. The average nucleosome occupancy of this group was reduced as 
compared to parental Raji cells but nearly identical between lytically induced Raji 3862 cells and Raji 3927 
cells. Subgroup 2b clustered on the lower part of the dendrogram and encompassed four ZREs. An accentuated 
loss of average nucleosome occupancy was observed in this group, when full length (wild-type) BZLF1 bound to 
the ZREs of this subgroup as compared to Raji 3927 cells, which expressed only the DBD of BZLF1.  
(D) Bioinformatical evaluation of 32 randomly chosen regions that lack ZREs. Left panel: Subtractions of the 
log2-ratios of lytically induced Raji 3862 cells and latent parental Raji cells for the 32 positions were visualized 
in a heat map similar to (B). The subtraction of the two datasets mostly resulted in values close to zero, 
indicating that there was no significant difference between the datasets. The dendrogram clustered the positions 
into three groups, but the datasets did not display a noticeable difference as compared to (B) and (C) (right 
panel). Average nucleosome occupancy profiles of parental Raji cells (black line), Raji 3927 cells (green line) 
and lytically induced Raji 3862 cells (red line) of the 32 positions were displayed as in (A). The profiles did not 
reveal obvious differences between the analyzed datasets of three different Raji derivates.  
 
The previous analysis looked at differences between latent parental Raji cells and lytically 
induced Raji 3862 cells. Next, I concentrated on the differences between Raji 3927 cells that 
express the truncated BZLF1 protein constitutively and lytically induced Raji cells. This 
analysis addressed the role of BZLF1’s N-terminal transactivation domain on the 
displacement of nucleosomes. Subtractions of the log2-ratios of the eleven ZREs of group 2 in 
lytically induced Raji 3862 cells and Raji 3927 cells are visualized in a second heat map (Fig. 
5.7 C). A second cluster analysis was performed with this heat map matrix, similar to the first 
analysis. The dendrogram distinguished two subgroups of ZREs. Subgroup 2a of ZREs 
showed similar average nucleosome occupancies between the two datasets, indicating a 
similar displacement of nucleosomes, as shown in the heat map. The average nucleosome 
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occupancy profile of subgroup 2a certified the previous observation (Fig. 5.7 C, upper right 
panel): The log2-ratios of both MND-on-Chip experiments with Raji 3862 cells and Raji 3927 
cells dipped likewise as compared to the high average nucleosome occupancy in parental Raji 
cells. In addition, full length BZLF1 including its transactivation domain induced the 
precipitous loss of nucleosomes at ZREs of subgroup 2b (red matrix in Fig. 5.7 C, lower right 
panel). The overlay of the average nucleosome occupancy profiles of subgroup 2b showed a 
high nucleosome occupancy in latent parental Raji cells (black line), as expected. Binding of 
truncated BZLF1 (Raji 3927 cells, green line) caused a drop in the log2-ratios, indicating a 
lower average nucleosome occupancy. The induction of the lytic phase in Raji 3862 cells 
resulted in a collapse of the log2-ratios (red line) as compared to Raji 3927 cells and parental 
Raji cells, indicating the formation of hypersensitive sites.  
The subtraction of the log2-ratios of MND-on-Chip data with lytically induced Raji 3862 cells 
and parental Raji cells at 32 randomly chosen positions of the EBV genome without ZREs did 
not reveal differences between the two datasets (Fig. 5.7 D, left panel). A cluster analysis 
identified three different groups, as indicated in the dendrogram on the left side of the heat 
map, but noticeable differences were not obtained as compared to the analysis of the 32 ZRE 
sites. The overlay of the average nucleosome occupancy profiles confirmed, that there was no 
remarkable difference between the three Raji cell derivates (Fig. 5.7 D, right panel).  
In conclusion, the MND-on-Chip experiments suggested different functional groups of ZREs 
according to nucleosomal changes. Group 1 ZREs had low average nucleosome occupancies 
during latency, indicating that the promoters belonging to this group were not tightly occupied 
with nucleosomes. Binding of full length or truncated BZLF1 did not rearrange nucleosomes. 
Subgroup 2a of ZREs displayed a high average nucleosome occupancy in latency, which 
disappeared after binding of truncated BZLF1 or after induction of the lytic phase with full 
length BZLF1. The initial finding indicated a tight repression of the respective promoters 
during latency, which BZLF1 could overcome by simply binding to the ZREs. ZREs of 
subgroup 2b revealed a high average nucleosome occupancy in latency, similar to 
subgroup 2a, but binding of truncated BZLF1 was insufficient to remodel the nucleosomes 
completely. The transactivation domain of BZLF1 induced the complete loss of nucleosomes. 
This finding implied, that certain ZRE-regulated promoters are tightly controlled and 
repressed during latency. As a consequence, their activation requires energy to remodel the 
nucleosomes upon lytic induction, which could be provided by cellular chromatin remodeling 
complexes that rely on ATP as the energy source. Fig. 5.8 shows the single profiles of two 
representative ZREs for each group.  
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Fig. 5.8 Close-up of six single ZREs of different ZRE groups 
MND-on-Chip experiments in conjunction with bioinformatical analysis identified ZREs, which belong to 
different groups. The nucleosome occupancy profiles of two members of each group is shown in a window of 
±1000bp, centered at the start of the ZRE, similar to Fig. 5.7.  
(A) Subgroup 2b of ZREs had a high average nucleosome occupancy during latency (parental Raji cells, black 
line), which dramatically dropped after induction of the lytic phase (induced Raji 3862 cells, red line). This 
observation was confirmed by looking at the individual nucleosome occupancy profiles of the promoters of 
BMLF1 and BRLF1. The binding of the DBD of BZLF1, only, (Raji 3927 cells, green line) induced modest 
changes at the ZRE of the BRLF1 promoter, but did not modify the nucleosome occupancy at the BMLF1 
promoter.  
(B) ZREs of the subgroup 2a displayed high average nucleosome occupancy in latency in parental Raji cells, 
similar to subgroup 2b. Unlike ZREs of the subgroup 2b, BZLF1 DBD alone was sufficient to rearrange and 
diminish the average nucleosome occupancy (green line). Full length BZLF1 did not alter the average 
nucleosomal pattern any further (red line). The BBLF4 promoter and the BKRF3 promoter exemplify the 
nucleosome pattern of members of this subgroup.  
(C) ZREs of group 1 comprised moderate average nucleosome occupancy during latency. Upon induction of the 
lytic phase, this nucleosomal pattern remained stable, as it was observed in the BARF1 promoter and the ZRE in 
the BNRF1 reading frame.  
 
The individual nucleosome occupancy profiles of both promoters in a window of ±1000bp, 
centered at the start position of the ZRE, showed elevated log2-ratios during latency in 
parental Raji cells (black line). The log2-ratios dropped in the BRLF1 promoter, but not in the 
BMLF1 promoter in Raji 3927 cells, expressing the DBD of BZLF1, only. At both promoters, 
the log2-ratios collapsed in Raji 3862 cells, presumably forming a hypersensitive site 
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downstream of the ZRE (Fig. 5.8 A). The ZRE of the BBLF4 promoter and the BKRF3 
promoter are examples of members of subgroup 2a. The individual nucleosome occupancy 
was high in latent parental Raji cells in both promoters (black line). Both Raji derivates 
exhibited a loss of the nucleosomal signal, indicating that the binding of truncated BZLF1 
lacking its transactivation domain was sufficient to rearrange nucleosomes. At the BBLF4 
promoter, a hypersensitive site formed upon binding of BZLF1. The nucleosome occupancy 
in the BKRF3 promoter dropped to average levels (Fig. 5.8 B). Examples of members of 
group 1 are the BARF1 promoter and the BNRF1 reading frame. Both ZREs did not show 
elevated levels of nucleosome occupancies in parental Raji cells, and a substantial difference 
between all Raji derivates was not visible (Fig 5.8 C). Table 5.2 lists the ZREs hierarchically 
and according to their functional group.  
 
Tab. 5.2 Catalog of functional groups of ZREs  
Cluster analysis identified three groups of ZREs as indicated. The table gives an overview of the members of 
each group and the function of the corresponding gene (DBD: DNA binding domain, AD: activation domain, 
n.o.s. not otherwise specified). 
group ID location function of respective gene 
10 oriLyt origin of lytic replication 
24 BMLF1 promoter RNA export factor, lytic replication 
34 BRLF1 promoter transcription factor, lytic replication 
Subgroup 2b 
- high occupancy in latency 
- DBD and AD are necessary for 
remodelling of nucleosomes 21 BMRF1 promoter polymerase associated factor, lytic replication 
40 BBLF2/3 promoter primase associated factor, lytic replication 
38 BBLF4 promoter helicase, lytic replication 
55 BALF5 reading frame DNA polymerase, lytic replication 
36 BKRF3 promoter uracil DNA glycosidase 
28 BLLF1 reading frame gp350/220, glycoprotein 
45 BDLF3 promoter gp150, glycoprotein 
Subgroup 2a 
- high occupancy in latency  
- DBD is sufficient for 
remodelling of nucleosomes 
59 BNLF2a/b promoter immune evasion 
19 Barf1 promoter glycoprotein 
2 BNRF1 reading frame tegument protein 
1 BNRF1 reading frame tegument protein 
30 EBNA3B reading frame latency 
31 BZLF1 promoter transcription factor 
52 BILF2 promoter glycoprotein 
29 n.o.s. n.o.s. 
26 BSRF1 promoter tegument protein 
16 BPLF1 reading frame tegument protein 
51 BdRF1 promoter structural protein 
47 BcLF1 reading frame major capsid antigen, structural protein 
3 BCRF1 reading frame viral IL10, immune evasion 
14 BFLF1 promoter glycoprotein 
12 BFLF2 promoter viral maturation at the membrane 
Group 1 
- low occupancy in latency 
- no remodelling of nucleosomes 
41 BGLF5 promoter alkaline exonuclease 
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The individual ZRE clusters indicated a functional relationship between the group and the 
function of the regulated gene. Genes that are absolutely essential for EBV’s DNA replication 
upon lytic induction are BMLF1, BRLF1, BMRF1, BBLF2/3, BBLF4, BALF2, and BALF5 
(Fixman et al., 1992; Feederle et al., 2000). Five out of seven promoters of genes responsible 
for lytic DNA replication belonged to subgroup 2b or subgroup 2a, indicating that theses 
promoters are repressed very tightly during latency. The promoters of BMLF1, BRLF1 and 
BMRF1 probably require active chromatin remodeling for nucleosome rearrangements upon 
lytic induction. The promoters of BBLF2/3 and BBLF4 also appeared tightly repressed during 
latency. The BALF2 gene is missing in Raji cells and is thus not included in this analysis. The 
seventh gene important for lytic replication is the DNA polymerase BALF5. A ZRE located in 
the gene body of BALF5 behaved similar to the ZREs of the five other promoters of genes 
important for DNA replication, which are present in Raji cells. Its role is enigmatic but could 
contribute to the transcriptional regulation of BALF5. 
5.2.3 Indirect endlabeling and Chromatin Immunoprecipitation 
experiments confirm the loss of nucleosomes at ZREs 
MND-on-Chip experiments indicated a loss of nucleosomes at ZREs, which was validated in 
two additional, independent experiments (Fig. 5.9) with parental Raji cells (latent) and 
doxycycline induced Raji 3862 cells (lytic). Chromatin Immunoprecipitation (ChIP) is a 
method to analyze interactions of proteins with DNA. Chromatin of parental Raji cells and 
induced Raji 3862 cells, that express full length BZLF1, was isolated and crosslinked with 
formaldehyde to covalently fix the interaction between proteins and DNA. Chromatin was 
sonicated to an average DNA size of 400bp.  
Incubation with an antibody specific for histone H3 and precipitation with sepharose beads 
resulted in an enrichment of DNA that was wrapped around nucleosomes containing histone 
H3. DNA was purified and analyzed by qPCR for the enrichment of two different promoters 
that contained ZREs (BRLF1 and BMRF1) in comparison with the ZRE-free W promoter 
(Wp). The three promoters were enriched in histone H3 during latency in parental Raji cells 
(2-3% of input DNA). The ZRE-containing promoters of BRLF1 and BMRF1 showed a clear 
reduction of the histone H3 signal (1% of input DNA) in lytically induced Raji 3862 cells. 
The ZRE-free Wp was not affected by lytic induction (Fig. 5.9 A).  
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Fig. 5.9 Chromatin Immunoprecipitation and indirect endlabeling experiments confirm the loss of 
nucleosomes at ZREs 
(A) Left panel: Chromatin Immunoprecipitation (ChIP) experiments were performed to confirm the drop in 
nucleosomal occupancy around ZREs in the presence of BZLF1. Chromatin was crosslinked with formaldehyde 
and sheared to an average DNA size of 400bp. After incubation with an antibody specifically recognizing 
histone 3 (H3), the complexes of antibody, protein, and DNA were precipitated with sepharose beads. After three 
washing steps with increasing stringencies and subsequent Proteinase K digestion, DNA was purified and 
analyzed by qPCR. The experiment was repeated three times with chromatin preparations from parental Raji 
cells and uninduced Raji 3862 cells (latent) and compared with three chromatin preparations of Raji 3862 cells 
induced with 100ng/ml doxycycline over night. Right panel: Quantitative PCRs of histone H3 ChIPs confirmed 
the loss of nucleosomes in two promoters containing ZREs (BRLF1 and BMRF1) in lytically induced cells. In 
contrast, the ZRE-free W promoter was not affected.  
(B) Indirect endlabeling experiments confirmed the microarray hybridization and ChIP results. Chromatin was 
prepared and treated with limited amounts of MNase. Subsequently, the chromatin was cleaved with a suitable 
restriction endonuclease to obtain a defined starting point for the analysis. After separation on an agarose gel and 
Southern blotting, nucleosomal patterns were visualized by hybridizing with a probe specific for a region close 
to the restriction site as indicated. Bands in the autoradiogram after hybridization reveal the boundaries of 
nucleosomes and hypersensitive sites. Upper row: Indirect endlabeling experiments in Raji cells covering three 
different promoters as indicated. The annotations on the right side of the autoradiogram show the cleavage site of 
the restriction endonuclease, the binding site of the probe, the locations of ZREs, the start of the three transcripts 
and the coding region of BRLF1, BMRF1, and the W promoter and adjacent genes. Lower row: The three regions 
were re-analyzed in Raji 3862 cells, either uninduced (-) or induced with 100ng/ml doxycycline over night (+). 
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In general, the pattern in uninduced cells was similar to the one seen in parental Raji cells. Induction of the lytic 
phase led to rearrangements in the nucleosomal pattern at ZREs. The BRLF1 promoter gained a hypersensitive 
site situated in the ZRE regions after induction of the lytic phase, reflected by a strong additional band of 1000bp 
in the induced cells. Concomitantly, the signal of faster and more slowly migrating bands are reduced. The 
BMRF1 locus also lost nucleosomes at the ZRE locations. A strong signal beyond the cluster of ZRE sites 
disappeared. In line with the results of panel (A), the nucleosomal pattern of the W promoter, which does not 
contain ZREs, was not affected by the induction of the lytic phase, as expected.  
 
The same promoter sites were also analyzed in indirect endlabeling experiments (Fig. 5.9 B). 
Chromatin was treated with limited amounts of MNase and cleaved with an appropriate 
restriction endonuclease at a site close to the region of interest. The DNA was purified, 
separated on an ethidium bromide agarose gel and transferred to a nylon membrane by 
Southern blotting. The membrane was hybridized to a radioactively labeled probe that was 
complementary to a region downstream but close to the cleavage site of the restriction 
endonuclease. The bands that are visible in the autoradiogram show the boundaries of 
nucleosomes and hypersensitive sites with fragment sizes that indicate the distance of the 
boundaries from the restriction endonuclease cleavage site.  
The upper panel of Fig. 5.9 B shows the results of indirect endlabeling experiments in 
parental Raji cells. Raji chromatin was partially digested with increasing amounts of MNase 
as indicated and analyzed for nucleosome occupancies in the promoter regions of BRLF1, 
BMRF1, and Wp. The restriction endonuclease cleavage sites, the probe location, and selected 
features of EBV’s genome are depicted on the right side of the autoradiogram. Bands in the 
autoradiogram displayed nucleosome boundaries and hypersensitive sites. The evaluation of 
exact positions is difficult and only possible in very regularly spaced arrays of nucleosomes, 
as it can be seen in Wp upstream of the BWRF1 reading frame. The bands were 200bp apart 
from each other, which corresponds to the average size of DNA encompassing one 
nucleosome plus its linker region. One band seemed to be missing at a height of 1000bp in the 
array of nucleosomes indicating that this site was not protected from cleavage by a 
nucleosome. Probably a different protein occupied the DNA in this region. A pattern 
indicative of a hypersensitive site was present in the BMRF1 promoter, approximately 2200bp 
from the restriction endonuclease cleavage site in the BMRF1 locus. The autoradiogram 
displayed a very strong band and signals from slower migrating fragments were missing. This 
observation indicated that MNase preferentially and entirely cleaved this site in the Raji 
DNA. The lower panel (Fig. 5.9 B) shows the same promoter sites in Raji 3862 cells, without 
or with addition of doxycycline and induction of the lytic phase of EBV. The uninduced cells 
displayed a pattern similar to the latent parental Raji cells, as expected. The induction of 
EBV’s lytic phase after the doxycycline-dependent expression of full length BZLF1 caused 
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major rearrangements in the promoters of BRLF1 and BMRF1, but not in the ZRE-free W 
promoter. The BRLF1 promoter acquired a pattern that was typical for a hypersensitive site 
approximately 800bp upstream of the restriction endonuclease cleavage site. The 
hypersensitive site was situated in the same location as the BRLF1 ZRE sites, confirming the 
microarray and ChIP experiments. The BMRF1 promoter showed overall reduced signal 
intensities in bands that were more than 1000bp apart from the restriction endonuclease 
cleavage site after lytic induction, indicating a loss of nucleosomes in this BZLF1-regulated 
promoter as well. Residual signal originated probably from uninduced cells, as the cells were 
not sorted for GFP expression after doxycycline induction and induced to 80%, only. 
My experiments suggested that different lytic promoters are occupied and presumably 
repressed by nucleosomes. A fraction of early lytic genes, including genes important for 
EBV’s lytic DNA replication, are tightly repressed during latency, because their ZREs are 
densely occupied by nucleosomes. Microarray experiments, Chromatin 
Immunoprecipitations, and indirect endlabeling experiments confirmed that the induction of 
the lytic phase caused a loss of nucleosomes at these promoters. Furthermore, microarray 
experiments revealed that the DNA binding domain of BZLF1 was sufficient to remodel 
chromatin at certain promoters. Other promoters required the transactivation domain of 
BZLF1 for chromatin remodeling and eviction of nucleosomes. A different subgroup of early 
lytic gene promoters that contain ZREs did not display high levels of nucleosomes during 
latency (Fig. 5.7 and 5.8). This observation implied that the corresponding genes were 
repressed less stringently during the latent state. Induction of the lytic phase did not lead to 
rearrangements of nucleosomes indicating that nucleosomes in these promoters were no 
functional barriers to transcriptional activation. The analysis revealed that the positioning of 
nucleosomes is an important regulatory mechanism for EBV, repressing lytic genes during 
viral latency. 
5.3 Histone modifications and chromatin modifying 
enzymes in EBV 
Post-translational modifications of histone tails influence the functional state of a promoter. 
Histone modifications can either have repressive or activating effects on transcription, for 
example by adjusting the contact strength between DNA and histone proteins by adding 
negative or positive charges or by recruiting non-histone proteins to the site of modification 
(Kouzarides, 2007). Methylation of lysine residues can occur at different lysines in the 
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histone tail to different degrees, as lysines can be mono-, di-, or trimethylated. The diversity 
of lysine methylation can result in many different functions. Two prototypical lysine 
modifications that repress gene expression are trimethylation of histone H3 at lysine 9 or 
lysine 27 (H3K9me3 and H3K27me3). H3K9me3 is implicated in heterochromatin formation 
and H3K27me3 leads to a stable and inherited repression of genes through interaction with 
Polycomb group proteins (Hansen et al., 2008). A characteristic lysine methylation mark that 
has a positive effect on transcription is trimethylation of histone H3 at lysine 4 (H3K4me3). 
H3K4me3 is mainly enriched in promoters and 5’ ends of the coding region of active genes at 
transcriptional start sites. H3K4me3 is connected to actively transcribing RNA Polymerase II 
(Barski et al., 2007). In certain gene promoters of silent genes, H3K27me3 colocalizes with 
H3K4me3; these regions also encompass inactive RNA polymerase II. This so-called 
“bivalent chromatin” is indicative of genes that are “poised” to become active (Bernstein et 
al., 2006). The epigenetic mode of repressed viral lytic genes has never been assessed before. 
I performed Chromatin Immunoprecipitation (ChIP) experiments to explore the pattern of 
histone modifications at latent, early lytic, and late lytic genes in parental Raji cells and in 
lytically induced Raji 3862 cells that express full length BZLF1 upon addition of doxycycline. 
I could show that lytic genes typically encompass H3K27me3 in the latent state, presumably 
because Polycomb group proteins (PcGs) sustain this repressive histone code at these 
promoters. Induction of the lytic phase caused major changes in the histone modification 
pattern. The repressive mark H3K27me3 entirely disappeared in the EBV genome, as did 
PcG-proteins. H3K4me3 was established selectively at promoters of early lytic genes upon 
lytic induction, where it was absent during latency.  
5.3.1 Histone H3 and its post-translational modifications at EBV 
promoters 
ChIP experiments were performed as described before (chapter 5.2.3 and Fig. 5.9) with 
parental Raji cells to assess the histone modification pattern in the latent state and with 
doxycycline induced Raji 3862 cells to analyze the changes in the histone modification 
pattern after the lytic switch. The promoters of latent, early lytic, and late lytic genes were 
analyzed by qPCR for footprints of histone H3, H3K4me3, H3K9me3, and H3K27me3. Fig. 
5.10 shows the results of this survey. The amount of ChIP DNA was assessed as percentage 
of input DNA (% input) and is depicted on the y-axis; the loci tested are indicated on the x-
axis. Black bars show results for EBV’s latent state in parental Raji cells (latent) and light 
grey bars depict the results after the lytic switch in induced Raji 3862 cells (lytic). 
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Fig. 5.10 Chromatin immunoprecipitation of histone H3 and its N-terminally modified versions  
ChIPs were performed as described in Fig 5.9 with antibodies directed against histone H3 and its 
posttranslational modifications. DNA was analyzed by qPCR for enrichment at different loci in the human or the 
EBV genome. Amplicons of Centromer1 (Cen) served as a control of an epigenetically repressed locus, while 
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the promoter of the housekeeping gene GAPDH is indicative of chromatin with active epigenetic marks. 
Enrichment of EBV DNA was evaluated with primer pairs covering latent, early lytic, and late lytic promoters.  
The left panel provides the results of the promoter regions analyzed, while the right panel gives a close-up of two 
early lytic promoters (BMRF1 and BBLF4). Note the different scales of the y-axis.  
(A) Lytic induction caused the loss of H3 at early lytic gene promoters (p-value: 6x10-9), which is in line with 
the results depicted in Fig. 5.7-5.9. Late lytic promoters were slightly affected, while latent promoters were 
completely unchanged. 
(B) The activation mark H3K4me3 is only found at the EBERs, the Q promoter, and at oriP in latency. After 
induction of the lytic phase, H3K4me3 levels were found elevated at early lytic promoters (p-value: 1.4x10-3) 
and at the Q promoter. Late lytic genes do not show any sign of this modification. H3K4me3 was more prevalent 
at the transcribed gene body than at the promoter because this modification is linked to RNA Pol II active 
transcription (right panel).  
(C) The latent C and W promoters contained H3K9me3, and also oriP displayed this repressive mark at low 
levels in latently infected cells, which was lost upon induction of the lytic phase (p-value: 1x10-3). In two early 
lytic promoters, BMRF1 and BBLF4, induction of EBV’s lytic phase did not alter the levels of H3K9me3 (right 
panel), indicating that this modification is not important for the repression of early lytic genes.  
(D) The repressive modification H3K27me3 correlated with repressed early lytic and late lytic gene promoters, 
indicated by the strong enrichment in latently infected cells. The repressive mark was completely lost in early 
lytic promoters and at the W promoter after induction of the lytic phase (p-value: 6x10-5). Late lytic promoters 
showed a significant reduction in H3K27me3 levels, but the enrichment at theses promoters was still slightly 
above background level.  
 
The left panel provides two cellular control loci: Centromer 1 (Cen), a silent locus and 
GAPDH, an active locus, together with promoters and transcripts of latent genes (EBER, oriP, 
Cp, Qp, and Wp), five early lytic promoters, that encompass ZREs and meZREs (oriLyt, 
BRLF1, BZLF1, BMRF1, and BBLF4), and three late lytic promoters, that are not regulated by 
BZLF1 (BcLF1, BDLF4, and BLLF1). The right panel is a close-up of two early lytic 
promoters (BMRF1 and BBLF4).  
Histone H3 levels were high in Cp and Wp during latency, but not in the EBER locus, oriP 
and the Q promoter (Fig. 5.10 A). The lytic switch did not cause any change in the tested 
latent promoters. Early lytic promoters had elevated levels of histone H3 during latency, but 
the signal diminished significantly after the induction of the lytic phase. The close-up of the 
BMRF1 promoter and the BBLF4 promoter confirmed this observation. Late lytic promoters 
were also occupied with histone H3. Similar to latent promoters, the lytic switch did not 
induce a change in the histone H3 pattern. The ChIP results of histone H3 were in line with 
the results of the MND-on-Chip analysis. Histone H3 is part of the protein core of 
nucleosomes; a reduction in the amount of this protein indicates a loss of the nucleosome. 
ChIP experiments confirmed, that the nucleosomal loss is specific for promoters of early lytic 
genes that encompass ZREs. The ChIP results of latent promoters indicated that Cp and Wp 
are occupied and presumably repressed by nucleosomes during latency. The Q promoter was 
the only latent promoter with low levels of histone H3, implying that latent gene expression in 
Raji cells is initiated at this promoter (Fig. 5.10 A).  
H3K4me3 levels were dramatically high at the EBER locus, indicating that the EBERs are 
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actively transcribed in latent Raji cells (Fig. 5.10 B). Enrichment of H3K4me3 was also 
detected at oriP and Qp but to a lesser extent. Early and late lytic promoters did not show any 
sign of H3K4me3 modification during latency. Lytic induction caused a slight but significant 
increase in H3K4me3 levels at early lytic promoters, which increased towards the 5’ end of 
the gene body, as indicated in the close-up of the BMRF1 promoter and the BBLF4 promoter. 
Also EBERs, oriP, and Qp showed elevated levels of H3K4me3 indicating an upregulation of 
latent gene expression upon lytic induction as well. Trimethylation of H3K9 was elevated in 
oriP, Cp and Wp during latency (Fig. 5.10 C) but to a lesser extent than the positive control 
(Cen). Lytic induction caused a loss of this modification in all latent H3K9me3-positive loci. 
The early lytic promoters of BRLF1, BZLF1, and BMRF1 were not enriched in H3K9me3. 
Only BBLF4 appeared to encompass little amounts of this epigenetic modification. Lytic 
induction did not induce any change in the H3K9me3 pattern in early lytic promoters, which 
was confirmed in the close-up of the promoters of BMRF1 and BBLF4. OriLyt showed a 
similar pattern as oriP; both origins of replication carry H3K9me3 in latency, but lose the 
modification upon lytic induction. Late lytic promoters showed only background levels of 
H3K9me3. The results indicated that H3K9me3 did not contribute to repression of lytic gene 
promoters.  
H3K27me3 levels were dramatically increased in early lytic and late lytic promoters during 
latency (Fig 5.10 D). This modification was also prevalent at Wp. Induction of the lytic phase 
caused a major drop of the H3K27me3 signal, indicating a complete loss of this repressive 
mark. The close-up of the BMRF1 promoter and the BBLF4 promoter showed high levels of 
H3K27me3 at binding sites of BZLF1 (ZREs and meZREs, indicated as black and red circles, 
respectively) during latency. Lytic induction reduced the levels of H3K27me3 in the tested 
regions, signals dropped virtually to background levels.  
In summary, levels of histone H3 and its N-terminally modified versions suggested the mode 
of repression during latency. Latent gene promoters that are not used in latent Raji cells, i.e. 
Wp and Cp, were enriched in histone H3 and carried H3K9me3 and H3K27me3 marks, 
indicating a strong repression of these promoters. H3K4me3 modification, an active mark, 
was absent. The active latent regions, i.e. the EBER locus, oriP, and Qp, showed an inverse 
picture with elevated levels of H3K4me3 and missing repressive modifications. Surprisingly, 
oriP encompassed H3K9me3 in addition to activation marks. A colocalization of H3K9me3 
and H3K4me3 is so far not described, but resembles bivalent chromatin, that comprises 
H3K4me3 in conjunction with H3K27me3. But it is not clear whether H3K9me3 and 
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H3K4me3 colocalize on the same EBV episome. Sequential ChIP assays that make use of two 
antibodies in a row could address this point. At early lytic gene promoters, H3K27me3 marks 
dominated during latency, together with an unusually high occupancy with histone H3. 
Induction of the lytic phase caused a loss of histone H3 and H3K27me3 epigenetic marks at 
early lytic promoters and an increase in H3K4me3 levels, indicating an activation of the 
BZLF1-regulated early lytic genes. H3K9me3 appeared to be unimportant for early lytic gene 
regulation. Late lytic gene promoters exhibited a similar pattern as early lytic promoters 
during latency. Induction of EBV’s lytic phase erased the H3K27me3 marks but histone H3 
levels were unchanged and elevated, and trimethylation of H3K4 was undetectable. 
Together my findings demonstrated that the loss of the repressive modification H3K27me3 
upon lytic induction affects the entire EBV genome but depletion of nucleosomes and the 
addition of activating marks are specific for early lytic genes, only. 
5.3.2 Polycomb proteins set up the repressed state in EBV’s lytic 
promoters 
H3K27me3 is a modification that is associated with repression by PcG-proteins. ChIP 
experiments were performed with an EZH2*-specific antibody. EZH2 is a methyltransferase 
responsible for the trimethylation of H3K27 and is part of one out of two Polycomb 
repressive complexes (PRCs), termed PRC2.  
 
 
Fig. 5.11 Chromatin immunoprecipitation of the H3K27-methyltransferase EZH2 
Chromatin Immunoprecipitations and qPCR were carried out as described in Fig. 5.10. Enhancer of zeste 2 
(EZH2) is a histone methyltransferase responsible for trimethylation of histone H3 at lysine 27 (H3K27me3). It 
is part of the Polycomb Repressive Complex 2 (PRC2), which together with PRC1 leads to an inherited and 
stable repression of local chromatin. In line with the results of H3K27me3 ChIPs, this protein was present at 
promoters of early and late lytic genes, and also at the W promoter during latency. After induction of the lytic 
phase, the signal is lost (p-value: 7x 10-4 for early lytic genes; 4x 10-4 for late lytic genes).                                                         
* human enhancer of zeste 2 
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ChIP experiments were performed with the same conditions and with the same readout as in 
5.3.1 to test whether PRC2 colocalizes with H3K27me3. Fig. 5.11 shows the results of EZH2 
ChIPs in parental Raji cells (latent, black bars) and in induced Raji 3862 cells (lytic, light grey 
bars). Similar to H3K27me3, Cp and Wp showed elevated levels of EZH2 during latency. 
Lytic induction resulted in a loss of the EZH2 signal to background levels. Early lytic and late 
lytic genes likewise showed a high enrichment of EZH2 protein in the promoter region. The 
induction of EBV’s lytic phase caused the loss of the protein at the early lytic promoters. 
EZH2 ChIPs perfectly mirrored the results of H3K27me3 ChIPs indicating that this 
methyltransferase is responsible for the trimethylation of H3K27 in repressed EBV promoters. 
The results demonstrated that Polycomb repression is an important mechanism to maintain 
EBV’s lytic genes in a silent state during latency. 
5.4 Occupation of EBV promoters with RNA 
polymerase II 
Transcription of all protein-coding genes is carried out by RNA polymerase II (RNA Pol II). 
The largest subunit of RNA Pol II, i.e. RPB1, contains a long carboxy-terminal domain 
(CTD) with 52 repeats of the consensus heptapeptide sequence YSPTSPS (Corden et al., 
1985). The heptapeptide is target of a number of post-translational modifications that regulate 
the function of RNA Pol II. Non-consensus repeats are more frequent towards the C-terminus 
and might provide special functions to specific regions within the CTD (Fong et al., 2001). 
Unphosphorylated RNA Pol II is termed Pol IIA; RNA Pol II encompassing phosphorylated 
serine residues in the CTD is described as Pol II0 form. The two forms of RNA Pol II can be 
discriminated in a ChIP experiment by the use of CTD-specific antibodies. RNA Pol II is 
detected in promoter regions of active genes, paused genes, and so-called poised genes; and 
the CTD-modification pattern of Pol II is indicative for the promoter type (reviewed in 
Brookes et al., 2009).  
RNA Pol II is recruited in a hypophosphorylated form to promoters of active genes. The 
initiation of transcription, the so-called promoter escape, requires the phosphorylation of 
serine 5 of the CTD. For transcript elongation, RNA Pol II is additionally phosphorylated at 
serine 2, and termination of transcription involves the erasure of phosphorylation marks, 
which again allows the recruitment of RNA Pol II to active promoters. This active cycle of 
RNA Pol II is characterized by a specific pattern of CTD- and histone modifications at the 
promoter of the active gene. ChIP experiments detect a peak of serine 2-unphosphorylated 
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RNA Pol II at the transcriptional start site (TSS), elevated levels of serine 5-phosphorylated 
RNA Pol II at the TSS and the gene body, and enrichment of serine 2-phosphorylated 
RNA Pol II in the gene body. Additionally, H3K4me3 can be found upstream of the CDS.  
In paused genes, initiation of RNA Pol II takes place similar to active genes, but a lack of 
serine 2-phosphorylation and the involvement of negative elongation factors stall the 
polymerase at a promoter-proximal position. Low levels of serine 2-unphosphorylated and 
serine 5-phosphorylated RNA Pol II, and a minor enrichment of H3K4me3 at the TSS 
characterize paused genes.  
A poised polymerase is phosphorylated at serine 5 and lacks serine 2-phosphorylation. 
Transcriptional elongation of these genes is possible at very low levels without the 
phosphorylation of serine 2. Poised polymerases are associated with “bivalent chromatin” that 
is repressed by PcG-proteins through trimethylation of H3K27 but is additionally 
trimethylated at H3K4. In ChIP experiments, the polymerase can only be detected with an 
antibody directed against the serine 5-phosphorylated form of RNA Pol II. An antibody 
recognizing unphosphorylated serine 2 at the CTD is not able to detect the polymerase 
indicating that the CTD owes a not characterized modification or is in an unusual 
conformation (reviewed in Brookes et al., 2009).  
In my experiments, epigenetic modifications in early lytic promoters indicated a tight 
repression during latency and an activation of transcription after EBV’s switch to the lytic 
phase. Occupation of the promoters by RNA Pol II has not been analyzed previously. ChIP 
experiments using antibodies specific for different RNA Pol II CTD modifications were 
performed to clarify whether lytic promoters were paused, poised, or silent during latency and 
whether an active polymerase could be detected after the switch to the lytic phase. I could 
show that lytic promoters did not encompass any form of the polymerases during latency 
indicating that the genes were completely silent. After the switch to the lytic phase, 
RNA Pol II was detected in promoter regions of early lytic genes with an antibody specific for 
the amino-terminal domain of the polymerase, but all tested CTD-specific antibodies failed to 
detect any form of the polymerase. Cleavage of the CTD was excluded by western blot 
immunodetection, indicating that the RNA Pol II CTD is intact and present in lytically 
induced cells but might be in an atypical conformation. The unusually modified CTD of 
RNA Pol II clearly supported transcription of early lytic genes.  
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Fig. 5.12 Chromatin Immunoprecipitations of RNA Pol II and its CTD-modified versions 
Chromatin Immunoprecipitations and qPCR were carried out as described in Fig. 5.10 with antibodies 
recognizing the inactive (Pol IIA) and the initiated form (Pol II0) of the polymerase. N20 is an antibody specific 
for the N-terminal part of RNA Pol II, which detects both forms, 3E8 is directed against the serine5-
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phosphorylated C-terminal domain (CTD) of the polymerase and recognizes the Pol II0 form; 1C7 and 8WG16 
are mainly specific for the Pol IIA form.  
(A) ChIP experiments using an antibody specific for the N-terminal part of RNA Pol II (N20) showed an 
increase at early lytic promoters (p-value: 4x10-4), at oriP and the Q promoter after induction of the lytic phase. 
During latency, the polymerase was hardly detectable at any EBV locus. Only the EBERs showed a tiny amount 
of RNA Pol II.  
(B-D) Antibodies against different modifications of the C-terminal domain (CTD) of RNA Pol II failed to 
immunoprecipitate the polymerase at EBV promoters. Note the different scales of the y-axes of the left and the 
right panel.  
 
5.4.1 ChIP experiments of RNA Pol II and its CTD-modified versions 
ChIP experiments were carried out as described before with parental Raji cells (latent) and 
lytically induced Raji 3862 cells (lytic). Different antibodies were used to detect the different 
forms of RNA Pol II. The antibody N20 is specific for both forms of the polymerase, Pol IIA 
and Pol II0, because it recognizes an epitope in the amino-terminal domain of the polymerase. 
The Ser5-P (3E8) antibody is specific for the serine 5-phosphorylated form of RNA Pol II and 
recognizes the Pol II0 form. Anti-RNAPII (1C7) antibody was generated with a serine 7-
phosphorylated peptide. It recognizes a variety of phosphorylated CTD forms in ELISA, but 
in a western blot immunodetection it is specific for the Pol IIA form. The antibody CTD 
(8WG16) recognizes a serine 2-unphosphorylated form of the CTD, and is mainly specific for 
the Pol IIA form. Fig. 5.12 illustrates the result of the ChIP experiments, which are similarly 
presented as the experiments in Fig. 5.10 and Fig. 5.11.  
ChIP experiments with the N20 antibody detected RNA Pol II at the EBER locus during 
latency at a low level compared to the positive control, i.e. GAPDH (Fig. 5.12 A). Early lytic 
and late lytic promoters did not give rise to any enrichment of the polymerase in ChIP 
experiments in Raji cells. This indicated, that the promoters are completely silent during 
latency. In lytically induced cells, oriP and the latent Q promoter showed increased presence 
of RNA Pol II. Early lytic promoters encompassed significantly higher levels of the 
polymerase after lytic induction although the standard was low compared to GAPDH 
enrichment in latent Raji cells. RNA Pol II was not detectable at late lytic promoters after 
lytic induction. CTD-specific antibodies did not detect the polymerase at any EBV locus after 
lytic induction, except very minor enrichments at the Q promoter (Fig. 5.12 B-D). The 
effective enrichment of the positive control indicated, that the ChIP experiments were 
technically successful. This finding was surprising because RNA Pol II is clearly recruited to 
promoters of early lytic genes as revealed with an antibody (N20), which binds to the N-
terminal domain of RNA Pol II. Lytic induction resulted also in a loss of the polymerase at 
GAPDH, which is a housekeeping gene.  
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The results prompted the hypothesis, that the onset of the lytic phase induced a peculiar 
change of RNA Pol II, which might include a proteolytical cleavage of the CTD. The CTD-
less form of the polymerase is described as Pol IIB form. The Pol IIB form was originally 
isolated from calf thymus DNA (Corden et al., 1985) but described to be an artifact from 
sample preparation later (Kim et al., 1986). Pol IIB is not able to initiate and support 
transcription on promoter sites but mediates nonselective transcription on calf thymus DNA at 
nicks and gaps in the DNA, as demonstrated in vitro (Dahmus et al., 1983). Later, RNA Pol II 
mutants lacking the last non-consensus repeat (CTD52) and mutants lacking the repeats one 
to three (CTD1-3) of CTD were shown to transform into the Pol IIB form, suggesting a role 
for the removal of the CTD in vivo. It was hypothesized that dipping the CTD could be a 
response to stress, particularly after UV irradiation (Chapman et al., 2004; Chapman et al., 
2005), but the mechanism of regulation is still unclear. A cleavage of CTD upon lytic 
induction could be a viral strategy to govern the transcription machinery and to concentrate 
the activity of RNA polymerase II entirely to the expression of viral genes. 
5.4.2 The Pol IIB form cannot be detected in western blot 
immunodetection after induction of the lytic phase 
The Pol IIB form can be detected in a western blot immunodetection with an antibody 
specific for the amino-terminal part of RNA Pol II (Pol 3-3). This antibody is able to 
recognize all forms of the polymerase. Raji 3862 cells were induced for 6, 12, and 24 h with 
100ng/ml doxycycline. Uninduced cells, parental Raji cells with and without doxycycline, and 
B95.8 cells served as controls. Fig. 5.13 shows the result of the western blot 
immunodetection.  
Raji 3862 cells contained two forms of the polymerase, Pol II0 and Pol IIA. The CTD-less 
polymerase (Pol IIB) was not detected in the samples, neither during latency nor after lytic 
induction with doxycycline. A minor fraction of B95.8 cells spontaneously supports the lytic 
phase of EBV. This cell line contained all three forms of the polymerase. Whether the Pol IIB 
signal originated from cells undergoing the lytic switch remained an open question, as the 
induced lytic phase in Raji 3862 cells did not yield the truncated Pol IIB form.  
The western blot immunodetection did not detect the presumed proteolytic cleavage of the 
CTD, which might support lytic gene transcription upon induction of the lytic phase. The 
failure of CTD-specific antibodies to detect the polymerase in ChIP experiments could be a 
hint for unknown CTD modifications that are not recognized by the antibodies used in this 
study, but likely favors viral as opposed to cellular transcription. Another explanation for the 
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result could be an atypical folding of the CTD that precludes the antibodies from binding to 
their epitopes. 
 
Fig. 5.13 Western blot immunodetection of RNA Pol II in lytically induced cells 
Protein lysates of Raji 3862 cells after different time points post induction with doxycycline, parental Raji cells, 
and B95.8 cells were analyzed in a western blot immunodetection with an antibody recognizing the N-terminal 
part of Pol II (Pol-3-3). This antibody recognizes the initiated form of Pol II (Pol II0), the unphosphorylated 
form of Pol II (Pol IIA), and the CTD-less form of Pol II (Pol IIB). Tubulin was used as a loading control (α-
Tub, bottom panel). Signal detection was performed either after 30s (top panel) or after 180s (middle panel). All 
cells contained the Pol IIA and II0 forms of the polymerase. Only B95.8 cells showed a faint signal for the CTD-
less Pol IIB.  
5.4.3 The binding of RNA Pol II at promoters of early lytic genes 
strongly increased gene transcription 
Quantitative RT-PCR experiments were performed in Raji 3862 cells in the time course of 
lytic induction to analyze the potential of the uncommonly modified RNA Pol II to activate 
gene expression (Fig. 5.14 A). Raji 3862 cells were induced with 100ng/ml doxycycline for 
46 h. RNA was prepared every four hours and treated with DNase I to remove contaminating 
DNA from the preparation. The success of DNase I treatment was controlled by PCR. RNA 
was reversely transcribed into cDNA and absolute transcript levels of selected mRNAs were 
quantified by qPCR. Expression of a set of early and late lytic genes was tested together with 
the latent gene EBNA1 and the housekeeping gene cytochrome C (cytC). Transcript levels 
were calculated on the basis of a single cell.  
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Fig. 5.14 Kinetics of viral gene expression after induction of EBV’s lytic phase  
(A) Flowchart of the experimental procedure. Raji 3862 cells were induced with 100ng/ml doxycycline for 46 h. 
A fraction of the cells was harvested every four hours, RNA was prepared and DNase I treated to eliminate 
contaminating DNA. DNase treatment was controlled by PCR. RNA was transcribed into cDNA and analyzed in 
a Roche LightCycler 480 real-time PCR system. Expression levels of selected transcripts were determined and 
calculated at the level of single cells.  
(B) In a control experiment, different latent and lytic cells (parental Raji cells, Raji 3862 cells ± doxycycline 
induction, B95.8 cells) were analyzed for the expression of latent, early lytic, and late lytic EBV genes as well as 
cytochrome C as a housekeeping gene. Results are displayed as transcript levels per cell on the y-axis.  
Parental Raji cells and uninduced Raji 3862 cells did not show expression of lytic genes except BMRF1 in 
uninduced Raji 3862 cells. Expression of EBNA1, which is a paradigmatic latent gene, is extremely low. After 
induction of the lytic phase with doxycycline for 46 h, Raji 3862 cells show a dramatic increase in the expression 
of early lytic genes, and a slight increase in the expression of late lytic genes. In the B95.8 cell line, a minor 
fraction of cells spontaneously undergoes the lytic phase of EBV. B95.8 cells served as a positive control. 
Cytochrome C is affected slightly by the addition of doxycycline, as can be seen in parental Raji cells that had 
been incubated in medium with doxycycline. 
(C) The temporal induction of different EBV genes suggests grouping into four different functional groups of 
viral genes. Group 1 (red) responds within four hours to the addition of doxycycline and encompasses BZLF1 
(Z), BMRF1, and BMLF1. Group 2 (orange) consists of BBLF4, BBLF2, BSLF1, and BALF5. They reached the 
expression peak eight hours post induction. EBNA1 and BRLF1 levels increased slowly over time (group 3, 
green) peaking at 28 hours after induction, while the late lytic genes (group 4, grey) showed a very low 
expression upon lytic induction with kinetics comparable to group 3. 
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In a control experiment, transcript levels of different latent Raji cell derivates (Raji cells with 
or without doxycycline treatment, Raji 3862 cells without doxycycline treatment) and 
lytically induced Raji cells (Raji 3862 cells with doxycycline treatment for 46 h), as well as 
B95.8 cells, which contain a fraction of virus-producing cells, were determined (Fig. 5.14 B). 
As expected, lytic genes were not detectably expressed in latent cells. Only uninduced Raji 
3862 cells displayed very low levels of BMRF1 expression, which was probably caused by a 
certain leakiness of the tet-promoter. Lytic induction increased the levels of certain early lytic 
genes per cell, but late lytic genes were expressed at low levels, only. A minor fraction of 
B95.8 cells spontaneously undergoes lytic reactivation, which is reflected in the expression of 
early and late lytic genes. The expression of the housekeeping gene cytC varied under 
doxycycline treatment in Raji cells and in Raji 3862 cells.  
The induction of lytic gene expression was studied in a time course experiment in Raji 3862 
cells after induction with doxycycline (Fig. 5.14 C). The kinetics of induction differed among 
the early lytic genes. The expression levels of the transgene BZLF1 peaked after four hours of 
doxycycline induction. Expression of BMRF1 and BMLF1 was equally fast. The BBLF4, 
BBLF2, and BALF5 genes were maximally expressed eight hours post induction. BSLF1, 
EBNA1, and BRLF1 levels continuously increased for a time period of 28 h of induction. Late 
lytic genes were expressed at very low levels, with a kinetic similar to BSLF1, EBNA1, and 
BRLF1. The results of the analysis indicated that induction of early lytic gene expression was 
possible with the unconventionally modified RNA polymerase. The time course revealed 
different kinetics of activation indicating that some genes are direct targets of BZLF1, while 
other genes are probably induced by a combination of transcription factors or are secondary 
targets of BZLF1. Expression of late lytic genes was detectable but at very low levels. This 
observation indicated, that the expression of late lytic genes is in principle possible without 
lytic DNA replication. Probably the very low expression levels are not adequate for the 
synthesis of sufficient amounts of viral structural proteins to form capsids and to release 
progeny virus. 
 6. DISCUSSION 
Textbooks and most of temporary literature state that EBV’s life cycle is biphasic, consisting 
of an initial latent and a second lytic phase. Accordingly, EBV-encoded genes are classified 
either as latent or lytic genes. Latent genes and transcripts comprise the EBV-encoded nuclear 
antigens (EBNAs), the latent membrane proteins (LMPs), the two non-coding RNAs EBER1 
and EBER2, and 44 EBV-encoded microRNAs (miRNAs). Lytic genes are further subdivided 
into immediate early, early, and late lytic genes. Immediate early genes are defined as genes 
that are expressed upon lytic induction prior to the translation of new proteins. BZLF1 and 
BRLF1 are classified as immediate early genes. They encode EBV’s own transcription 
factors. Early genes are direct targets of BZLF1, BRLF1, or both. They code mainly for 
proteins that are essential for lytic viral DNA replication. Late lytic genes are classically 
defined as genes that are expressed after the onset of lytic DNA replication. Agents that 
inhibit lytic replication also inhibit late gene expression, indicating that DNA replication in 
cis might be required for their synthesis. This model describes EBV’s life cycle to follow the 
general concepts of herpes simplex virus replication (Roizman et al., 2007). 
In the list of previous results of others and our group, the model of a biphasic life cycle 
appears to be oversimplified in the case of EBV. The most apparent conflict with the 
commonly accepted concept is the expression of a set of lytic genes immediately after 
infection of primary B cells (Zeidler et al., 1997; Altmann et al., 2005; Wen et al., 2007; Kalla 
et al., 2010). But lytic gene expression during this so-called “abortive lytic phase” fails to give 
rise to viral progeny. Another controversy is the immediate early status of BRLF1 because its 
expression is induced by the transcription factor BZLF1 demonstrating that de novo protein 
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synthesis of BZLF1 is mandatory for BRLF1 expression (Flemington et al., 1991; Amon et 
al., 2004). Late lytic genes are likewise a matter of debate. Previous reports demonstrated that 
BRLF1 is able to induce the expression of gp350 without viral replication (Feederle et al., 
2000). Other reports claim that late gene expression of BcLF1 and BFRF3 does not require 
DNA replication in cis (Serio et al., 1997). Together, these findings indicate that the 
conventional classification of herpesviral genes and life phases is insufficient to describe 
EBV’s infectious cycle.  
I propose here another concept of EBV’s life cycle, in which genes and life phases are 
classified according to the epigenetic status of the respective promoter and the dependence on 
viral cofactors. Characteristics of each promoter class and their temporal activation during the 
infectious cycle of EBV are summarized in Tab. 6.1. 
Tab. 6.1 classification of EBV promoters 
Promoters are clustered according to the epigenetic state of their template and the requirement for cofactors. The 
table shows examples for each promoter class, the favored chromatin template, the requirement of a viral 
cofactor, and the activity during EBV’s life cycle.  
examples class template viral factor active during 
BZLF1, BRLF1, BALF1, 
BHRF1, BNLF2a, BCRF1 
default-on 
(former: latent, early lytic 
& late lytic promoters) 
naïve chromatin no abortive lytic & lytic phase after DNA replication 
Cp, Qp, gp350/220  
poised-on 
(former: a fraction of 
latent & late lytic 
promoters) 
naïve chromatin yes latent & lytic phase after DNA replication 
BBLF4, BMRF1, BALF5 
(meZRE promoters) 
default-off 
(former: a fraction of 
latent promoters) 
CpG-methylated yes lytic phase prior to DNA replication 
no evidence - CpG-methylated no - 
 
Promoters that are operative during the early phase of infection are termed default-on 
promoters. Default-on promoters are free of repressive chromatin modifications because 
incoming virus is epigenetically “naïve”. Default-on promoters do not need any additional 
viral factor for their activation, but encounter a cellular environment, in which the basal 
cellular transcription machinery binds and activates their promoter elements. Default-on 
promoters include the W promoter that initiates the early expression of latent genes, the 
promoters of the two EBV-encoded transcription factors BZLF1 and BRLF1, and the 
promoters of BALF1, BHRF1, BNLF2a, and BCRF1. It is unclear whether the promoters need 
any additional component such as transcription and enhancer factors provided by the cell for 
their activation. The efficiency of transcription probably varies. I hypothesize that the 
multiplicity of the W promoter (Wp), which is part of a repeat array in EBV’s genome, could 
reflect a rather inefficient binding of the transcription machinery. The establishment of 
several Wp copies would compensate a weak affinity of RNA Pol II. This initial phase, in 
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which default-on promoters are active, comes to an end when the viral DNA acquires 
components of cellular chromatin. Reactivation of silenced default-on promoters during lytic 
replication probably requires DNA replication in cis to obtain an epigenetically unmodified 
template again.  
The second class of EBV promoters persists in a poised-to-be-on modus and the promoters 
are accordingly termed poised-on promoters. The chromatin state of them tolerates expression 
of genes in principle, but a viral factor that is necessary for their activation is missing early 
after infection. Poised-on promoters encompass for example the C promoter and the Q 
promoter. It is well established, that the C promoter is activated by EBNA1, a gene product of 
the default-on promoter Wp. But also the promoters of genes encoding for EBV’s structural 
proteins belong to this class. They rely on the expression of a so far unknown, probably viral 
factor, which is provided upon lytic DNA replication. Poised-on promoters that are not 
actively hold in an open configuration acquire repressive chromatin marks to be stalled in an 
inactive state later during infection similar to default-on promoters. Silenced poised-on 
promoters need DNA replication in cis for efficient gene activation in order to provide an 
epigenetically unmodified template.  
The third and most interesting class of EBV promoters belongs to the default-off class of 
promoters. They encompass BZLF1-regulated, methylation-dependent promoters, like the 
BBLF4 promoter. The regulation of default-off promoters has long been enigmatic, because 
the early and default-on expression of BZLF1 was insufficient to induce gene transcription. 
The observation that meZREs* are only bound and transactivated by BZLF1 if they are 
methylated in their central CpG dinucleotide solved this paradox: Default-off promoters are 
simply not in the correct epigenetic state at the time of viral infection. Epigenetic 
modifications are not that early and thus prevent an early expression of the meZRE-regulated 
genes. Moreover, BZLF1’s default-on promoter is shut down upon chromatinization, 
preventing the expression of this molecular switch gene when latency is established. Once the 
signaling cascades that lead to BZLF1`s reactivation are induced, BZLF1 protein rescues and 
activates default-off promoters from their repressed state. Until now, there is no evidence for a 
fourth promoter class, which depends on CpG-methylation but does not require a viral factor 
to become active.  
Fig. 6.1 summarizes the characteristics of each promoter class and their temporal activation 
during EBV’s infectious cycle graphically.                                                         
* methylated BZLF1 responsive elements 
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Fig. 6.1 EBV promoters can be classified into different subgroups dependent on the epigenetic state of the 
template and the presence of cofactors 
Upon infection of primary B cells, the viral chromatin is in a naïve configuration. The transcription of default-on 
promoters is possible, because they do not depend on the presence of a cofactor. BZLF1 as a default-on gene is 
expressed during the abortive lytic phase but fails to induce default-off promoters because they are not CpG-
methylated (left panel). Upon chromatinization, default-on promoters become silenced. A fraction of poised-on 
promoters is provided with the necessary cofactor, which is the EBNA1 protein, and is kept in an epigenetically 
unmodified and active state during latency. Poised-on promoters that are not provided with the essential 
cofactor, default-on promoters, and default-off promoters are epigenetically silenced and hold inactive during 
latency (middle panel). CpG-methylated DNA is the correct chromatin template for the activation of default-off 
promoters. Upon BZLF1 expression, they become active and express genes that are essential for lytic viral DNA 
replication. In the onset of the lytic phase, viral DNA replication in cis gives rise to epigenetically unmodified, 
naïve templates again, which allows the re-initiation of transcription at default-on promoters. Presumably, a so 
far unknown viral cofactor is also provided, which permits the expression of the full set of poised-on genes (right 
panel).  
 
In the next chapter I want to integrate established concepts of epigenetic regulation in EBV 
into my proposed new concept of viral regulation. I want to recapitulate the results of my 
thesis in light of this model. Last, I want to discuss open questions and possible means to 
address them.  
6.1 State of the art 
Promoter selection during the establishment of viral latency is one key process in EBV’s life 
cycle that depends on epigenetic regulation. Upon infection of primary B cells, expression of 
EBNA1, EBNA2, and EBNA3A-C is initiated at Wp (Woisetschlaeger et al., 1990). Wp is a 
default-on promoter and free of repressive epigenetic modifications at that stage of infection. 
Therefore, Wp is accessible for the basal transcription machinery. As mentioned above, Wp is 
part of a repetitive unit and present in multiple copies, which could indicate its rather weak 
affinity for RNA polymerase II. How Wp is repressed about four days post infection is not 
completely understood and discussed controversially. DNA methylation was proposed to be 
responsible for the promoter shutdown (Tierney et al., 2000), but studies with low-passage 
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lymphoblastoid cell lines (LCL) showed a variable methylation of Wp, only (Elliott et al., 
2004). Methylation increased with higher passage number. Therefore, it was proposed that 
alternate repressive mechanisms proceed and DNA methylation of Wp is a secondary event 
(Park et al., 2007). Initially, EBNA1 (among other EBNA genes) is expressed from the Wp 
promoter. The EBNA1 gene product binds to and activates the second promoter of EBNAs, Cp 
(Altmann et al., 2006). Cp is a poised-on promoter and, once its viral cofactor is present, 
induces in cell culture expression of all EBNA genes, which represents the so-called “latency 
III” gene expression profile. In vivo, the latency III program triggers an immune response in 
healthy individuals, which in turn requires downregulation of Cp by DNA methylation and a 
second promoter switch to Qp (Schaefer et al., 1995; Paulson et al., 1999). This scenario 
demonstrates that the epigenetically open condition of poised-on genes is vulnerable for 
repressive epigenetic changes as well. Transcription initiation from Qp results in the 
expression of EBNA1, only, and is described as the “latency I” program. Qp is the only 
promoter that maintains an active chromatin configuration in vivo, which is probably 
supported by the binding of the chromatin insulator CTCF that prevents the spread of 
repressive epigenetic modifications into the promoter region of Qp (Tempera et al., 2010). 
This observation suggests that poised-on promoters do not only depend on additional factors 
in trans but also have to be actively protected from repression by epigenetic modifications.  
Another key checkpoint during EBV’s life cycle depends on epigenetic mechanisms as well: 
the switch to the lytic phase is controlled by DNA methylation. BZLF1 is the master regulator 
of EBV’s lytic switch in latently infected B cells (Countryman et al., 1987). The viral 
transcription factor has the ability to bind to methylated DNA (Bhende et al., 2004; Karlsson 
et al., 2008; Dickerson et al., 2009). We could previously show that CpG-methylation of 
promoters of early lytic genes is a prerequisite to enable the switch to the lytic phase. Binding 
of EBV’s transcription factor BZLF1 to the methylated promoter elements of the class of 
early lytic genes abrogates repression, induces the expression of lytic genes, and promotes the 
production of progeny virus (Bergbauer et al., 2010; Kalla et al., 2010). This scenario 
illustrates the characteristics of the default-off state: Virion DNA with default-off promoters 
reaches the cell in an epigenetically unsuitable configuration because default-off promoters 
are initially unmethylated. They first have to be core DNA-methylated before the viral factor, 
i.e. the transcription factor BZLF1, is able to bind to and activate this class of promoters.  
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6.2 Scope and aim of my thesis work 
Epigenetic mechanisms play a remarkable role regulating EBV’s life cycle. But the picture is 
still incomplete because we have only snapshots of this viral life cycle. In my thesis work I 
wanted to understand the underlying principles of epigenetic modifications that are necessary 
to guarantee an efficient infection, successful transformation of B cells, long-term persistence 
in the host cell, and escape from latency to spread the progeny virus. The two major questions 
at the beginning of my thesis work were: 
 
 1. How does the virus establish and maintain latency? 
 2. How does the virus escape from latency? 
 
We know now that the viral life cycle consists of three stages: an initial lytic but abortive 
phase, a latent phase, and lastly, a complete lytic phase, which supports viral synthesis. In the 
perspective of this model of EBV’s life cycle, I wanted to unravel the epigenetic mechanism 
that lead to the repression of default-on promoters and the concomitant termination of the 
initial abortive lytic phase. As mentioned above, DNA methylation and its role in the switch 
from Wp to Cp is controversially discussed. I wanted to address this uncertainty. The 
epigenetic state of latent promoters, which are according to my model a fraction of poised-on 
promoters, is well understood. The methylation profile and the histone modification pattern of 
certain promoters are known (Minarovits, 2006). But it is unclear how default-on promoters, 
default-off promoters, and poised-on promoters except Cp and Qp are kept in a silent modus. 
The virus has to cope with two problems: (i) the promoters require tight repression to evade 
an immune response during latency, but (ii) activation has to proceed rapidly and 
synchronously after induction of the lytic phase. It was uncertain, how default-off promoters 
can become activated. BZLF1 can bind to and activate methylated default-off promoters, but 
their methylation state was unclear. Whether these promoters are equipped with other 
repressive epigenetic modifications that need to be overcome upon lytic induction was 
unknown.  
I wanted to elucidate these open issues. I analyzed the early phase of infection and focused on 
the establishment of epigenetic marks on EBV’s DNA. Furthermore, I studied the epigenetic 
state during latency to understand the repression of lytic genes in latently infected B cells. At 
last, I investigated epigenetic changes on EBV’s DNA upon lytic induction to understand how 
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EBV is able to escape epigenetic repression. I used different model systems to portray 
epigenetic events in EBV: Primary infected B cells from adenoids were used for experiments 
in the early phase of an EBV infection. The cell line Raji is our model system for a latency III 
infected cell line. I analyzed two different derivates of Raji cells in order to reproduce 
epigenetic events that occur upon lytic induction: one Raji cell line constitutively expressed a 
truncated form of BZLF1, which lacks the N-terminal activation domain. A second Raji cell 
line was engineered to carry stably a doxycycline-inducible plasmid encoding full length 
(wildtype) BZLF1. My analysis of the different states of an EBV infection together with 
published data provided information that led to novel insights and improved our model about 
EBV’s life cycle.  
6.3 How to establish and maintain latency? 
6.3.1 The temporal establishment of an epigenetic pattern on EBV DNA 
The initial abortive lytic phase lasts approximately four days, until the transcription from 
default-on promoters is downregulated (Altmann et al., 2006; Kalla et al., 2010). The 
mechanisms of promoter shutdown were unclear but hardly discussed (Tierney et al., 2000; 
Elliott et al., 2004; Park et al., 2007). I performed experiments with freshly infected B cells 
from adenoids to obtain information about early epigenetic events during an EBV infection. I 
concentrated on the kinetics of DNA methylation and the kinetics of nucleosome acquisition 
during an EBV infection. I wanted to clarify, whether DNA methylation could play a role in 
the termination of the abortive lytic phase and the downregulation of default-on promoters.  
CpG-methylation of EBV’s DNA was assessed by MeDIP-on-Chip analysis on primary 
infected B cells at different time points post infection (pi). The DNA methylation profile of 
EBV showed weak DNA methylation at one week pi, with the most substantial increase 
between week two and three pi. The methylation profile appeared to be stable thereafter and 
MeDIP experiments with LCLs originating from different donors had similar profiles. These 
observations indicated the existence of a characteristic LCL methylation pattern that evolves 
slowly after infection of primary B cells. Cellular methyltransferases were found upregulated 
one week pi, which is in line with the time point of increase in EBV’s DNA methylation over 
time (Fig. 4.3). Similar experiments with EBV’s close relative KSHV* also indicated a slow 
increase in the viral-specific methylation pattern upon infection (Gunther et al., 2010). These                                                         
* Kaposi Sarcoma-associated herpesvirus 
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observations exclude the possibility that EBV’s DNA methylation could be a mechanism for 
the promoter shutdown of default-on promoters, because the temporal course of both events 
does not coincide and CpG-methylation traits behind.  
The packaging of EBV’s DNA into nucleosomes could be an alternate mean to establish an 
epigenetically repressed gene expression profile in LCLs and to downregulate default-on gene 
expression. I analyzed the occupancy of EBV’s DNA with oriP nucleosomes in the time 
course of an EBV infection using a qPCR approach. The occupancy of EBV’s DNA with 
nucleosomes appeared to be a fast and gradual process, which starts immediately after 
infection (Fig. 4.6). The first discovery of nucleosome-incorporated EBV DNA matched the 
timepoint at which default-on promoters are shut down approximately three to four days pi. 
Default-on promoters include the lytic gene promoters of BALF1, BHRF1, BZLF1, BRLF1, 
BNLF2a, BCRF1, and Wp (Zeidler et al., 1997; Altmann et al., 2005; Kalla et al., 2010). 
BHRF1 and BALF1 are two homologs of the cellular anti-apoptotic gene BCL-2. BZLF1 has a 
pro-proliferative effect on resting primary B cells, similar to its cousin AP-1. BNLF2a is 
targeted to the TAP-transporter*, which impairs HLA class I-restricted antigen presentation 
(Horst et al., 2009). BNLF2a is a classic “late lytic” gene and is expressed already eight hours 
pi. In addition, its mRNA is incorporated into virions and transferred to newly infected cells 
(Simon Jochum, personal communication), which reflects its important role during the 
abortive lytic phase. BCRF1 is a homolog to cellular IL-10 and also involved in the 
suppression of innate host immune responses. The anti-apoptotic, pro-proliferative, and 
immunosuppressive effects that the viral proteins provide to the cells initially are pivotal for 
the success of viral infection and the establishment of the virus in the host cell. The function 
of default-on genes is substantial in the very early phase of infection, but a rapid 
downregulation is crucial for a persistent infection. The prevalence of BZLF1 and BRLF1 
specific CD8+ T-cells very early after infection illustrates the need to downregulate default-on 
promoters in order to escape an early immune response prior to the establishment of latency 
(Iskra, 2010). The rapid acquisition of nucleosomes establishes a defined chromatin structure 
on EBV’s DNA, which terminates the activity of default-on promoters. Nucleosomes are not 
only barriers to transcription: Histone proteins are also important for a multitude of other 
cellular tasks. For example, packaging of DNA into nucleosomes is essential during the cell 
cycle for a proper DNA replication during S-phase and successful chromosome segregation 
during mitosis (Lipford et al., 2001). It is essential for EBV to adapt to these cellular 
mechanisms to guarantee the heredity transmission of its genomes in dividing cells. The fast                                                         
* transporter associated with antigen processing 
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occupancy of EBV’s DNA with nucleosomes seemingly reflects the importance of an early 
establishment of the viral episome in infected cells, too.  
6.3.2 Epigenetic modifications help to maintain the latent state 
Herpesviral latency is associated with genomic persistence and a highly restricted viral gene 
expression in the host cell (Speck et al., 2010). The initiation of latent gene expression from 
different poised-on promoter types has been studied extensively (Minarovits, 2006). As 
pointed out before, EBV acquires chromatin modifications during its infectious cycle. 
Nucleosomes are positioned very early while DNA methylation is a slow process. However, 
according to my results, the chromatin state that allows the induction of default-off genes is 
set after two to three weeks pi, which matches the timepoint of the first detectable virus in 
LCLs (Kalla et al., 2010). I could also show that latent Raji genomes are highly methylated 
(Fig. 4.2), but default-off genes are not expressed in latent cells until BZLF1 is expressed. The 
mode of repression of default-off genes during latency has not been studied so far. Therefore, 
I wanted to determine the state of latent genomes in order to understand the epigenetic quality 
of the repression of default-off genes during latency in our model cell system Raji. I assessed 
the DNA methylation pattern, the nucleosome occupancy profile, and a set of important 
histone modifications to understand the epigenetic nature of latency. The results I obtained 
delivered the following picture:  
Qp was the only poised-on EBNA promoter that allowed latent gene expression in Raji cells. 
The promoter region was entirely free of methylation and the nucleosome occupancy was 
low. The repressive histone modifications H3K9me3 and H3K27me3 were absent, but the 
promoter encompassed significant levels of the activation mark H3K4me3. EBERs and oriP 
comprised a similar epigenetic pattern indicating an active state during latency. Furthermore, 
my experiments demonstrated a strict repression of default-on, default-off, and poised-on 
promoters except Qp during latency. All three promoter classes were highly methylated 
during latency. Importantly, default-off promoters encompassed a strong invariable CpG-
methylation of meZREs. The strong methylation of meZREs provides the default-off 
promoters with an epigenetic background that is permissive for transcriptional activation by 
BZLF1. But unless BZLF1 is expressed, DNA methylation represses transcription according 
to the “textbook” knowledge, which links silencing and DNA methylation.  
I could show that DNA methylation is not the only mean to establish a tight repression during 
latency. The promoters encompassed densely positioned nucleosomes, a finding that was 
typical for BZLF1-regulated promoters (default-off promoters). More interestingly, MND-on-
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Chip experiments indicated a hierarchy of gene repression during latency. Promoters of genes, 
which were shown to be essential for lytic DNA replication (Fixman et al., 1992; Feederle et 
al., 2000), comprised the highest nucleosome occupancy indicating the strictest repression. A 
hierarchy of repression appears plausible: If proteins indispensable for lytic replication are 
absent due to a strong gene repression during latency, the whole signaling cascade of lytic 
reactivation cannot come to pass. Infrequent and accidental expression of genes that are not 
required for lytic DNA replication can probably be tolerated during latency because protein 
products will not trigger the activation of further promoters that could cause an immune 
response. Default-off, default-on, and poised-on promoters have additional means of 
repression during a stable latency: I could demonstrate that PcG*-proteins bind and seal 
repressed promoters with the repressive mark H3K27me3 to stably maintain repression during 
cell cycle progression. During latency, activation marks were absent among default-off, 
default-on, and repressed poised-on promoters. RNA Pol II was oblivious, but it is 
questionable whether a polymerase would ever be able to bind to promoter elements that are 
padded tightly with nucleosomes, as it is the case for default-off promoters (Lorch et al., 
1987). My observations argue against the existence of a so-called bivalent chromatin structure 
in the EBV genome. Bivalent marks were described to be important for lytic reactivation of 
KSHV, a close relative of EBV (Gunther et al., 2010; Toth et al., 2010). Sequential ChIP 
assays indicated the co-existence of H3K4me3 and H3K27me3 at the immediate early 
promoters of ORF50 and ORF48. The concomitant presence of these modifications is a 
hallmark of bivalent chromatin (Bernstein et al., 2006). ORF50 encodes the BRLF1 homolog 
RTA. RTA is sufficient to induce the complete cascade of KSHV’s lytic replication. 
Furthermore, H3K27me3 and the histone H3K27 methyltransferase EZH2† were detected in 
the entire KSHV genome. The third characteristic for a bivalent chromatin structure, i.e. a 
poised polymerase, was not analyzed in the KSHV background. I analyzed all features of 
bivalent chromatin in EBV but I could not detect any colocalization of H3K4me3 and 
H3K27me3. A polymerase was not present at default-off promoters during latency. My 
experiments apparently demonstrated that bivalent chromatin is not present in EBV and 
pointed to a different mode of gene regulation in EBV as compared to KSHV.  
 
                                                        
* proteins of the Polycomb group  
† human enhancer of zeste 2 
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6.4 How to escape the latent state? 
Exogenous signals such as antigen contact or unknown stochastic events induce the lytic 
phase, which leads to the expression of the full set of viral genes, lytic reproduction of the 
virus, and the release of progeny to infect other cells. In EBV, signaling cascades downstream 
of the B cell receptor most likely trigger induction of the lytic phase (Campbell, 1999). The 
foremost event of a productive lytic phase is the activation of default-off genes. Default-off 
genes encode proteins for lytic DNA replication. DNA replication yields epigenetically 
unmodified EBV genomes, so that the initial epigenetic “default setting” of the virus is 
restored. This is a prerequisite for the activation of silent poised-on genes, which are 
necessary for the synthesis of structural proteins and packaging of newly replicated viral 
DNA into capsids. Activation of default-on genes, which were silenced after the 
establishment of latency by epigenetic repression, follows the same rules. I wanted to gain 
deeper insights into the mechanism of lytic reactivation with special focus on the activation of 
default-off genes.  
6.4.1 Primary infected B cells are ready for lytic reactivation two 
weeks pi 
DNA methylation is indispensable for the switch to the lytic phase in EBV. Early expression 
of BZLF1 fails to give rise to progeny virus, indicating that lytic induction is only possible in 
latently infected B cells (Kalla et al., 2010). Default-off promoters encompass meZREs, which 
are exclusively bound by BZLF1 when they carry methylated cytosines (Bergbauer et al., 
2010). As a consequence, EBV’s DNA requires DNA methylation marks to switch to the lytic 
and productive phase. As I pointed out before, I could show that DNA methylation is 
predominantly established between week two and three pi in primary infected B cells (Fig. 
4.3). In agreement with my observation, progeny virus is not released earlier than two 
weeks pi (Kalla et al., 2010). These findings demonstrated that the timing of EBV’s DNA 
methylation governs its capacity to switch to the lytic phase.  
6.4.2 Chromatin changes at default-off promoters after lytic induction 
My experiments demonstrated the solid repression of default-off promoters during latency. 
The promoters were not only intensively methylated, but also occupied by nucleosomes 
(Fig. 5.3 and 5.7). They encompassed repressive histone tail modifications and binding of 
PcG-proteins promoted long-term silencing (Fig. 5.10 and 5.11). It was previously shown that 
BZLF1 is able to bind to methylated DNA (Bergbauer et al., 2010), but the role of the 
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alternate repressive epigenetic marks was unclear. A major question remained. Does 
activation of the lytic phase include a remodeling of EBV’s chromatin or is the binding of 
BZLF1 to methylated DNA sufficient to recruit the transcription machinery to default-off 
promoters?  
The methylation state of default-off promoters remained unchanged upon lytic reactivation 
demonstrating that DNA methylation does not prevent transcriptional activation per se 
(Fig. 5.5). In contrast, other repressive epigenetic marks were strongly affected by the 
induction of the lytic phase. I could show that binding of BZLF1 to promoters of a subset of 
default-off genes resulted in major rearrangements of nucleosomes. The high nucleosome 
occupancy that was present in latency was lost, indicating a local opening of the promoter to 
permit access for the transcription machinery. Remodeling was mainly independent of the N-
terminal activation domain of BZLF1, as a truncated form that lacks the N-terminus was also 
able to remodel EBV’s chromatin at most BZLF1-responsive promoters. The N-terminal 
transactivation domain of BZLF1 constituted to the loss of nucleosomes at certain promoters 
like BMRF1, only. I hypothesize that BZLF1 interacts with different chromatin remodelers in 
order to cause a local release of DNA in promoters of default-off genes. Previous studies 
already identified the histone acetylase CBP* as an interaction partner of BZLF1. CBP 
induces chromatin rearrangements and mediates RNA Pol II recruitment to promoter sites of 
DNA. Interaction of BZLF1 and CBP required both the C-terminal domain of BZLF1 and the 
N-terminal activation domain of BZLF1 (Adamson et al., 1999; Zerby et al., 1999). However, 
I already obtained chromatin remodeling at certain BZLF1-regulated promoters with a 
BZLF1-mutant that lacked the N-terminal activation domain, which was reported to be 
detrimental for CBP interaction (Adamson et al., 1999). A closer look at the protein structure 
of BZLF1 might be helpful to understand why the mutant-BZLF1 is still able to remodel 
chromatin. BZLF1 is a bZIP (basic leucine zipper) transcription factor. The protein has a 
length of 245 amino acids and consist of several protein domains: The N-terminal activation 
domain, a regulatory domain, a central DNA binding domain, a coiled-coil dimerization 
domain, and a C-terminal tail of 23 amino acids, whose function is unclear and debated. The 
small C-terminal tail was proposed to be important for stabilizing the coiled-coil dimer. The 
proximal part of the C-terminal domain was also assumed to be required for promoter 
transactivation (Hicks et al., 2003; Schelcher et al., 2007). A more recent study denies the 
impact of the C-terminal domain for transactivation, and instead supposes a role for BZLF1-
mediated DNA replication (McDonald et al., 2009). The truncated version of BZLF1 I used in                                                         
* CREB binding protein 
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my experiments comprised this C-terminal tail of unknown function, which might be 
important for BZLF1-dependent chromatin remodeling upon lytic reactivation of the virus. 
Probably the domain provides interaction surfaces for so-far unidentified chromatin 
remodelers.  
The differences in the two modes of chromatin remodeling at the two subsets of promoters 
matched the hierarchy, i.e. the extend of repression I mentioned in the last chapter: Genes that 
are central for lytic viral DNA amplification displayed the tightest repression by nucleosomes 
during latency. The N-terminal domain of BZLF1 comprising the C-terminal tail was not 
sufficient and the activation domain was essential to remodel nucleosomal occupancy in the 
majority of promoters of this subset indicating that they require the most energy to be 
activated for gene expression. Similar to my findings, a previous study on genes activated by 
Toll-like receptors in macrophages suggested a hierarchical regulation of nucleosome 
remodeling that depended on the strength of repression in the inactivated state. The authors 
found a correlation between the nucleosome density, the need for chromatin remodelers, and 
the function of the corresponding gene: Promoters of genes with highly specialized tasks 
assembled into stable nucleosomal structures and required remodeling upon induction. A 
minimal basal transcription of the corresponding genes would be detrimental to the cell. In 
contrast, promoters of genes that are activated by common transcription factors encompassed 
only unstable nucleosomes and did not rely on the energy consuming remodeling of their 
promoter nucleosomes (Ramirez-Carrozzi et al., 2006; Ramirez-Carrozzi et al., 2009). 
Another hallmark of default-off promoters in EBV during latency was trimethylation of 
histone H3K27 and the local prevalence of the PcG-protein EZH2. Lytic induction caused the 
rapid loss of H3K27me3 and EZH2. Concomitantly, the H3K4me3 activation mark was 
established at default-off promoters. The epigenetic changes at default-off promoters created a 
chromatin environment that allowed binding of RNA Pol II and an efficient initiation of 
transcription.  
My experiments revealed that default-off promoters are accessible for BZLF1-binding during 
latency but that remodeling of the repressive chromatin structure is necessary for the switch to 
the lytic phase presumably to provide admission for the basal cellular transcription 
machinery. These observations clearly demonstrated that binding of BZLF1 rescues default-
off promoters from an epigenetically repressed state. Interestingly, KSHV uses a different 
mechanism to escape from latency. As mentioned before, the KSHV protein RTA is sufficient 
to induce the lytic phase and the promoter region of ORF50, the gene that encodes RTA, 
encompasses bivalent chromatin structures during latency. In KSHV, inhibition of the 
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methylase EZH2 or overexpression of the H3K27me3 demethylase was sufficient to 
reactivate the RTA promoter, but not the BZLF1 promoter in cell lines that carry both viruses 
(Gunther et al., 2010; Toth et al., 2010). This observation indicates, that epigenetic repression 
and reactivation of KSHV and EBV has evolved independently. While KSHV makes use of 
bivalent chromatin for its rapid lytic reactivation, EBV has evolved a crafty mechanism to 
overcome tight epigenetic repression by its transcription factor BZLF1.  
6.4.3 Two default-off promoters in a close-up: Epigenetic regulation at 
BBLF4 and BMRF1  
Two examples of default-off promoters are the promoter of the EBV-encoded helicase BBLF4 
and the promoter of the DNA-polymerase associated factor BMRF1. Both gene products 
belong to the seven proteins that are indispensable for lytic DNA replication of EBV’s 
genome. Fig. 6.2 and 6.3 graphically portray the results of all epigenetic information that were 
collected during my thesis, in order to demonstrate the complexity of epigenetic regulation of 
the promoters during the different phases of EBV’s life cycle. 
The BBLF4 promoter encompasses several meZREs (Fig. 6.2, lower y-axis, red and green 
line). All meZREs were highly methylated during latency (Fig. 6.2, upper panel, lower y-axis, 
each CpG dinucleotides is represented as a bar, the degree of methylation is indicated in red). 
The promoter site of BBLF4 was highly enriched in nucleosomes in contrast to the BBLF4 
gene body (Fig. 6.2, grey area). The modifications of histone tails and the binding of 
chromatin-associated proteins are depicted as differently colored areas on the upper y-axis. 
The whole promoter encompassed high levels of the repressive mark H3K27me3 (Fig. 6.2, 
dark grey area) and the H3K27 methyltransferase EZH2 (Fig. 6.2, green area). Repression by 
H3K9me3 was present, but on a low level, only (Fig. 6.2, blue area). The activation mark 
H3K4me3 was absent, similar to RNA Pol II. Induction of the lytic phase caused dramatic 
changes at the promoter site (Fig. 6.2, lower panel): Nucleosomes in the promoter region were 
lost; a hypersensitive site was established at the 5’ end of the gene. H3K27me3 and EZH2 
levels dropped and became indistinguishable to background levels. The activation mark 
H3K4me3 was established at the promoter site (Fig. 6.2, red area), and was even more 
prominent towards the gene body of BBLF4. RNA Pol II followed the same pattern (Fig. 6.2, 
orange area). Histone H3K9me3 levels remained unchanged indicating that this modification 
is not important for the maintenance and for reversion of gene repression. 
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Fig. 6.2 Epigenetic regulation of EBV: Close-up of the default-off BBLF4 promoter  
Summary of all information that I collected during my PhD work to assess the epigenetic state of the early gene 
promoter of BBLF4 during latency (A) and after lytic induction (B). Displayed are binding sites of BZLF1 
(plotted on the lower y-axis, please refer to Fig. 5.1 for details), the methylation state of the promoters evaluated 
by bisulfite sequencing on the lower y-axis (experimental details are given in Fig. 5.3), the nucleosomal 
occupancy analyzed by MND-on-Chip analysis (grey area, compare Fig. 5.8), and the results of ChIP 
experiments of EZH2 (light green area), H3K27me3 (dark green area), H3K9 (blue area), H3K24me3 (red area) 
and RNA Pol II (orange area) plotted on the upper y-axis (compare Fig. 5.10-12). Results are provided as 
relative, dimensionless numbers, but the scaling of each experiment is equal in all the graphs shown.  
Repressive modifications characterize the BBLF4 promoter during latency. They are erased after induction of the 
lytic phase with the exception of CpG-methylation. The ZREs are densely occupied by nucleosomes, which 
presumably serve to repress this promoter in the latent phase. Repression by Polycomb group proteins maintain 
the repressed state, as can be seen by the enrichment of the PRC2 protein EZH2 and the histone modification 
H3K27me3. Nucleosomes and repressive marks are removed after lytic induction. A hypersensitive site becomes 
established upstream of the ZREs in front of the coding sequence of BBLF4. H3K9me3 levels are low but visible 
during latency and after lytic induction. The activation mark H3K4me3 is absent in latency, but is found at the 
promoter and at higher levels in the gene body after lytic induction. RNA Pol II parallels the H3K4me3 pattern.  
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Fig. 6.3  Epigenetic regulation of EBV: Close-up of the default-off BMRF1 promoter  
Summary of all information that I collected during my PhD work to assess the epigenetic state of the early gene 
promoter of BMRF1 during latency (A) and after lytic induction (B). Figure details can be found in Fig. 6.2.  
In principle, the BMRF1 promoter shows the same epigenetic pattern seen in the BBLF4 promoter, although 
repression by nucleosomal occupancy and methylation seems to be less tight, as not all CpG sites are completely 
methylated and nucleosomes are slightly reduced during latency. However, after the switch to the lytic phase, the 
mechanisms found in the BBLF4 promoter also apply here: Repressive marks are removed and activation marks 
and RNA Pol II are enriched in the lytic phase.  
 
The BMRF1 promoter exhibited a similar epigenetic regulation. The promoter comprises 
meZREs (red and green line, lower y-axis), which were highly methylated (red bars, lower y-
axis). The nucleosome occupancy was relatively high at the promoter site. The BMRF1 gene 
body contained a hypersensitive site, which sharply separated the methylated promoter site 
from the hypomethylated region downstream within the gene body. The complete region 
displayed high levels of H3K27me3 (dark grey area) and EZH2 (green area), but only low 
amounts of H3K9me3 (blue area). Activation marks and RNA Pol II binding were absent 
during latency. The picture changed dramatically upon lytic induction: The promoter was 
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completely remodeled; nucleosomes and repressive modifications were evicted and erased, 
respectively. Instead, the H3K4me3 levels and RNA Pol II occupancy rose (red and orange 
area, respectively), inducing the transcription of BMRF1.  
Summing up, the pictures illustrate the dramatic changes that are necessary to induce 
transcription of BBLF4 and BMRF1, two representatives of default-off genes. Clearly, the 
promoter sites are tightly repressed by epigenetic mechanisms during latency. The chromatin 
configuration allows binding of BZLF1, but the epigenetic state of the promoter has to be 
reverted to make it available for RNA Pol II binding and gene expression. This demonstrates 
that BZLF1 is able to bind to and access a repressed promoter, but its binding is not sufficient 
to establish RNA Pol II at the promoter site. Hence, after BZLF1 binding, the chromatin has 
to be remodeled in a “classical” way.  
6.4.4 Chromatin changes at default-on and poised-on promoters upon 
lytic induction 
The epigenetic pattern of default-on and poised-on promoters during latency pretty much 
resembles the mode of repression of default-off promoters. However, both promoter classes 
do not encompass binding sites for BZLF1. I wanted to figure out the epigenetic 
consequences of lytic induction on default-on and poised-on promoters to dissect the 
influence of BZLF1 binding on the chromatin state.  
Interestingly, PcG-mediated repression was erased at default-on and repressed poised-on 
promoters similar to default-off promoters: H3K27me3 and EZH2 levels dropped upon lytic 
reactivation. Repressive modifications appeared to be completely removed from the EBV 
genome. This finding indicated that BZLF1 binding in cis is not a prerequisite for the removal 
of repressive modifications. However, certain chromatin changes at default-off promoters 
occur locus-specifically: Default-on and poised-on promoters did not acquire activation 
marks, and RNA Pol II did not bind to the promoters. The nucleosome levels were still 
elevated and appeared to inhibit the binding of the transcription machinery. The kinetics of 
transcriptional activation in lytically induced cells pictured a low-level induction of some 
poised-on genes. Perhaps, erasure of repressive marks led to a certain leakiness of these 
promoters. This state might be an artifact of the Raji cell line because lytic viral DNA 
replication does not proceed as the viral BALF2 gene is deleted in the viral genome. 
Therefore, activation of poised-on promoters cannot be studied in the model cell line Raji.  
But comparison of default-off and poised-on promoters provides important insights about the 
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contribution of BZLF1 to epigenetic changes: nucleosome remodeling is a direct effect of 
BZLF1 binding but Polycomb repression disappears independently of BZLF1 binding. 
6.5 Open questions and outlook 
The life cycle of EBV clearly depends on epigenetic modifications. My results contributed to 
a clearer understanding of the dynamic epigenetic changes that govern the regulation of 
EBV’s life cycle. Still, many questions remain unanswered and need to be addressed in the 
future.  
6.5.1 Why are certain parts of the EBV genome kept in an open 
configuration? 
This is also a key question in embryonic development and its epigenetic regulation. What 
defines the trajectory the marble takes on its way down the hill in Waddington’s epigenetic 
landscape (Fig. 1.1)? One theory is the importance of early transcription: In a previous study 
it was found that transcription initiation and H3K4me3 are hallmarks of promoters of most 
protein-coding genes in human ES cells. This situation could serve to create a chromatin 
structure at transcriptional start sites that is more accessible to transcription than the rest of 
the genome (Guenther et al., 2007). H3K4me3 modification inhibits the binding of DNMT3L 
protecting these sites from de novo CpG-methylation. Thus, active RNA polymerase probably 
protects CpG islands and promoter sites from DNA methylation (Cedar et al., 2008). The 
cooperation of early transcription and chromatin insulators like CTCF could be a mechanism 
to prevent establishing repressive epigenetic modifications on parts of EBV’s genome that are 
active during latency. The solution of this enigma will explain how a stable latency is 
established and maintained in EBV-infected cells. In addition, EBV could serve as a model 
system to understand the establishment of a restricted gene expression pattern in metazoan 
cells.  
6.5.2 What is the mechanism of chromatin remodeling upon lytic 
induction? 
Binding of BZLF1 to promoters of default-off genes induces major nucleosome 
rearrangements and causes a local opening of the tightly packed chromatin. My results 
suggested at least two different means to remodel chromatin upon BZLF1 binding: One 
mechanism relied on the function of the N-terminal activation domain of BZLF1. The second 
depended on the C-terminal half of BZLF1, only. I speculated that the C-terminal domain 
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could contribute to chromatin remodeling, but it is just as well possible that binding of BZLF1 
alone is sufficient to induce a local chromatin rearrangement. The mechanisms of chromatin 
remodeling can be addressed using additional BZLF1 mutant forms that lack the C-terminal 
domain. Interaction partners of BZLF1 can be identified by immunoprecipitation experiments, 
probably in conjunction with mass spectrometry. Knowledge about cellular factors that are 
necessary for promoter activation upon lytic induction will enhance our understanding about 
epigenetic regulation in EBV.  
6.5.3 What is the mechanism of poised-on and default-on promoter 
activation upon lytic induction? 
Raji cells are deficient in the gene locus BALF2, which encodes for the single strand DNA 
binding protein of EBV’s DNA replication machinery (Hung, 1999, Nakayama 2009). BALF2 
is one of the genes that is absolutely essential for lytic DNA replication and the completion of 
the full lytic cycle because repressed poised-on and default-on genes probably require the 
newly replicated, naïve DNA templates for their transcription (Summers et al., 1976; Yajima 
et al., 1976; Datta et al., 1981). However, there is at the moment no proper model system to 
elucidate the mechanistic background of poised-on and default-on promoter activation upon 
lytic induction. Late events in EBV’s lytic phase still remain a black box. As a consequence, 
indications that newly replicated transcripts are necessary for the transcription of “late lytic 
genes”, i.e. poised-on genes, is only based on indirect hints.  
The complete lytic cycle can be rescued by the introduction of the BALF2 open reading frame 
into Raji cells (Decaussin et al., 1995). A Raji cell derivate, in which the lytic phase can be 
reproduced, would be a perfect means to analyze events that are necessary for the expression 
of poised-on genes and epigenetically silenced default-on genes. Ideally, the engineered Raji 
cell line should encompass an inducible version of BZLF1 and BALF2 in order to produce 
progeny virus. Whether the poised-on transcripts originate from the established EBV episome 
or from newly synthesized EBV genomes is a still unanswered key question regarding late 
events of the lytic phase. A way to examine the nature of the template is to measure its 
methylation state. Chromatin immunoprecipitation of the RNA Pol II-associated template 
DNA and a subsequent methylation analysis by bisulfite sequencing could be a means to 
answer this open question.  
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6.5.4 What is the nature of RNA Polymerase II during lytic replication 
of EBV? 
I performed Chromatin Immunoprecipitations of RNA Pol II with different CTD*-
modification-specific antibodies but I could only enrich RNA Pol II at default-off promoters 
by using an antibody directed against the N-terminal part of the protein. All antibodies 
recognizing epitopes of the regulatory CTD of RNA Pol II were unable to precipitate DNA 
upon lytic induction, but their functionality was demonstrated in positive controls in the same 
samples. This is a surprising finding. First, we hypothesized an EBV-induced clip-off of the 
CTD to redirect the cellular transcription machinery to EBV gene transcription, but this 
hypothesis could not be confirmed in western blot immunodetections: The CTD-less 
polymerase was not detected in lytically induced Raji cells. However, the virus apparently 
uses a special and so far unknown mechanism for the transcription of its default-off genes 
because standard CTD-modifications appear to be absent during lytic transcription. The usage 
of CTD-specific antibodies that are specific for uncommon modifications would be a means 
to shed light on this issue.  
6.5.5 Which concepts of EBV can be transferred to cellular epigenetic 
mechanisms? 
As I pointed out above, EBV could serve as a model system to study the establishment of an 
epigenetic pattern in metazoan cells. Furthermore, epigenetic regulation in EBV comprises 
concepts, that are so far not known in the epigenetic regulation of cellular genes: It is 
questionable whether EBV has invented or adopted a transcription factor that is able to 
convert an epigenetic repressed state, as it is the case for BZLF1. The same holds true for the 
unidentified mechanism of RNA Pol II regulation: Peculiar modifications of RNA Pol II’s 
CTD could be a virus specific mechanism to redirect cellular transcription to the benefits of 
the virus, but it could just as well be a crucial mechanism of transcriptional regulation in other 
scenarios of stress response, for example in gene regulation induced by UV-irradiation or 
inflammatory cytokines. Conceivably, the examination of epigenetic events in EBV may 
contribute to extend our knowledge about epigenetic regulation of human DNA during 
development and disease. 
                                                        
* C-terminal domain 
 7. SUMMARY 
Cellular gene regulation depends on fundamental epigenetic mechanisms, but epigenetic 
modifications also govern the regulation of the life cycle of Epstein-Barr virus (EBV). 
Promoter usage during latency depends on DNA methylation of the viral genome and CpG-
methylation of certain promoters with meZREs* is an indispensable prerequisite to switch 
from the latent to the lytic phase. In my thesis, I wanted to assess the underlying epigenetic 
principles of EBV’s gene regulation during the establishment of latency and upon lytic 
reactivation. My results suggested a new classification of viral promoters and phases of gene 
regulation that depend on the epigenetic state of the viral chromatin. According to this new 
model, EBV’s infectious cycle consists of an initial abortive lytic, a latent, and a productive 
lytic phase, and the viral promoters can be classified into default-on, poised-on, and poised-off 
promoters.  
Default-on promoters are immediately active upon infection of primary B cells leading to the 
so-called abortive lytic phase of an EBV infection. Default-on promoters encounter the cell in 
an environment that supports binding of the basal transcription machinery to activate viral 
gene transcription. Default-on promoters include the promoters of BALF1, BHRF1, BZLF1, 
BRLF1, BNLF2a, BCRF1, and Wp. The protein products are indispensible for the permanent 
establishment of EBV’s genome in latently infected cells supporting growth transformation, 
immune evasion, and anti-apoptotic cellular pathways. Default-on promoters are 
epigenetically silenced upon occupancy of EBV’s DNA with nucleosomes very early after 
infection and a switch to poised-on promoters is initiated.  
                                                        
* methylated BZLF1 responsive element 
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Poised-on promoters embody an epigenetically active state upon infection, but their activation 
requires an additional, virus-encoded factor to allow initiation of transcription. Wp-induced 
expression of EBNA1 promotes the switch to the poised-on promoter Cp to sustain long-term 
EBNA expression. Other poised-on genes including the viral structural proteins are not 
provided with their cofactor initially. During latency, these promoters are repressed through 
compaction of chromatin by high nucleosome occupancy, trimethylation of H3K27, and a 
stable transmission of repressive modifications by Polycomb-mediated long-term silencing. 
The establishment of a defined DNA methylation pattern on EBV’s DNA further represses 
poised-on promoters.  
DNA methylation is a prerequisite for the activation of a third promoter class, termed default-
off promoters. Default-off promoters are bound and transactivated by BZLF1 in a 
methylation-dependent manner. Upon infection of primary B cells, EBV’s DNA is completely 
unmethylated, impeding an early expression of default-off genes. Only two to three weeks 
post infection the viral genome has acquired a proper epigenetic configuration that supports 
transcription of default-off genes. Binding of BZLF1 alone does not suffice to recruit the 
cellular transcription machinery including RNA polymerase II, but the chromatin requires 
remodeling, including a loss of nucleosomes and repressive modifications at default-off 
promoter sites. Default-off genes encode the viral lytic DNA replication machinery. The 
newly synthesized DNA templates lack epigenetic modifications because lytic DNA 
amplification is uncoupled from cellular DNA replication, eliminating the epigenetic 
maintenance mechanisms during the synthesis of viral progeny. As a consequence, default-on 
promoters and silenced poised-on promoters, which rely on unmethylated, epigenetically 
naïve templates, become also activated in the onset of the lytic phase. Silenced poised-on 
promoters require additionally a viral cofactor for their activation. This so-far unknown factor 
is probably provided upon lytic DNA amplification allowing the transcription of genes 
encoding for structural proteins that are necessary for the packaging of viral progeny. The 
released EBV progeny is epigenetically unmodified and ready to infect other cells.  
In essence, the regulation of EBV’s life cycle by epigenetic mechanisms is a paradigm for 
viral coevolution with its host. Repressive epigenetic modifications are common cellular 
defense mechanism to fight invading pathogens. EBV has hijacked this system for the 
regulation of promoter usage during its own life cycle, which has become a key principle of 
EBV’s success in infecting and persisting in its host.  
 8. ABBREVIATIONS 
5mC 5-methylcytosine 
A adenosine 
AA amino acid 
AD activation domain 
AP-1 activator protein 1 
ATP adenosine-5'-triphosphate 
BCR B cell receptor 
BL Burkitt's lymphoma 
bp base pair 
BSA bovine serum albumine 
bZIP basic leucine zipper 
C cytosine 
C-terminal carboxy-terminal 
CD  cluster of differentiation 
cDNA complementary DNA 
CENPA centromer protein A 
ChIP Chromatin Immunoprecipitation 
ChIP seq Chromatin Immunoprecipitation with subsequent genome-wide sequencing 
CMV cytomegalovirus 
CpG cytosine-phosphatidyl-guanosine 
CRE cAMP responsive element 
CTCF CCCTC-binding factor 
CTD carboxy-terminal domain 
cytC cytochrome C 
DBD DNA binding domain 
DD DNA dimerization domain 
DMSO dimethylsulfoxid 
DNA deoxyribonucleic acid 
DNase  deoxyribonuclease 
DNMT DNA methyltransferase 
dsDNA double stranded DNA 
DTT dithiothreitol 
E early 
E.coli Escherichia coli 
e.g. exempli gratia 
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EBERs EBV-encoded RNAs 
EBNA EBV-encoded nuclear antigen 
EBV Epstein-Barr virus 
ECL enhanced chemiluminescence 
EDTA ethyldiamintetraacetic acid 
ES cells embryonic stem cells 
et al. et alii 
EZH human enhancer of zeste 
f.e. for example 
Fig.  figure 
G guanosine 
GAL galactose metabolism 
GFP green fluorescent protein 
gp glycoprotein 
h hour 
H2O water 
H3 histone H3 
H3K27 histone H3 lysine 27 
H3K27me3 trimethylated histone H3 at lysine 27 
H3K4 histone H3 lysine 4 
H3K4me3 trimethylated histone H3 at lysine 4 
H3K9 histone H3 lysine 9 
H3K9me3 trimethylated histone H3 at lysine 9 
HAT histone acetyltransferase 
HDAC histone deacetylase 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HKMT histone lysine methyl transferase 
HLA human leukocyte antigen 
hmC 5-hydroxymethylcytosine 
HOX homeobox 
HP1 heterochromatin protein 1 
HRP horseradish peroxidase 
i.e. id est 
IE immediate early 
IFN interferon 
Ig immune globuline 
IL interleukin 
IM infectious mononucleosis 
INF interferon 
INO inositol 
ISWI imitation swi 
kDa kilo dalton 
KSHV Kaposi Sarcoma associated herpesvirus 
L late 
LCL lymphoblastoid cell line 
LMP latent membrane protein 
M.HhaI DNA cytosine C5 methyltransferase from Haemophilus hemolyticus 
MAP mitogen-activated protein 
MBD methyl-CpG binding domain 
MBP methyl binding protein 
MeCP methyl cytosine binding protein 
meZRE methylated BZLF1 responsive element 
MHC major histocompatibility complex 
min minute 
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miRNA microRNA 
mRNA messenger RNA 
N-terminal amino-terminal 
ncRNA noncoding RNA 
NDR nucleosome depleted region 
NFkB nuclear factor "kappa-light-chain-enhancer" of activated B cells 
NURD nucleosome remodeling factor 
ORC origin recognition complex 
oriLyt origin of lytic replication 
oriP origin of plasmid replication 
PAA polyacrylamide 
PBMCs peripheral blood mononuclear cells 
PBS phosphate buffered saline 
PCNA proliferating cell nuclear antigen  
PCR polymerase chain reaction 
PHO phosphate metabolism 
PcG Polycomb group 
PRC Polycomb repressive complex 
PRE polycomb responsive element 
PRMT1 Protein arginine N-methyltransferase 1 
RNA ribonucleic acid 
RNA Pol II RNA polymerase II 
rpm rounds per minute 
RPMI Roswell Park Memorial Institute 
RSC remodels the structure of chromatin 
RT room temperature 
RT-PCR reverse transcriptase PCR 
RTA replication and transcription activator 
s second 
S. cerevisiae Sacharomyces cerevisiae 
S. pombe Schizosaccharomyces pombe 
SDS sodium dodecyl sulfate 
SDS page SDS polyacrylamide gel electrophoresis 
SUMO small ubiquitin-like modifier 
SWI/SNF switch/sucrose nonfermentable 
T thymine 
TAP transporter associated with antigen processing 
TBP TATA box binding protein 
TEMED tetramethylendiamine 
TET ten-eleven translocation proteins 
TF transcription factor 
TRD transcriptional repressing domain 
Tris 2-amino-2-hydroxymethyl-propane-1,3-diol 
tRNA transfer RNA 
TSS transcriptonal start site 
U untis 
U uracil 
UV ultra violett 
V volt 
w/v weight per volume 
WHO world health organization 
ZRE BZLF1-responsive element 
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10. APPENDIX 
10.1 Oligonucleotides 
10.1.1 RT-PCR Primer 
Tab. A1 PCR primer pairs for reverse transcript PCR (RT-PCR)  
locus forward backward 
BZLF1  GGTTTCCGTGTGCGTCGTG  AGCCTGCTCCTGAGAATGCTT 
BBLF4 CTGGGCAAGGTGACAAATGTAATC  GAAGCAGGCGAGGCAAGAAC 
BALF4 CTGGGGGGTGAGGAAGTCG CAACACAACCGTGGGCATAGAG 
BcLF1 CCTCCCTGACCGTTCCCAG GCAGTTTGAGACCGCCACATC 
BDLF1 GCACCTCCTCTGCTATGGGC TGATACTCACCAAGATTGTTCCAGG 
gp350 ACCGAGCATTTCTGTTTTTACGC GATGTCTACTTTCAAGATGTGTTTGGAAC 
cytC CAATGCTCCGTTGTTGGCAG  CCTGGTGGGCGTGTGCTAC 
DNMT1 AAGGAGCCCGTGGATGAGG CTCGCTGGAGTGGACTTGTGG 
DNMT3a CTTGGGCATTCAGGTGGACC GCGAGCAGGGTTGACGATG 
DNMT3b TACTGCCCCGCACCCAAG GAGCCCCCCCTCAAAGAGAG 
NP95 TGCTGCTCCTCCTCCTCCC GGCAACCGCTACGATGGC 
DNMT3LF1B3 TGCGGAAGTCTCCAGGTTCAC CACAGGTAGCACACCCAGTTGC 
gusB CGCCCTGCCTATCTGTATTC TCCCCACAGGGAGTGTGTAG 
NP95neu AGATCCAGGAGCTGTTCCAC AAGAGGGTATGGCCGTCCT 
PCNA TGGAGAACTTGGAAATGGAAA GAACTGGTTCATTCATCTCTATGG 
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10.1.2 qPCR Primer 
Tab. A2 Primer pairs for qPCR analysis 
 forward backward 
Cp ACAAGGGGACAAGTGTGGCA TGACTGGTGGGGGGCATC 
EBER CGCTACATCAAACAGGACAGC AGCCGAATACCCTTCTCCCAG 
Lmp1p GAAATGGAAAGGCAGTGCGG TCACCTGAACCCCCCTAAAGC 
OriP TCAAACACTTGCCCACAAAAC GCCCACCGTGCTCTCAGC 
Qp TGTCACCACCTCCCTGATAATGTC CATACACCGTGCGAAAAGAAGC 
Wp1 GCCTAAAACCCCCAGGAAGC GACCCCCTCTTACATTTGTGT 
Wp2 CAGACAGGGGAGTGGGCTTG GATTCCTTGGAGGGGGCG 
CEN AAGGTCAATGGCAGAAAAGGA CAACGAAGGCCACAAGATGTC 
GAPDH  TACTAGCGGTTTTACGGGCG TCGAACAGGAGGAGCAGAGAGCGA 
OriLyt1 GGTCTCTGTGTAATACTTTAAGGTTTGCTC AGCCCCTCCTCCTCTCGTTATC 
BARF1 AACGCATTGTGAGGGATGGG CGGGAGGCAGGAGACACG 
BBLF3 CTGCTGTCCACCCTGGTCAAG CCCGAGGTCAGAAAGAGGCTC 
BBLF4 GTGCTACACAGCCGCTCCG CGATACTCCTGATGGTCCTCTCG 
BFRF1 TCCAGGGCACAAAGTCCTCC AACCCAGAAGACCTCACCTTGC 
BKRF4 ACTCAACACCATCCTGACCGTG CTTCTGCTGGGCACTCTTTCG 
BMLF1 GCTGACCCAGGCGACGAG TTCAAAACCTCTTACATCACTCACTGC 
BMRF1 CACACCACCCCCCAAGGAC GCAGCAGCAGAAGCCAACG 
BRLF1 CCGGCTGACATGGATTACTGG AGGAACCAAAATAACCGAGCCTC 
BSRF1 CCAAAAATAGTAAGCAGCCGTGAC GAAACAGCCACAGGGGGATG 
BVRF2 GTAAATAAACTCATCGCACGGGG TGCCTTGTCCACTGGGGTG 
BZLF1 GGTGCAATGTTTAGTGAGTTACCTGTC TGACACCAGCTTATTTTAGACACTTCTG 
BcLF1  AATCAAATGGTTGGACACGGC TCAGGGTGGGCAGAGGACC 
BDLF4 GTGTCCGTAATGGATGGGGG CAGCCAGCGACTTGGAGGG 
BLLF1 TACAAGGGGGGTGCGGTG CAGGTGGGCATCTTCTGCTTC 
BMRF1 1 TCCACGGGGAGACTTATGCTAAC GCCACCTTGTCACGGAGCC 
BMRF1 2 GCCAATAACTACATAAGTAGGGATGAGC TCTCCACGAGCCTCGATGAAG 
BMRF1 3 CACACCACCCCCCAAGGAC GCAGCAGCAGAAGCCAACG 
BMRF1 4 CCGTCCTGTCCAAGTGCTATGAC TCTGGGCTCTGGTGATTCTGC 
BMRF1 5 CGCACCTGTGTCCTGGGC CAATCATCTGCTCGTTCCTCAGC 
BBLF4 1 TCCCGTGACCAGGCAGTCC  TCCCCCGAGTTTGACCCG 
BBLF4 2 TCACGGAGGCGTCTGAGGTC TTGGCGTAGATGGTCTGTCCC 
BBLF4 3 GAGGCAGGTGTTTACCCATTTG CAGGTCACGCACGGTCAGC 
BBLF4 4 GTGCTACACAGCCGCTCCG CGATACTCCTGATGGTCCTCTCG 
BBLF4 5 TCCCCCAGTTTACGGAGGTG CATGAAAATGTTCTGGTAGAGGCG 
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10.1.3 Deep bisulfite sequencing primer 
Tab. A3 List of Primers for deep bisulfite sequencing 
The table includes the contig (Cg.), the ID, the promoter site, the start and stopp position of the PCR product, 
and the sequences for the forward and reverse primer.  
Cg. ID prom. start stopp forward (5' 3') reverse (5' 3') 
33 EBER 6303 6741 AAGGTTAGTTTGTAAGGTGGATG TAAAAAAACAACCACAAACACC  
33_3 EBER 6722 7245 TGTTTGTGGTTGTTTTTTTAGA  TATCCAAAAAACCCTATCACAA  
33_2 EBER 6726 7107 TGTGGTTGTTTTTTTAGATTT TACCCTTCTCCCAAAAAAATTA 
1 
57 OriP 7125 7441 TTTTTTGTGGTTAGTTTTGTATTT  TACAATCAACATATAATACCCAATAA  
31 OriP 8357 8930 TTGTTTTTGTTTATGGGTTTTATT AACCATTTTAATCACAAAAACAA 
2 
32 OriP 8909 9437 TGTTTTTGTGATTAAAATGGTTT CCAAACACAAAAAAATTCTCTAA 
3 50 BCRF1 9457 9946 TGGAATAGGGTTTAGTTGGTAA  ACCTATAACATAACTTCCTCCAAA 
26 Cp 11172 11522 GGGTTGGGTAAAGGGGTTT ATTAAAACCTCCTAAAAAAACCTCAA 
4 
25 Cp 11499 11982 GAGGTTTTTTTAGGAGGTTTTAA CAATAAAAAACATCTAAAACCCA 
34 Wp 14033 14379 AGTTTTGGAGGATTTTAAAATTT CCAAAAATAACTACAAAACCACT 
5 
35 Wp 14411 14918 GTAAGAGGGGGTTTTTTATTTT  ACTAACCCCCAAATTCCTATA 
46 BHLF1 49563 50128 GGTAGGGGTAAGGGTAAGTTTA AAAACACCAATTTTAACAAACC 
6 
47 BHLF1 50106 50560 AGGTTTGTTAAAATTGGTGTTT  TACCCATAAAATACTCAAACCC 
14 OriLyt 52565 52947 GTTTAGGGGTTTAGGGGGTAG CAAATACCACCCACCTAATAACA 
15 OriLyt 52925 53355 TGTTATTAGGTGGGTGGTATTT TAAAATTCCCTTCCTCTAAATTCT 
16 OriLyt 53183 53590 TTTAGTTAGGTTTTTATTGGGG TCAAAATAATACATCCCAAAAA 
7 
17 BHRF1 53567 54118 TGTTTTTGGGATGTATTATTTT CTAAAAAAAAAAATAACCCACC 
62 BFLF2 
BFLF1 
57055 57509 TTTTGGTTATTTGTGTGGATTT  CCTCCTAACCCCCATATTTAA  
63 BFLF2 
BFLF1 
57490 57881 TAAATATGGGGGTTAGGAGGTA  CTTCAAATCCATATAACCCAAAA  
64 BFLF2 
BFLF1 
57856 58547 TGGTTTTGGGTTATATGGATTT  CACCTTACCACCCAAATATATCATA  
8 
65 BFLF2 
BFLF1 
58516 58964 TGTGAGTTATGATATATTTGGGTG  AACCCAAAATCACACAAAAATA  
27 Fp/Qp 61755 62339 TGGGGTTGGTGTTTATGTAT AATCACCCAATTTCTATCTATTAAAA 
9 
28 Fp/Qp 62334 62829 GTGATTATTGAGGGAGTGTTTT AAACACAAAAACCCCAAAATA 
10 51 BORF1 74893 75254 AGGGTYGTTTTTAGATGGT AACCCCTAAACCTTCATAAC 
7 BMRF1 79351 79823 TGTTGATTGAAGGTATTTTTTTT AATAACCACCCTAACTCAAAAA 
11 
8 BMRF1 79813 80406 GGGTGGTTATTTGTTTAGGTTTT TAAACATCAACAACACCTACCC 
12 52 BMRF2 80706 81167 TTTGGTATTATAGTTGTGGTGGT AAACAAAAAACACAAACCCC 
18 BSLF2 83317 83820 AGTTATGTGTTTTTGTTGGTTGAT TTACACCAAAAACCACAAAAAA 
19 BSLF2 83809 84342 TTTTTGGTGTAAGAGGAGTTGTT  AAACCAATCAAAACAACACTACA  13 
20 BSLF2 84266 84649 GAGAGTTTTTGAGAAGGAATTATTT CTCATAAACACCCTAACAACAA 
21 BSLF2 85120 85678 TAATAGTATGGTTTTTAGGTAGGGG CAATAAAATCCCAAAAAACAA 
22 BSLF2 85250 85678 TGGGTGGGTTTTGGATAT  CCAATAAAATCCCAAAAAACA  
23 BSLF1 
/BSRF1 
86389 86862 GGGAGTTAAAGGTGTTAATGAATT  TCAAAACCCTTATAACCTCAAAC  14 
24 BSLF1 
/BSRF1 
86695 87237 GTTTTTTGGGTAGGTGAAGTTGT TTAACCACCTAAACCTCCACC  
15 53 BLLF1 91966 92291 AGATTAAGTTGATGTTTTTTGTTT  CTTCCATATTATCATCCAAAAC  
42 BZLF1 103093 103493 AGGTATTTGGTATGGGTTAGGT TAAATCTAAACTCCCCCCTAAC  
16 
41 BZLF1 103501 103856 TGTTATGGATTTTAGTGTTGTGG  ATCAACCAAAAAAAATCAAACC  
1 BRLF1 105121 105560 TTGTTTTTTGATTTTAGGAGTTAGTTT TCCTAATCAAAACCCAAAATCT 
2 BRLF1 105541 105946 ATTTTGGGTTTTGATTAGGAAAT CCATCCTAAAATATTATCCAACTACA 
3 BRLF1 105925 106503 TTGGATAATATTTTAGGATGGTATG TCCATAAAACAAACAAAAAAAAA 
17 
4 BRLF1 106487 107035 TTTGTTTGTTTTATGGAATGTT ATCCAATAACCACTAAAAACCT 
43 BBLF4 114054 114315 ATATAGGTTGAAAAGGGTAGGAA  ACTTTCCCTACAAAATCTCAAA  
44 BBLF4 114286 114714 TTYGATTTTTTGAGATTTTGTA  CCCTCAAACTCTTTATCTTAAAA  18 
45 BBLF4 114701 115165 AAAGAGTTTGAGGGATAGGTG  AACTTAACCAACAAATTCAACAA  
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Cg. ID prom. start stopp forward (5' 3') reverse (5' 3') 
11 BBLF2/3 118531 119068 GAGTATGGGGGTATGTTTGTTTT AAAAATCCAATCCTCCTCAAAT 
12 BBLF2/3 119047 119623 ATTTGAGGAGGATTGGATTTT CCAAAAAATACAAAAAATACACAAAA  
19 
13 BBLF2/3 119758 120356 TTGTATTTGGGGTGTTTTGT CATTAAAAAAAAATCTCCTCCTC 
20 54 BGRF1 124496 124945 GTGGGTTAATATTTGTAAGGTTT TACRAAACATACAACATATTCAA 
21 55 BDRF1 128721 129279 GTTGGTTTTGTGTGTTTTG ACCTCCTTCTTAATAAAATTAACC 
60 BcLF1 137428 137762 GGGGAAGGGTTTGTTTTTTATAT  ACTCCAAACTCTAAACTCCAAA  
22 
61 BcLF2 137674 137999 AATGAATGATTGTTAGGAGTTGT  AACCAACATCTTTACAAAATTTC  
9 BALF5 156458 156978 AGATATGGAAGTTTAGAGGGTTTT AAAAATCCAAACATTAATCCCA 
23 
10 BALF5 156956 157422 AATGGGATTAATGTTTGGATTT AAAACATTAACTTTACCTCCCTAAA 
5 BALF2 164666 165223 TTTTTTAAGAGGGTAGGTGGT CTCATCAAAACCTCCCTAAAA 
24 
6 BALF2 165230 165736 GAGGATTAGGGTTGGTAAAGGT AAAAAACCCCTAAAAAACCACT 
37 LMP2a 166736 167245 TTTATGAGGATTTATATTGGGGT  CCTTCAAAAAAATATCCAAAAAA  
25 
38 LMP2a 167222 167695 ATTTTTTGGATATTTTTTTGAAG  ACCTAACTCATACCAACAAAAA  
39 LMP1 169017 169496 ATTTTTAGGGAATGTTAGATTTTATT  CTCCTAACACACTACCCTAAAA  
26 
40 LMP1 169480 169772 GGGTAGTGTGTTAGGAGTAAGGT  CCTTTCCATTTCCTATTACACTTAA  
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10.2 Deep bisulfite sequencing analysis 
10.2.1 Matlab script  
1 inputfile='6303-7441.xls'; 
2 outputfile=[inputfile(1:end-4) 'out.xls']; 
3 data=xlsread(inputfile); 
4 startpos=data(1,1); 
5 data=data(3:end,2:end); 
6 dim=size(data); 
7 numlines=dim(1); 
8 numcol=dim(2); 
9 distances=[]; 
10 c=1; 
11 while c<=numcol 
12    distances=[distances data(1,c)]; 
13    c=c+2; 
14 end 
15 positions=distances; 
16 positions(1)=distances(1)+startpos+1; 
17 for c=2:length(distances) 
18    positions(c)=positions(c-1)+distances(c)+2; 
19 end 
20 positions=positions(1:end-1); 
21 meth=[]; 
22 notmeth=[]; 
23 c=2; 
24 while c<=numcol 
25    states=data(:,c); 
26    meth=[meth length(find(states==1))]; 
27    notmeth=[notmeth length(find(states==0))]; 
28    c=c+2; 
29 end 
30 percentmeth=[]; 
31 for i=1:length(meth) 
32    percentmeth(i)=meth(i)/(meth(i)+notmeth(i))*100; 
33 end 
34 both=meth+notmeth; 
35 outdata=[[1:1:length(meth)]' positions' percentmeth' both']; 
36 out=cell(0,0); 
37 out{1,1}='CpG'; 
38 out{1,2}='Position'; 
39 out{1,3}='Percent methylated'; 
40 out{1,4}='Total'; 
41 for i=1:length(meth) 
42    out{i+1,1}=outdata(i,1); 
43    out{i+1,2}=outdata(i,2); 
44    out{i+1,3}=outdata(i,3); 
45    out{i+1,4}=outdata(i,4); 
46 end 
47 xlswrite(outputfile,out); 
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10.2.2 Complete list of deep bisulfite sequencing results 
Tab. A4 Methylation state of viral CpG dinucleotides 
ID, genome location (pos.), percentage of methylation (meth.), and coverage (cov.) of all CpG positions 
analyzed. Results, which originate from LCLs are colored in yellow. A coverage below ten reads/bp is indicated 
in red. CpG dinucleotides that are not present (n.p.) in the Raji EBV genome are indicated. 
ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov. 
1  6327  0.00  73  50  7366  0.00  1  99  14115  100.00  38  148  50381  96.87  1659 
2  6348  0.00  63  51  7384  0.00  1  100  14143  91.89  37  149  50388  96.29  1670 
3  6353  0.00  90  52  8049  45.27  634  101  14161  97.44  39  150  50410  97.57  1688 
4  6389  0.00  89  53  8060  15.50  684  102  14259  97.62  42  151  50413  97.63  1690 
5  6402  1.10  91  54  8066  4.63  713  103  14261  97.62  42  152  50438  97.66  1710 
6  6408  1.92  52  55  8099  9.16  928  104  14288  95.45  44  153  50474  95.30  1744 
7  6413  1.41  71  56  8107  5.35  954  105  14290  97.73  44  154  50514  95.00  1741 
8  6427  0.00  89  57  8136  94.85  1010  106  14296  97.78  45  155  50518  97.88  1748 
9  6481  0.00  96  58  8145  86.99  1007  107  14381  n.p.  /  156  50537  93.91  1642 
10  6485  1.02  98  59  8147  75.37  1023  108  14391  n.p.  /  157  52587  97.64  127 
11  6487  0.00  98  60  8163  60.52  1031  109  14445  81.25  64  158  52589  100.00  133 
12  6504  1.03  97  61  8190  72.15  1034  110  14462  95.68  139  159  52597  100.00  144 
13  6538  0.00  92  62  8229  96.64  1131  111  14497  85.90  624  160  52599  98.61  144 
14  6565  0.00  99  63  8241  96.16  1147  112  14509  94.17  617  161  52604  96.58  146 
15  6570  0.00  101  64  8291  95.62  1255  113  14513  94.91  609  162  52610  98.69  153 
16  6575  0.99  101  65  8298  96.94  1274  114  14531  92.49  799  163  52621  95.21  167 
17  6581  0.00  102  66  8301  96.14  1271  115  14534  94.68  808  164  52623  97.60  167 
18  6637  0.97  103  67  8315  97.05  1286  116  14543  94.41  823  165  52627  92.86  168 
19  6668  0.00  100  68  8317  94.70  1284  117  14566  93.90  869  166  52643  95.86  169 
20  6688  0.00  98  69  9517  93.51  185  118  14590  83.97  923  167  52646  88.82  161 
21  6693  0.00  97  70  9519  96.30  189  119  14595  88.25  919  168  52661  0.00  2 
22  6706  1.06  94  71  9528  97.04  203  120  14604  95.82  934  169  52672  65.54  177 
23  6719  2.27  88  72  9545  95.63  206  121  14610  96.16  911  170  52698  94.12  187 
24  6757  0.68  1612  73  9580  86.88  221  122  14693  66.01  1018  171  52700  95.21  188 
25  6763  0.90  777  74  9681  98.02  252  123  14709  93.54  1021  172  52707  92.43  185 
26  6786  0.26  2286  75  9801  18.85  244  124  14731  94.78  1034  173  52727  94.23  208 
27  6836  0.49  2637  76  9830  16.48  267  125  14735  70.52  1038  174  52730  95.22  209 
28  6852  0.15  2729  77  11193  93.46  474  126  14770  79.31  1068  175  52738  97.60  208 
29  6862  0.18  2765  78  11197  59.10  489  127  14776  93.18  1071  176  52741  97.61  209 
30  6883  0.28  2827  79  11209  95.85  530  128  14790  92.76  1078  177  52746  95.24  210 
31  6893  0.18  2799  80  11220  97.23  541  129  14817  95.32  1089  178  52768  97.64  212 
32  6903  0.24  2870  81  11237  96.22  556  130  49596  97.37  38  179  52772  98.12  213 
33  6908  0.24  2883  82  11243  94.78  556  131  49604  97.44  39  180  52780  96.26  214 
34  6938  0.38  2915  83  11275  96.27  590  132  49670  35.19  54  181  52783  97.67  215 
35  6943  0.21  2916  84  11364  95.38  692  133  49727  88.61  79  182  52789  97.22  216 
36  6964  0.58  2940  85  11386  97.32  709  134  49733  62.96  81  183  52794  97.27  220 
37  6981  0.24  2951  86  11404  96.08  714  135  49753  94.57  92  184  52799  97.26  219 
38  6990  0.50  2974  87  11439  95.31  725  136  49766  97.14  105  185  52804  96.40  139 
39  6996  0.33  2989  88  11479  94.52  693  137  49786  95.80  119  186  52905  36.55  290 
40  7005  0.54  2989  89  11649  21.05  133  138  49826  93.22  118  187  52969  94.45  1711 
41  7014  0.17  2975  90  11766  92.03  138  139  49856  94.41  143  188  52993  93.47  1777 
42  7019  0.27  2936  91  11772  94.16  137  140  49868  91.03  145  189  52995  92.72  1785 
43  7032  0.21  1903  92  11778  97.04  135  141  49950  43.05  151  190  53011  85.50  1841 
44  7056  0.42  1887  93  11852  11.19  143  142  50039  26.09  161  191  53069  96.18  2040 
45  7110  1.82  220  94  14077  97.06  34  143  50094  6.33  158  192  53074  95.72  2057 
46  7119  0.46  217  95  14085  94.44  36  144  50177  86.93  1163  193  53147  5.12  2109 
47  7165  0.00  224  96  14101  92.11  38  145  50182  94.05  1211  194  53230  53.22  3322 
48  7331  0.00  1  97  14103  94.74  38  146  50223  95.28  1376  195  53248  96.28  2714 
49  7356  0.00  1  98  14105  94.74  38  147  50356  89.13  1619  196  53394  27.63  2092 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Tab. A4 (continued) Methylation state of viral CpG dinucleotides 
ID, genome location (pos.), percentage of methylation (meth.), and coverage (cov.) of all CpG positions 
analyzed. Results, which originate from LCLs are colored in yellow. A coverage below ten reads/bp is indicated 
in red. CpG dinucleotides that are not present (n.p.) in the Raji EBV genome are indicated. 
ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov. 
197  53428  70.52  2225  246  57566  64.57  1682  295  58718  94.38  427  344  62145  90.20  102 
198  53436  92.20  2256  247  57577  93.71  1733  296  58720  93.91  427  345  62148  96.08  102 
199  53446  95.47  2275  248  57580  93.52  1729  297  58759  89.38  433  346  62161  96.12  103 
200  53448  94.37  2275  249  57590  93.89  1750  298  58790  84.74  439  347  62166  96.15  104 
201  53492  96.02  2359  250  57592  94.25  1775  299  58803  94.39  446  348  62178  88.68  106 
202  53499  96.61  2359  251  57601  83.01  1783  300  58851  73.33  450  349  62208  0.00  106 
203  53538  17.09  1182  252  57625  51.06  1516  301  58865  95.19  457  350  62222  0.95  105 
204  53558  42.14  2404  253  57635  65.78  1812  302  58895  91.36  463  351  62227  2.83  106 
205  53604  20.56  107  254  57647  61.83  1842  303  58901  94.86  467  352  62230  0.93  108 
206  53611  16.39  183  255  57673  63.68  1875  304  58920  62.58  465  353  62254  0.00  108 
207  53663  93.60  297  256  57712  99.05  1690  305  58932  65.24  466  354  62272  0.91  110 
208  53681  96.01  326  257  57738  49.34  1753  306  61782  87.50  32  355  62275  0.00  109 
209  53686  97.98  346  258  57769  91.84  1778  307  61791  92.50  40  356  62282  0.91  110 
210  53692  95.94  345  259  57787  92.22  1760  308  61800  86.36  44  357  62374  0.59  170 
211  53751  22.11  502  260  57790  75.57  1764  309  61818  100.00  52  358  62384  1.30  231 
212  53777  88.81  581  261  57893  54.00  50  310  61821  90.20  51  359  62386  0.00  155 
213  53804  89.83  639  262  57904  0.00  2  311  61827  94.23  52  360  62398  0.80  251 
214  53840  92.38  682  263  57943  87.72  57  312  61836  96.15  52  361  62405  0.40  253 
215  53883  94.89  705  264  57979  81.48  54  313  61856  n.p.  /  362  62411  0.00  260 
216  53893  71.97  710  265  57993  93.22  59  314  61859  90.63  64  363  62429  0.66  303 
217  53953  30.22  771  266  58066  86.96  69  315  61865  79.69  64  364  62431  0.00  280 
218  53958  41.12  783  267  58137  86.24  109  316  61869  89.55  67  365  62439  0.00  345 
219  53981  94.58  793  268  58192  47.66  107  317  61881  81.82  77  366  62443  0.58  346 
220  53998  91.13  812  269  58222  21.49  121  318  61883  79.45  73  367  62449  0.29  343 
221  54008  87.73  815  270  58239  31.71  123  319  61918  23.94  71  368  62456  0.00  339 
222  54054  82.84  816  271  58267  55.91  127  320  61923  5.48  73  369  62506  0.31  325 
223  54096  32.74  733  272  58279  49.61  129  321  61925  8.33  72  370  62509  0.84  359 
224  57092  22.39  804  273  58307  97.64  127  322  61931  45.71  35  371  62529  1.00  100 
225  57101  12.27  823  274  58309  94.57  129  323  61937  32.47  77  372  62533  0.00  409 
226  57133  73.88  896  275  58345  93.65  126  324  61944  91.67  84  373  62552  0.00  417 
227  57143  75.22  900  276  58354  93.50  123  325  61947  92.77  83  374  62559  0.24  420 
228  57193  71.20  986  277  58378  60.00  125  326  61953  96.30  81  375  62574  1.67  420 
229  57197  83.25  985  278  58418  92.74  124  327  61956  91.67  84  376  62581  0.71  420 
230  57203  60.46  994  279  58420  93.39  121  328  61959  96.43  84  377  62586  1.68  417 
231  57235  83.68  1017  280  58441  69.49  118  329  61965  94.05  84  378  62588  1.90  421 
232  57263  96.18  1022  281  58451  47.01  117  330  61968  98.81  84  379  62590  2.38  421 
233  57317  30.75  1031  282  58480  96.43  112  331  61974  97.70  87  380  62600  3.37  415 
234  57343  87.34  1027  283  58498  85.71  126  332  61986  98.41  63  381  62605  3.31  423 
235  57373  93.50  1030  284  58504  98.41  126  333  62001  n.p.  /  382  62632  93.15  409 
236  57377  0.68  1026  285  58508  88.89  126  334  62007  97.73  88  383  62671  97.44  430 
237  57402  72.16  1020  286  58570  60.33  305  335  62012  95.45  88  384  62673  96.06  431 
238  57421  57.32  1024  287  58576  93.23  310  336  62014  95.45  88  385  62675  96.05  430 
239  57425  88.09  1016  288  58597  94.94  336  337  62016  1.28  78  386  62678  97.19  427 
240  57436  79.53  1031  289  58629  45.72  339  338  62023  92.05  88  387  62690  92.24  438 
241  57445  95.08  1037  290  58637  0.00  353  339  62044  18.89  90  388  62693  79.86  437 
242  57465  72.94  1031  291  58646  92.54  268  340  62104  36.17  94  389  62696  67.65  439 
243  57521  94.68  1411  292  58669  89.34  366  341  62113  94.12  102  390  62702  50.92  436 
244  57529  94.57  1528  293  58691  92.29  402  342  62121  93.20  103  391  62704  52.74  438 
245  57539  95.67  1549  294  58705  97.62  421  343  62133  93.20  103  392  62718  2.59  425 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Tab. A4 (continued) Methylation state of viral CpG dinucleotides 
ID, genome location (pos.), percentage of methylation (meth.), and coverage (cov.) of all CpG positions 
analyzed. Results, which originate from LCLs are colored in yellow. A coverage below ten reads/bp is indicated 
in red. CpG dinucleotides that are not present (n.p.) in the Raji EBV genome are indicated. 
ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov. 
393  62724  0.90  443  442  79561  93.02  673  491  80999  95.10  4369  540  84240  83.47  242 
394  62728  3.83  444  443  79586  61.73  682  492  81029  73.44  4375  541  84263  93.90  246 
395  62731  7.74  439  444  79593  37.04  683  493  81031  71.98  4389  542  84303  93.66  584 
396  62735  3.84  443  445  79623  96.74  705  494  81046  93.79  4431  543  84306  93.59  577 
397  62741  0.00  7  446  79651  96.35  713  495  81049  95.41  4424  544  84367  85.56  381 
398  62747  13.86  440  447  79655  95.51  712  496  81125  14.02  4030  545  84373  94.55  404 
399  62761  11.29  443  448  79659  95.10  715  497  83356  88.04  443  546  84391  94.71  416 
400  62777  94.43  449  449  79699  54.38  730  498  83377  94.91  609  547  84395  93.79  419 
401  74898  83.73  1518  450  79720  47.76  735  499  83384  80.34  590  548  84414  96.24  425 
402  74912  73.59  1882  451  79775  16.47  771  500  83429  94.48  870  549  84418  95.77  426 
403  74918  87.16  1901  452  79872  27.27  11  501  83436  91.92  928  550  84421  94.81  424 
404  74926  94.14  1912  453  79920  7.69  13  502  83445  88.54  951  551  84446  93.04  431 
405  74943  94.13  1960  454  79943  4.55  22  503  83457  63.22  949  552  84527  91.40  442 
406  74947  95.11  1962  455  80034  n.p.  /  504  83556  65.29  1190  553  84543  46.88  433 
407  74963  80.98  1972  456  80042  92.45  53  505  83565  9.09  11  554  84574  91.87  443 
408  74971  96.65  1970  457  80045  98.11  53  506  83584  94.30  1229  555  84587  74.89  462 
409  74979  96.20  1976  458  80054  79.63  54  507  83595  90.48  1240  556  85153  83.92  3115 
410  74982  95.70  1975  459  80062  3.64  55  508  83618  92.82  1282  557  85155  94.26  3120 
411  74985  94.87  1967  460  80066  10.71  56  509  83626  0.00  7  558  85172  66.75  2271 
412  74993  94.33  1974  461  80081  6.52  46  510  83638  95.40  1304  559  85211  92.12  3593 
413  74999  93.46  1971  462  80096  4.76  63  511  83665  56.90  1327  560  85216  95.01  3666 
414  75029  0.00  15  463  80105  0.00  63  512  83685  32.42  1351  561  85219  92.96  3665 
415  75031  96.61  2003  464  80140  1.37  73  513  83724  0.00  19  562  85278  94.43  4994 
416  75042  96.30  1998  465  80144  2.78  72  514  83736  75.25  1305  563  85281  96.69  5022 
417  75093  97.19  2029  466  80147  1.35  74  515  83749  96.80  1470  564  85290  97.25  5135 
418  75095  97.34  2029  467  80171  5.13  78  516  83752  90.57  1474  565  85302  95.60  5176 
419  75097  98.32  2028  468  80175  1.25  80  517  83771  97.22  1475  566  85305  95.90  5152 
420  75103  96.94  2023  469  80209  1.19  84  518  83792  95.98  1442  567  85309  90.05  5154 
421  75107  95.77  2035  470  80244  0.00  88  519  83794  95.03  1469  568  85314  95.19  5202 
422  75110  96.52  2009  471  80262  0.00  82  520  83797  92.30  1468  569  85340  39.33  5151 
423  75116  79.41  2045  472  80327  1.77  113  521  83846  57.89  19  570  85394  82.72  5520 
424  75139  95.71  2050  473  80350  1.89  106  522  83852  63.64  22  571  85401  86.87  5512 
425  75141  97.18  2055  474  80357  3.45  116  523  83872  51.67  60  572  85422  95.24  5520 
426  75146  93.47  2051  475  80372  0.86  116  524  83928  69.37  111  573  85441  94.75  5528 
427  75148  96.63  2046  476  80729  28.24  2737  525  83934  83.05  118  574  85499  73.89  5585 
428  75152  84.31  2052  477  80740  39.40  2855  526  83954  30.30  132  575  85512  93.50  5526 
429  75161  86.53  1960  478  80746  59.23  2813  527  83965  0.69  145  576  85523  58.35  5479 
430  75188  53.51  2052  479  80758  87.07  3025  528  83978  78.81  151  577  85534  40.40  5520 
431  75200  98.69  1992  480  80789  95.55  3239  529  83985  86.39  147  578  85541  78.89  5406 
432  75206  95.33  2057  481  80795  96.40  3248  530  84047  99.48  194  579  85567  95.43  5468 
433  75209  94.65  2055  482  80803  97.08  3286  531  84071  95.98  224  580  85616  96.48  5402 
434  75230  95.02  2009  483  80807  95.72  3438  532  84096  88.11  227  581  85623  96.23  5404 
435  75234  93.88  1992  484  80815  96.44  3483  533  84101  80.70  228  582  85635  96.86  5155 
436  79404  89.73  292  485  80844  85.86  3691  534  84177  85.36  239  583  85642  94.69  5030 
437  79410  88.82  170  486  80877  17.04  4060  535  84187  60.70  229  584  86420  91.72  640 
438  79476  88.44  545  487  80890  32.17  4140  536  84195  92.47  239  585  86431  97.45  667 
439  79478  96.08  561  488  80914  87.15  3899  537  84201  92.50  240  586  86433  97.46  669 
440  79521  88.50  626  489  80947  93.41  4202  538  84212  93.85  244  587  86442  94.92  649 
441  79554  92.41  659  490  80968  83.42  4211  539  84231  95.10  245  588  86445  95.13  678 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Tab. A4 (continued) Methylation state of viral CpG dinucleotides 
ID, genome location (pos.), percentage of methylation (meth.), and coverage (cov.) of all CpG positions 
analyzed. Results, which originate from LCLs are colored in yellow. A coverage below ten reads/bp is indicated 
in red. CpG dinucleotides that are not present (n.p.) in the Raji EBV genome are indicated. 
ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov. 
589  86458  93.27  683  638  87035  93.69  206  687  105513  24.93  726  736  106836  53.23  124 
590  86469  96.64  715  639  87041  94.69  207  688  105518  44.49  717  737  106859  96.15  130 
591  86477  91.03  736  640  87046  93.30  209  689  105535  45.40  718  738  106862  83.97  131 
592  86482  94.99  739  641  87108  91.51  212  690  105566  96.53  1614  739  106866  89.31  131 
593  86484  95.02  743  642  87139  91.43  210  691  105613  96.10  1767  740  106876  94.57  129 
594  86518  95.67  785  643  87162  91.24  217  692  105625  94.82  1797  741  106889  0.79  126 
595  86539  92.33  795  644  87176  97.63  211  693  105630  96.91  1815  742  106904  93.70  127 
596  86546  97.00  800  645  87184  89.05  210  694  105643  96.76  1823  743  106913  98.45  129 
597  86552  97.76  802  646  87187  96.65  209  695  105646  95.83  1823  744  106925  95.35  129 
598  86556  97.26  803  647  87191  97.14  210  696  105676  96.42  1873  745  106929  91.54  130 
599  86567  94.15  803  648  87193  95.24  210  697  105678  95.57  1873  746  114086  73.97  726 
600  86569  95.91  806  649  87209  88.83  206  698  105689  96.51  1893  747  114095  62.03  748 
601  86571  96.79  810  650  91991  97.08  342  699  105720  63.98  1921  748  114106  52.16  740 
602  86592  92.18  818  651  91997  90.31  351  700  105726  90.98  1928  749  114116  79.74  844 
603  86597  96.93  815  652  92025  86.11  396  701  105756  83.65  1945  750  114128  91.29  873 
604  86599  96.82  817  653  92061  21.29  404  702  105760  95.07  1948  751  114142  93.66  883 
605  86606  98.16  817  654  92097  15.99  444  703  105777  88.93  1970  752  114144  95.48  885 
606  86609  95.72  818  655  92159  96.69  484  704  105781  95.69  1971  753  114147  94.14  888 
607  86617  96.95  819  656  92165  95.47  486  705  105788  95.55  1978  754  114180  95.77  923 
608  86619  96.46  819  657  92208  97.23  541  706  105790  97.36  1972  755  114187  92.96  923 
609  86642  96.45  789  658  92259  18.35  545  707  105839  94.17  2041  756  114193  92.22  925 
610  86645  95.06  809  659  92268  10.73  410  708  105904  7.54  2016  757  114218  84.99  946 
611  86657  91.40  814  660  103138  16.67  180  709  105950  72.40  250  758  114224  91.97  946 
612  86671  95.93  811  661  103181  97.84  185  710  105994  95.48  310  759  114230  90.27  946 
613  86676  93.12  814  662  103272  4.29  233  711  106000  96.96  329  760  114239  93.11  944 
614  86694  93.75  816  663  103467  2.50  80  712  106017  95.82  359  761  114245  86.03  945 
615  86725  93.39  938  664  103530  0.40  494  713  106042  94.38  480  762  114253  87.37  942 
616  86735  95.12  942  665  103544  0.36  558  714  106129  82.52  715  763  114274  55.28  937 
617  86740  76.43  946  666  103552  0.78  387  715  106185  87.89  743  764  114277  80.75  935 
618  86753  83.39  963  667  103638  13.97  981  716  106229  87.14  824  765  114283  66.49  934 
619  86758  94.34  971  668  103686  91.01  990  717  106238  95.25  842  766  114288  43.76  962 
620  86781  95.70  976  669  103698  96.16  808  718  106276  81.52  844  767  114317  91.41  198 
621  86791  93.24  976  670  103705  49.03  1077  719  106293  95.87  848  768  114323  83.42  199 
622  86799  96.02  980  671  103726  96.55  1132  720  106324  71.62  821  769  114344  92.95  312 
623  86801  94.09  981  672  103735  94.82  1140  721  106376  89.36  846  770  114354  95.45  330 
624  86815  83.11  983  673  103746  89.50  1219  722  106434  95.35  860  771  114362  93.55  341 
625  86828  95.89  974  674  103750  95.50  1244  723  106436  96.61  855  772  114373  92.18  358 
626  86866  91.14  158  675  103802  92.89  1576  724  106457  68.46  764  773  114402  88.01  392 
627  86869  92.54  134  676  103813  26.06  1558  725  106541  87.50  32  774  114421  95.98  423 
628  86875  96.77  155  677  103821  25.16  1391  726  106556  93.18  44  775  114425  97.64  424 
629  86892  78.62  159  678  105209  89.54  478  727  106559  88.89  45  776  114431  89.12  432 
630  86905  84.05  163  679  105256  25.00  552  728  106576  64.15  53  777  114455  61.52  434 
631  86908  48.97  145  680  105292  14.29  602  729  106634  28.95  76  778  114474  95.31  448 
632  86922  88.55  166  681  105298  9.56  607  730  106647  88.61  79  779  114481  83.74  449 
633  86949  83.67  196  682  105304  10.08  615  731  106655  87.18  78  780  114485  98.02  454 
634  86956  94.85  194  683  105406  89.44  682  732  106660  58.23  79  781  114493  87.42  453 
635  86975  97.51  201  684  105479  32.13  722  733  106687  77.91  86  782  114499  97.37  457 
636  87012  94.09  203  685  105487  41.24  725  734  106691  95.40  87  783  114504  93.22  457 
637  87030  92.20  205  686  105490  31.22  724  735  106742  87.50  96  784  114510  85.81  458   
  APPENDIX  136 
Tab. A4 (continued) Methylation state of viral CpG dinucleotides 
ID, genome location (pos.), percentage of methylation (meth.), and coverage (cov.) of all CpG positions 
analyzed. Results, which originate from LCLs are colored in yellow. A coverage below ten reads/bp is indicated 
in red. CpG dinucleotides that are not present (n.p.) in the Raji EBV genome are indicated. 
ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov. 
785  114524  46.29  458  834  118747  96.77  31  883  119438  81.25  16  932  124738  87.42  946 
786  114529  42.58  458  835  118750  90.91  33  884  119452  100.00  16  933  124746  93.90  951 
787  114538  23.14  458  836  118756  100.00  33  885  119465  87.50  16  934  124753  69.77  956 
788  114554  50.98  459  837  118759  69.70  33  886  119483  50.00  16  935  124792  16.15  997 
789  114558  38.66  463  838  118780  47.06  34  887  119495  76.47  17  936  124814  16.87  1002 
790  114585  95.27  465  839  118785  88.57  35  888  119514  73.33  15  937  124837  26.85  1002 
791  114600  92.74  468  840  118797  88.57  35  889  119583  77.78  18  938  124841  18.17  1007 
792  114605  95.07  467  841  118806  97.06  34  890  119594  100.00  11  939  124890  95.48  1039 
793  114621  81.20  468  842  118822  91.18  34  891  119786  100.00  9  940  124894  78.52  1043 
794  114641  90.27  473  843  118829  88.57  35  892  119798  100.00  12  941  124901  95.56  1036 
795  114647  96.60  470  844  118835  88.89  36  893  119805  83.33  12  942  124909  94.91  1041 
796  114659  95.10  469  845  118837  88.89  36  894  119865  88.89  27  943  124918  95.97  1043 
797  114662  91.45  468  846  118846  56.67  30  895  119909  84.00  25  944  124928  95.77  1041 
798  114722  90.76  249  847  118871  94.59  37  896  119935  67.65  34  945  124930  95.56  1037 
799  114729  80.83  240  848  118874  94.74  38  897  119958  95.45  44  946  128741  95.12  41 
800  114743  61.76  272  849  118894  74.36  39  898  119970  96.30  54  947  128748  80.39  51 
801  114764  94.18  275  850  118909  72.50  40  899  120006  93.44  61  948  128764  94.29  70 
802  114769  93.13  291  851  118930  100.00  40  900  120012  93.85  65  949  128767  93.06  72 
803  114787  83.95  299  852  118939  87.50  40  901  120024  95.71  70  950  128779  89.25  93 
804  114805  91.48  317  853  118949  85.37  41  902  120080  53.52  71  951  128805  96.19  105 
805  114817  88.47  321  854  118959  95.12  41  903  120106  n.p.  /  952  128844  92.86  126 
806  114835  95.72  327  855  118966  90.00  40  904  120124  94.59  74  953  128862  93.23  133 
807  114848  90.38  343  856  118994  80.49  41  905  120152  93.42  76  954  128871  92.59  135 
808  114859  93.47  352  857  119002  n.p.  /  906  120158  96.10  77  955  128895  29.37  126 
809  114866  90.83  360  858  119004  50.00  40  907  120185  80.52  77  956  128917  35.42  144 
810  114869  62.36  364  859  119014  97.50  40  908  120200  89.61  77  957  128944  72.15  158 
811  114894  95.03  382  860  119021  92.31  39  909  120202  93.42  76  958  128957  48.43  159 
812  114897  94.76  382  861  119023  92.50  40  910  120206  92.00  75  959  128974  87.27  165 
813  114925  81.77  384  862  119078  100.00  3  911  120216  90.79  76  960  128990  96.86  159 
814  114938  96.95  393  863  119084  33.33  3  912  120220  98.68  76  961  128992  93.64  173 
815  114943  95.18  394  864  119130  100.00  4  913  120226  98.72  78  962  129005  87.15  179 
816  114953  93.18  396  865  119159  57.14  7  914  120229  100.00  78  963  129029  95.72  187 
817  114961  75.13  398  866  119163  100.00  7  915  120232  98.72  78  964  129064  71.88  192 
818  114969  89.11  404  867  119174  100.00  6  916  120242  75.32  77  965  129105  90.10  202 
819  114999  94.65  411  868  119186  100.00  8  917  120282  61.84  76  966  129110  90.82  207 
820  115003  67.31  413  869  119219  100.00  10  918  120300  91.03  78  967  129116  90.34  207 
821  115039  42.51  414  870  119222  80.00  10  919  120309  96.20  79  968  129118  95.65  207 
822  115058  78.88  412  871  119238  100.00  10  920  120317  100.00  73  969  129126  93.24  207 
823  115067  85.71  385  872  119277  92.31  13  921  120323  97.22  72  970  129130  97.56  205 
824  115074  72.90  428  873  119292  100.00  12  922  120326  93.94  66  971  129193  88.84  215 
825  115122  83.49  436  874  119342  93.75  16  923  120333  95.45  66  972  129221  91.83  208 
826  118564  57.14  7  875  119357  93.75  16  924  124550  94.81  636  973  129253  28.64  206 
827  118570  90.91  11  876  119360  93.75  16  925  124557  95.52  647  974  137500  20.32  1378 
828  118602  64.29  14  877  119394  100.00  16  926  124626  86.43  781  975  137533  81.45  1547 
829  118616  87.50  16  878  119396  87.50  16  927  124631  57.97  790  976  137549  93.32  1588 
830  118690  100.00  25  879  119403  100.00  16  928  124671  13.36  876  977  137569  64.98  1622 
831  118693  100.00  26  880  119421  100.00  16  929  124706  28.32  925  978  137604  13.13  1676 
832  118707  96.00  25  881  119427  93.75  16  930  124726  80.79  937  979  137632  94.47  1718 
833  118713  68.00  25  882  119430  93.75  16  931  124734  90.58  945  980  137634  90.79  1716   
  APPENDIX  137 
Tab. A4 (continued) Methylation state of viral CpG dinucleotides 
ID, genome location (pos.), percentage of methylation (meth.), and coverage (cov.) of all CpG positions 
analyzed. Results, which originate from LCLs are colored in yellow. A coverage below ten reads/bp is indicated 
in red. CpG dinucleotides that are not present (n.p.) in the Raji EBV genome are indicated. 
ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov. 
981  137639  96.67  1710  1030  157009  98.39  62  1079  165109  9.08  804  1128  165424  11.63  3372 
982  137648  95.71  1724  1031  157015  90.74  54  1080  165111  11.93  805  1129  165453  9.23  4451 
983  137651  92.87  856  1032  157034  95.24  63  1081  165118  12.30  805  1130  165473  20.05  4503 
984  137662  79.02  1735  1033  157043  95.24  63  1082  165132  13.88  814  1131  165475  13.56  4500 
985  137665  94.50  1744  1034  157053  92.31  65  1083  165136  11.84  819  1132  165518  20.63  4950 
986  137672  95.49  1753  1035  157055  96.92  65  1084  165140  7.33  818  1133  165551  21.66  5119 
987  137701  59.87  5774  1036  157059  93.85  65  1085  165154  7.25  745  1134  165554  14.50  5173 
988  137721  95.71  6148  1037  157064  96.92  65  1086  165160  6.83  805  1135  165569  32.09  4132 
989  137728  92.85  6248  1038  157094  92.75  69  1087  165182  15.49  768  1136  165585  20.73  5441 
990  137773  69.90  4322  1039  157120  92.86  70  1088  165184  14.70  796  1137  165623  9.94  5613 
991  137803  16.82  4381  1040  157123  95.77  71  1089  165225  75.00  4  1138  165687  19.58  5915 
992  137817  77.73  3804  1041  157184  33.77  77  1090  165267  15.55  2874  1139  165698  8.82  5919 
993  137842  86.21  4548  1042  157216  75.32  77  1091  165278  17.97  5020  1140  166764  0.00  3 
994  137850  65.34  4536  1043  157249  86.84  76  1092  165280  20.78  5134  1141  166768  0.00  3 
995  137865  55.35  4600  1044  157255  84.21  76  1093  165325  13.50  6103  1142  166775  0.00  3 
996  137879  96.81  4696  1045  157270  89.33  75  1094  165329  19.59  6170  1143  166830  0.00  16 
997  137891  97.67  4720  1046  157299  93.06  72  1095  165332  15.96  6290  1144  166833  0.00  18 
998  137918  96.89  4893  1047  157306  94.81  77  1096  165335  16.23  6363  1145  166842  0.00  19 
999  137926  96.21  4992  1048  157309  93.51  77  1097  165341  22.95  6518  1146  166870  3.03  33 
1000  137939  97.34  5009  1049  157319  97.37  76  1098  165343  16.88  6551  1147  166896  12.82  39 
1001  137941  97.48  5009  1050  157338  94.44  72  1099  165350  21.42  6644  1148  166904  0.00  38 
1002  137949  95.97  4985  1051  157363  55.41  74  1100  165355  17.70  6361  1149  166979  0.00  47 
1003  137951  96.69  4983  1052  157374  60.81  74  1101  165359  19.48  6324  1150  166989  0.00  47 
1004  137954  97.14  70  1053  157381  82.43  74  1102  165409  21.56  7866  1151  167064  3.92  51 
1005  137976  0.04  4887  1054  157386  55.71  70  1103  165424  11.18  6787  1152  167086  0.00  54 
1006  156482  87.50  56  1055  164710  11.00  200  1104  165453  9.02  8915  1153  167103  1.89  53 
1007  156498  94.52  73  1056  164714  8.17  208  1105  165473  19.71  9046  1154  167108  1.96  51 
1008  156507  92.59  81  1057  164720  7.69  247  1106  165475  13.69  9042  1155  167113  0.00  55 
1009  156523  91.26  103  1058  164749  18.45  206  1107  165518  20.90  9973  1156  167117  0.00  55 
1010  156529  89.57  115  1059  164785  12.59  405  1108  165551  21.43  10346  1157  167130  0.00  55 
1011  156554  71.01  69  1060  164790  14.98  327  1109  165554  14.39  10425  1158  167132  0.00  55 
1012  156570  64.84  128  1061  164832  9.77  532  1110  165569  31.86  8350  1159  167140  7.02  57 
1013  156613  89.24  158  1062  164897  2.94  613  1111  165585  20.23  10990  1160  167149  1.75  57 
1014  156632  95.51  156  1063  164902  6.13  620  1112  165623  9.34  11298  1161  167166  89.29  56 
1015  156635  93.29  164  1064  164913  8.95  637  1113  165687  19.35  11908  1162  167172  87.50  56 
1016  156667  92.51  187  1065  164921  4.59  653  1114  165698  8.76  11921  1163  167179  94.44  54 
1017  156740  94.17  206  1066  164935  13.56  671  1115  165267  14.99  1421  1164  167189  100.00  52 
1018  156781  93.49  215  1067  164945  14.04  698  1116  165278  17.54  2492  1165  167197  90.74  54 
1019  156784  98.62  218  1068  164961  13.13  731  1117  165280  20.40  2549  1166  167248  95.42  502 
1020  156787  96.80  219  1069  164983  11.32  751  1118  165325  13.15  3058  1167  167251  96.53  518 
1021  156799  67.27  220  1070  164998  5.97  770  1119  165329  19.75  3083  1168  167261  95.19  561 
1022  156807  94.71  227  1071  165004  6.89  769  1120  165332  15.99  3139  1169  167286  14.73  577 
1023  156816  96.51  229  1072  165007  8.09  766  1121  165335  16.39  3172  1170  167290  22.54  639 
1024  156831  20.09  234  1073  165033  11.04  761  1122  165341  23.06  3252  1171  167375  95.55  741 
1025  156874  92.74  248  1074  165038  6.96  776  1123  165343  16.57  3271  1172  167387  96.14  725 
1026  156878  92.34  248  1075  165075  5.93  792  1124  165350  21.30  3314  1173  167415  96.88  769 
1027  156923  95.31  256  1076  165077  4.40  795  1125  165355  17.83  3186  1174  167426  95.76  779 
1028  157000  96.77  62  1077  165088  11.78  798  1126  165359  19.27  3145  1175  167435  95.01  781 
1029  157006  87.10  62  1078  165097  10.17  806  1127  165409  22.27  3933  1176  167467  89.00  791 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Tab. A4 (continued) Methylation state of viral CpG dinucleotides 
ID, genome location (pos.), percentage of methylation (meth.), and coverage (cov.) of all CpG positions 
analyzed. Results, which originate from LCLs are colored in yellow. A coverage below ten reads/bp is indicated 
in red. CpG dinucleotides that are not present (n.p.) in the Raji EBV genome are indicated. 
ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov.  ID  pos.  meth.  cov. 
1177  167477  6.94  792  1186  169150  97.14  70  1195  169550  8.22  657  1204  169645  59.15  541 
1178  167489  0.76  791  1187  169348  1.39  72  1196  169556  6.96  661  1205  169648  46.37  537 
1179  167512  8.36  718  1188  169370  5.88  68  1197  169567  25.42  657  1206  169669  13.21  477 
1180  167571  90.71  807  1189  169425  2.17  46  1198  169569  16.95  655  1207  169691  4.26  517 
1181  167642  95.77  804  1190  169434  2.00  50  1199  169591  3.05  459  1208  169712  1.99  453 
1182  167659  64.17  801  1191  169437  4.08  49  1200  169603  19.02  552  1209  169720  1.64  61 
1183  169054  86.15  65  1192  169439  0.00  45  1201  169613  21.29  559  1210  169742  0.23  440 
1184  169093  90.00  70  1193  169445  8.33  48  1202  169624  33.94  548         
1185  169111  94.29  70  1194  169465  n.p.  /  1203  169639  82.53  538 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10.3 Nucleosome occupancies at BZLF1 responsive 
promoters 
Tab. A5 List of ZREs that were part of the MND-on-ChIP analysis 
The ZREs and meZREs had to be at least 1500bp apart from each other in the 
EBV genome. In promoters that encompass more than one ZRE, the position 
with the strongest binding of BZLF1 was chosen. 
ID  ZRE type start of ZRE end of ZRE EBV genome feature 
1 meZRE 2531 2538 BNRF1 reading frame 
2 meZRE 4275 4282 BNRF1 reading frame 
3 ZRE 9159 9166 BCRF1 reading frame 
4 ZRE 49288 49295 n.o.s. 
10 ZRE 53630 53636 oriLyt 
12 meZRE 56777 56784 BFLF2 promoter 
14 ZRE 58518 58524 BFLF1 promoter 
16 meZRE 64602 64609 BPLF1 reading frame 
19 meZRE 77941 77948 Barf1 promoter 
21 ZRE 79760 79766 BMRF1 promoter 
24 meZRE 84646 84653 BMLF1 promoter 
26 meZRE 86548 86555 BSRF1 promoter 
28 meZRE 91000 91007 BLLF1 reading frame 
29 ZRE 93977 93984 n.o.s. 
30 ZRE 97961 97968 n.o.s. 
31 ZRE 103303 103311 BZLF1 promoter 
34 meZRE 106372 106378 BRLF1 promoter 
36 ZRE 110108 110115 BKRF3 promoter 
38 meZRE 114495 114502 BBLF4 promoter 
40 meZRE 119796 119803 BBLF2 promoter 
41 ZRE 122476 122483 BGLF5 promoter 
42 meZRE 126796 126803 BGLF2 promoter 
44 ZRE 129593 129600 BDLF4 promoter 
45 ZRE 131379 131386 BDLF3 promoter 
47 ZRE 137155 137162 n.o.s. 
48 ZRE 145154 145131 BVRF1 promoter 
51 ZRE 148198 148205 BdRF1 promoter 
52 ZRE 150517 150524 BILF2 promoter 
54 ZRE 152264 152271 n.o.s. 
55 meZRE 155182 155189 BALF5 reading frame 
56 meZRE 156993 157000 BALF5 promoter 
59 meZRE 167567 167574 BNLF2a/b promoter 
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